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ABSTRACT
CLIENT CHARACTERISTICS AND TREATMENT RETENTION IN AN
OUTPATIENT DRUG-FREE CHEMICAL
DEPENDENCY PROGRAM

Jessica A. Thull, B. A., M.A.
Marquette University, 2009

Substance abuse and dependence have detrimental effects at both micro and
macro societal levels. Even so, these disorders appear to be amenable to treatment and
persons who receive treatment for such problems generally achieve positive outcomes.
However, reported substance abuse treatment dropout rates have varied greatly and no
consistent “treatment dropout” profile has been detected. This study aimed to describe the
characteristics of clients entering an intensive outpatient chemical dependency treatment
program and to examine how these variables differed between clients who were retained
in treatment to completion and clients who dropped out of treatment prematurely.
Additionally, it explored whether meaningful subgroups of this sample could be
identified. Results indicated that age, marital status, income, psychological comorbidity,
substance(s) of use, and extent of substance use were related to treatment retention.
Cluster analysis findings delineated four subgroups of clients based on age, negative
consequences related to substance use, and ASI composite scores across medical,
employment, alcohol and drug, legal, social, and psychiatric domains. Identified
subgroups appeared to vary along two broad dimensions: degree of functional
impairment and type(s) of substance use. Results are compared and contrasted with the
existing substance abuse treatment literature. Study limitations are discussed, along with
implications regarding theory building, assessment, and treatment interventions. Future
investigations at the individual program level are recommended to guide the design,
implementation, and evaluation of clinically-relevant and empirically-driven assessment
procedures and treatment interventions to enhance substance abuse treatment retention
and outcomes within a particular program.
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Chapter I: Introduction

Substance Use Disorders in the United States
Definition of Substance Use Disorders
Substance use disorders have typically been defined as either symptom-based or
diagnosis-based. Symptom-based conceptualizations focus on the types and severity of
problems related to the use of a particular substance, while diagnosis-based descriptions
are based on whether or not a person meets a specified set of criteria generally associated
with the use of a particular substance (Sobell, Wagner, & Sobell, 2003). Practitioners and
researchers have tended to utilize the diagnostic classification of substance use disorders
to maintain consistency in their clinical nomenclature. This study will use the term
substance use disorder when referring to one of the two categories of substance-related
disorders delineated in the Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition, Text-Revision (DSM-IV-TR): substance abuse and substance dependence
(American Psychiatric Association, 2000).
The DSM-IV diagnostic criteria for substance abuse are:
A. A maladaptive pattern of substance use leading to clinically significant
impairment or distress, as manifested by one (or more) of the following,
occurring within a 12 month period:
(1) recurrent substance use resulting in a failure to fulfill major role
obligations at work, school or home (e.g., repeated absences or poor work
performance related to substance use; substance-related absences,
suspensions, or expulsions from school; neglect of children or household)
(2) recurrent substance use in situations in which it is physically hazardous
(e.g., driving an automobile or operating a machine when impaired by
substance use)
(3) recurrent substance-related legal problems (e.g., arrests for substancerelated disorderly conduct)
(4) continued substance use despite having persistent or recurrent social or
interpersonal problems caused or exacerbated by the effects of the
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substance (e.g., arguments with spouse about consequences of
intoxication, physical fights)
B. The symptoms have never met the criteria for Substance Dependence for this
class of substance. (APA, 2000, p. 199)
The DSM-IV diagnostic criteria for substance dependence are:
A maladaptive pattern of substance use, leading to clinically significant
impairment or distress, as manifested by three (or more) of the following,
occurring at any time in the same 12-month period:
(1) tolerance, as defined by either of the following:
(a) a need for markedly increased amounts of the substance to
achieve intoxication or desired effect
(b) markedly diminished effect with continued use of the same
amount of the substance
(2) withdrawal, as manifested by either of the following:
(a) the characteristic withdrawal syndrome for the substance [For
example, with alcohol withdrawal, two or more of the following
symptoms are necessary: autonomic hyperactivity, increased hand
tremor, insomnia, psychomotor agitation, anxiety, nausea or
vomiting; and rarely, grand mal seizures or transient visual, tactile,
or auditory hallucinations or illusions.]
(b) the same or closely related substance is taken to relieve or
avoid withdrawal symptoms
(3) substance is often taken in larger amounts or over a longer period than
intended
(4) there is persistent desire or unsuccessful efforts to cut down or control
the substance use
(5) a great deal of time is spent in activities necessary to obtain the
substance, use the substance, or recover from its effects
(6) important social, occupational, or recreational activities are given up or
reduced because of substance use
(7) the substance use is continued despite knowledge of having a
persistent or recurrent physical or psychological problem that is likely to
have been caused or exacerbated by the substance (e.g., current cocaine
use despite recognition of cocaine-induced depression, or continued
drinking despite recognition that an ulcer was made worse by alcohol
consumption). (APA, 2000, p. 197)
Prevalence of Substance Use Disorders
The annual National Survey on Drug Use and Health (NSDUH) is the primary
source of statistical information on the use of alcohol and illicit drugs in the civilian, noninstitutionalized population of the United States aged 12 years old or older (Substance
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Abuse and Mental Health Services Administration [SAMHSA], 2007). The most recent
NSDUH survey estimated that 22.6 million persons met criteria for a
substance use disorder in the past year. Of these, 3.2 million were
classified with dependence on or abuse of both alcohol and illicit
drugs, 3.8 million were dependent on or abused illicit drugs but not
alcohol, and 15.6 million were dependent on or abused alcohol but not
illicit drugs. These estimates have remained relatively stable since
2002 (SAMHSA, 2007).
The Cost of Substance Use Disorders
Estimates of annual overall economic costs of substance abuse and dependence in
the United States, including health- and crime-related costs as well as losses in
productivity, approach approximately $185 billion for alcohol and $181 billion for illicit
drugs (Harwood, 2000; Office of National Drug Policy, 2004). Detrimental societal
consequences include, though are not limited to, the spread of infectious disease, deaths
due to drug and alcohol use complications, effects of use on unborn children of pregnant
substance users, child abuse and neglect, accidents, homelessness, diminished work
productivity, and crime (Harwood, 2000; Office of National Drug Policy, 2004).
Considering the extent of this burden, which permeates the lives of substance users, the
family systems they are a part of, the communities they live in, the health care system,
the criminal justice system, and the economy, substance use disorders are of great public
concern (Fletcher, Tims, & Brown, 1997; Simpson, 1993).
The Value of Substance Abuse Treatment
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An upside to this seemingly dim state of affairs is that substance abuse treatment
evaluation studies conducted over the past 40 years have consistently found that
treatment “works.” In other words, when treatment is delivered to clients seeking services
for substance use problems, alcohol and drug use decreases, engagement in crime is
reduced, and other social functioning measures improve during and following treatment
(Anton et al., 2006; Hubbard, Craddock, Flynn, Anderson, & Etheridge, 1997; Hubbard
et al., 1989; Moyer & Finney, 2002; Project MATCH Research Group, 1998b; Simpson,
1993; Simpson & Sells, 1982; Weisner, Matzger, & Kaskutas, 2003). Furthermore, many
of these studies and numerous others have reported a positive relationship between length
of time spent in treatment and favorable outcomes, a finding that spans treatment
modalities, programs, and treatment models (Hubbard et al., 1997; Hubbard et al., 1989;
McLellan, Luborsky, Woody, O’Brien, & Duley, 1983; Moos & Moos, 2003; Simpson,
1981; Simpson & Sells, 1982).
Substance Abuse Treatment Dropout
At the same time, many clients do not remain in substance abuse treatment long
enough to reap its benefits. Although the percentage of clients who do not complete
substance abuse treatment due to dropout or expulsion varies widely and can be difficult
to measure because treatment modalities have diverse treatment expectations, some
general trends have been observed. Lower estimates of the dropout rates for inpatient
alcohol and drug treatment programs are around 20%, while upper estimates can reach
70% (Rabinowitz & Marjefsky, 1998; Stark, 1992; Wickizer et al., 1994). Outpatient
alcohol and drug treatments tend to fare much worse and often exhibit dropout rates
exceeding 60% to 70% (Stark, 1992; Wickizer et al., 1994). Overall, approximately 50%
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of clients involved in substance abuse treatment drop out within the first month (Stark,
1992). Despite these alarming statistics, they correspond to attrition rates in other health
service sectors. In a meta-analysis of 125 studies on psychotherapy dropout, Wierzbicki
and Pekarik (1993) found mean dropout rates of 47%. More recent studies conducted in
mental health centers in various countries found dropout rates routinely fluctuate between
35% and 55% (Barkham et al., 2006; Berghofer, Schmidl, Rudas, Steiner, & Schmitz,
2002). Estimates for medical treatment are even higher with attrition rates ranging from
50% to 80% (Meichenbaum & Turk, 1987). Nevertheless, clients who drop out of
treatment prematurely often incur high “front-end” costs due to the amount of program
resources that need to be dedicated to initial assessments and the treatment planning
process, and high attrition can reduce the operational efficiency and overall effectiveness
of a treatment program (Simpson, Joe, et al., 1997, p. 280). In light of these observations,
treatment retention has emerged as an important intermediate outcome measure in the
study of substance abuse treatment (Chou, Hser, & Anglin, 1998).
Importance of Evaluating Substance Abuse Treatment Retention and Outcomes
The increased utilization of research methodologies, assessment procedures, and
statistical analyses designed to evaluate the inherent complexities of treatment processes
(i.e., engagement, participation, therapeutic relationship) and how they relate to treatment
retention and outcomes is allowing researchers to expand areas of inquiry and to continue
building the theoretical and applied knowledge base in the treatment for substance use
disorders. Contemporary questions of interest have focused on identifying relationships
amongst client-, counselor-, and program-level variables and investigating how they
relate to treatment retention and outcomes; devising and evaluating innovative
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interventions to improve retention and outcomes; determining if certain modalities or
treatment philosophies are more appropriate for particular clients; ascertaining the
amount of treatment needed to be effective for certain clients; determining if specific
ingredients are necessary for treatment to be effective; and examining how treatment
systems and the clients they serve have transformed over time (Fletcher et al., 1997;
Moyer & Finney, 2002; Leshner, 1997; Simpson, 1993; Swearingen, Moyer, & Finney,
2003). It is the answers to these queries that have impacted and will continue to influence
substance abuse policy and decisions regarding the development of treatment service
components, evaluation methodologies, the allocation of funds, and third-party payer
guidelines (Etheridge, Hubbard, Anderson, Craddock, & Flynn, 1997; Fletcher et al.,
1997).
Importance of Program-Level Research
Despite these advances, uncertainties remain regarding the extent to which such
empirical evidence can be applied to substance abuse treatment programs at the local
level. Client attributes, problems, and treatment needs are highly diverse, leading to
systematic variations in the respective clientele served by individual substance abuse
treatment programs (Simpson, Joe et al., 1997). Additional programmatic heterogeneity
exists with reference to treatment approaches and services offered. Not surprisingly, these
inherent complexities of real-world clinical settings do not often correspond to the
homogeneous samples and manual-driven treatment conditions in efficacy trials and
controlled therapy research (Carroll & Rounsaville, 2003; Persons & Silberschatz, 1998;
Tucker & Roth, 2006). Since data from large-scale randomized trials and naturalistic
investigations are often collapsed across certain types of clients, sites, and even treatment
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modalities, relevant between- and within-program differences that might be of value to a
specific program are potentially masked. Consequently, individual substance abuse
treatment programs need to deduce if and how assorted research findings regarding
treatment effectiveness, retention, and outcomes pertain to their respective programs in
order to make informed decisions regarding interventions, policies, and resource
allocation (Etheridge et al., 1997). Ultimately, program-level investigations can help
shape substance abuse treatment practices and contribute to the general knowledge base
regarding the treatment of these disorders, both vital activities in trying to narrow the
observed science-practice gap that exists within the substance abuse treatment field
(Persons & Silberschatz, 1998; Tucker & Roth, 2006).
Importance of Group-Level Research
The characteristics of individuals participating in alcohol and drug treatment
programs have dramatically changed over the past several decades (Anglin, Hser, &
Grella, 1997). Considering the shifts in substances of abuse and demographic profiles of
individuals participating in treatment, an initial step in determining the relevance of
assorted research findings to a particular treatment program is to identify who is
participating in that program. Traditionally, the examination of client characteristics and
description of samples has remained at the individual level of analysis. However, Rapkin
and Dumont (2000) suggest it may be more meaningful to study multiple dimensions of
identity and behavior and to “discover the variables that define and delimit” meaningful
groups within a heterogeneous set of individuals (p. S396). More specifically, “a deeper
understanding of natural groupings would help us fine-tune questions about causes and
treatment of problem behaviors” and identify groups that may be responsive to certain
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types of treatment interventions, programs, or modalities (Rapkin & Dumont, 2000, p.
S396). Moreover, exploring different patterns of variables and their prevalence within a
certain population may also provide insight into potential complex relationships that exist
amongst those variables.
Statement of the Problem
Substance abuse and dependence have detrimental effects at micro and macro
societal levels, accruing both measurable economic costs (e.g., lost productivity,
increased health care utilization, and criminal justice involvement) and immeasurable
losses (e.g., premature death, child abuse, and relationship strain). Even so, these
disorders appear to be amenable to treatment. Based on the wealth of the extant substance
abuse treatment literature, when clients receive treatment for substance use problems,
they generally achieve positive outcomes (i.e., reduced alcohol and drug use, decreased
involvement in crime, improved social functioning). Although time spent in treatment is
positively related to more favorable outcomes, clients often are not retained in treatment
long enough to attain its benefits. Reported substance abuse treatment dropout rates have
varied greatly (20% - 74%) depending on factors such as treatment modality, program
philosophy, and clientele served, prompting researchers to examine how these
components affect whether or not a client stays in treatment. Diverse methodological
techniques have been employed across various programs serving assorted clients to
investigate the relationships amongst client, program, and treatment attributes, treatment
retention, and eventual outcomes. Unfortunately, no consistent “treatment dropout”
profile has been detected, and the generalizability of these findings are often questioned
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at the local level because of the stark differences that exist between particular treatment
programs and their clientele and those studied.
Purpose of the Study
A primary purpose of this study is to describe the characteristics of clients
entering an intensive outpatient chemical dependency treatment program and to examine
how these variables differ between clients who complete treatment and clients who drop
out of treatment prematurely. Additionally, in an effort to accurately depict this particular
treatment program population, this study will explore whether a classification system can
be used to categorize individuals into meaningful groups based on important pretreatment
characteristics. From a clinical perspective, it is difficult for a program to examine
treatment outcomes without first learning about who is entering treatment and who is
staying in treatment. The identification of variables that positively and negatively relate
to retention will further assist in the creation of an assessment procedure that allows
clinicians to quickly and efficiently detect clients who may be at risk for dropout.
Ultimately, such knowledge can begin to inform the design of interventions aimed at
enhancing treatment retention, which can potentially improve treatment outcomes as the
positive relationship between retention and outcomes is well-established in the literature.
Furthermore, exploring whether meaningful client subgroups exist in this population is an
initial step in determining if and how such information can be useful to the clinical staff.
For example, if treatment completion status emerges as a distinguishing variable amongst
subgroups, similarity to a particular profile may serve as a more comprehensive means to
identify clients at risk of premature treatment dropout, as opposed the presence of one or
more discrete variables associated with retention. Additionally, certain combinations of
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variables may relate to whether or not a client completes treatment, thus retentionenhancing interventions should target multiple areas to address the inherent complexity
of the presenting problems of clients engaging in substance abuse treatment.
From an empirical standpoint, this study will add to the existing literature that
aims to describe the characteristics of clients who participate in intensive outpatient
chemical dependency treatment programs at nonprofit, freestanding mental health
hospitals and elucidate the extent to which current scientific evidence regarding client
characteristics and their relationship to treatment retention applies to this particular
program and the clients it serves. Moreover, if meaningful subgroups of clients can be
identified, this study has the potential to provide insight into the complex relationships
amongst the variables of interest and provide evidence in support of or in opposition to
the existence of various subtypes of individuals with substance use disorders.
Research Questions
Considering the stated problem and purpose of this investigation, this study will
address the following research questions:
(1) How do clients who complete an intensive outpatient chemical dependency treatment
program at a nonprofit, freestanding mental health clinic differ from clients who do not
complete treatment on pretreatment variables including:
a. Patient attributes: gender, age, ethnicity/race, education, income
b. Substance use severity
c. Psychiatric symptom severity
d. Motivation for treatment
e. General functioning: health, employment, social relationships, legal issues
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(2) Can meaningful subgroups of this client population be identified based on important
pretreatment characteristics and treatment variables?
Overview of the Remainder of the Study
Chapter II begins with a brief history of substance abuse treatment evaluation in
the United States, and is followed by an overview and critique of large-scale drug and
alcohol treatment research that has been carried out. Major findings and implications are
reviewed, with an emphasis being placed on those related to pretreatment client
characteristics, treatment retention, and the relationship between these factors and
treatment outcomes. Focus then turns to the application of these large-scale research
findings to small-scale settings, and the inherent benefits and challenges of this endeavor.
A treatment model (The Texas Christian University Treatment Model) designed to assist
researchers and practitioners conceptualize the complex components of substance abuse
treatment is then described. Additional research related to this model is outlined
according to identified factors related treatment retention and outcomes including patient
attributes (e.g., gender, psychiatric symptoms, motivation) and treatment factors. An
alternative approach to organizing and analyzing such data, the utilization of taxonomic
methods, is then proposed, and then followed up with a review of research on typologies
of addiction.
Chapter III describes the methodology of this study including a detailed
description of the sample, assessment procedures, assessment instruments, and variables
of interest. The proposed statistical analyses for use in this study, including descriptive
statistics, comparative analyses, profile analysis, and cluster analysis, are also described.
Chapter IV outlines results of the statistical procedures, while Chapter V discusses the
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implications of these findings, limitations of the current study, and future research
directions.
Definition of Terms
Chemical Dependency – This term is used interchangeably with the diagnostic category
of substance dependence.
Dual Diagnosis – The presence of both a psychiatric disorder(s) and a substance use
disorders.
Polysubstance Use History –This term will be used to describe the use of more than one
substance (e.g., alcohol, illicit drugs). The use of this term in this study diverges
from the DSM-IV definition: type of substance dependence disorder in which an
individual uses at least three different classes of substances indiscriminately and
does not have a favorite drug that qualifies for dependence on its own.
Retention – For the purposes of this study, a client was considered retained in treatment if
s/he persisted to treatment completion.
Substance Use Disorder (SUD) – This term encompasses substance abuse and substance
dependence diagnoses.
Treatment Completion – For the purposes of this study, a participant who is discharged
from the treatment program due to the completion of treatment will be considered
to have completed treatment. This determination was made by a combination of
clinician report and chart review and will be described in detail in Chapter III.
Treatment Dropout – “A client who terminates treatment before it is completed”
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(VandenBos, 2007, p. 302). For the purposes of this study, a participant was
considered a dropout if s/he is discharged from the treatment program before
completing treatment. This term is used interchangeably with attrition.
Treatment Repeater – For the purposes of this study, a participant was considered a
repeater if s/he completed the treatment program and was subsequently admitted
for at least one inpatient and/or outpatient treatment at the same facility.
Treatment Stopout – For the purposes of this study, a participant was considered a
stopout if s/he was discharged from the treatment program before completing
treatment and was subsequently admitted for at least one inpatient and/or
outpatient treatment at the same facility.
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Chapter II: Review of the Literature

Overview
This section begins with a brief history of substance abuse treatment research in
the United States and descriptions of several large-scale drug and alcohol treatment
research studies and meta-analyses. Major findings and implications are reviewed, with
an emphasis on the relationship amongst pretreatment client characteristics, treatment
retention, and treatment outcomes. The focus then shifts to how this large-scale research
pertains to small-scale settings, and the inherent challenges of this endeavor. The Texas
Christian University Treatment Model, a model designed to assist researchers and
practitioners conceptualize the complex processes involved in substance abuse treatment,
is described and evaluated. Research related to this model is outlined according to
identified factors related treatment retention and outcomes including patient attributes,
gender, psychiatric symptoms, motivation, and treatment factors. Lastly, arguments for
more comprehensive descriptive and exploratory investigations regarding the patient
attributes that contribute to treatment processes are elucidated.
Brief History of Substance Abuse Treatment Research
The establishment of the National Institute of Health (NIH), and its divisions of
alcohol and drug abuse, can be traced back to the alarming rates of psychological
disorders that were detected among service men and women and veterans following
World War II. By the 1970s, it became apparent that the NIMH and its alcohol and drug
divisions were not adequately dealing with the rampant alcohol and drug problems
sweeping the nation. Multiple indicators of alcohol abuse and dependence, including
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hepatic cirrhosis and violence-related mortality, had been increasing since World War II;
moreover, relatively localized abuse of cocaine and heroin abuse transformed into an
epidemic in the late 1960s and was followed by the emergence of hallucinogen and
stimulant abuse (Westermeyer, 2005). In response, the National Institute of Alcohol
Abuse and Alcoholism (NIAAA) and National Institute of Drug Abuse (NIDA) were
formed under the Alcohol, Drug Abuse, and Mental Health Administration (ADAMHA)
located within the Department of Health and Human Services. ADAMHA promoted the
development of substance abuse research, training, clinical treatment services, and
prevention. To a large extent, governmental support for these endeavors stemmed from
elected officials who were personally affected by substance use disorders, through either
first-hand or familial experiences (Westermeyer, 2005).
Collaborative research efforts of NIDA and NIAAA have addressed critical
empirical and clinical questions regarding the treatment of substance use disorders
including treatment outcomes and how they relate to program type, client characteristics,
treatment received, therapeutic approaches, and aftercare. The components of effective
treatment and treatment processes, including factors that engage and retain clients in
programs, have also been explored (Fletcher et al., 1997; Project MATCH Research
Group, 1997a; The COMBINE Study Research Group, 2003). At the same time, macrolevel studies of alcohol and drug use disorders and their treatment have remained
relatively separate endeavors, with each faction adopting distinct research programs,
modes of inquiries, and questions of interest. Consequently, comprehensive substance
abuse treatment research will be reviewed and critiqued separately below.
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Comprehensive Substance Abuse Treatment Research
The Drug Abuse Reporting Program
The Drug Abuse Reporting Program (DARP) represented the first evaluation
program of the federally-funded, community-based drug abuse treatment system that
began to emerge in the late 1960s (Simson & Sells, 1982). Data were collected on nearly
44,000 clients from 52 federally-funded programs representing four modalities of
treatment: methadone maintenance (MM), therapeutic community (TC), outpatient drugfree (ODF), and detoxification (DT). The primary data collection period spanned from
1969 to 1974. Information was gathered through intake interviews, during-treatment
progress reports, and a series of follow-up interviews at 3 to 12 years posttreatment. The
extensive research program consisted of multiple studies that essentially aimed to
describe the types of drug users entering treatment in the early 1970s, the types of
treatment that were provided to these clients, and what happened to these clients during
and after treatment. DARP also moved the field toward a more objective and
behaviorally-based orientation and away from a focus on clinical impressions by utilizing
a standardized assessment design for data collection and a set of standardized outcome
criteria. Furthermore, effective procedures for ensuring high respondent compliance rates
and maintaining quality control in the data were established (Simpson, 1993).
DARP findings demonstrated the effectiveness of three of the treatment
modalities (MM, TC, and ODF) in reducing the prevalence of daily opiate use and
involvement in criminal behavior, and increasing employment levels. Moreover, a
significantly higher percentage of clients participating in these programs for longer than
90 days had more favorable outcomes than those who did not stay in treatment this long.
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In fact, clients who remained in drug abuse treatment for less than 90 days actually had
similar drug use outcomes at the one-year follow-up point than clients who did not attend
treatment sessions following DT or only completed an intake session (Simpson, 1981;
Simpson & Sells, 1982). Longer-term outcomes were more ambiguous. Simpson, Joe,
and Bracy (1982) reported that similar statistically significant differences in outcomes
continued to be observed through the first three years following treatment, though these
effects were no longer statistically significant by the six-year follow-up point due to the
collective effects of subsequent treatments, incarcerations, and other life events.
Fletcher and colleagues (1997) noted the DARP research program contributed
much to the field of drug treatment evaluation. It delineated types of treatment;
established a well-founded methodology for longitudinal treatment evaluation research;
identified outcome patterns related to treatment readmissions, criminality, and
employment; and provided data on the natural history of opiate addiction in a population
of individuals who received drug treatment. DARP also proved that carrying out
methodologically rigorous, longitudinal, field-based research with a challenging
population could be accomplished. Consequently, periodic national multi-site evaluations
of drug abuse treatment have become part of federal research. Together with initiatives
examining changing drug use trends and their effects on the health care and criminal
justice systems, such strategies have continued to inform researchers, practitioners,
policymakers, and other key stakeholders of patterns, problems, and progress in the study
of drug use and the treatment of drug use disorders throughout the past four decades
(Fletcher et al., 1997; Simpson, Chatham, & Brown, 1995).
The Treatment Outcome Prospective Study
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The Treatment Outcome Prospective Study (TOPS) was the second national
study of community-based drug abuse treatment programs undertaken in the United
States (Hubbard et al., 1989). Similar to DARP, it was designed to provide longitudinal
information on clients entering federally-funded programs in order to allow the
evaluation of short- and long-term treatment outcomes. The data collection period
spanned from 1979-1981. Information was gathered on more than 11,000 clients admitted
to over 40 treatment programs purposely selected to yield a sample of stable, established
programs within three main modalities: MM, ODF, and long-term residential (LTR),
which included therapeutic communities. TOPS aimed to obtain more data on patient
attributes, program environments, and services delivered in treatment as compared to
DARP and it was expected that it would also provide a model framework for
investigating a variety of emerging topics in the field at that time including changing drug
use patterns, psychiatric comorbidity, criminal behavior, the impact of legal involvement
on treatment, the effects of posttreatment aftercare, cost-benefit analyses, and overall
cost-effectiveness of drug abuse treatment (Fletcher et al., 1997; Hubbard et al., 1989).
As in DARP, results suggested that MM, LTR, and ODF treatment was effective
in reducing the use of heroin and other illicit drugs and decreasing levels of predatory
crime during and after treatment. Length of time spent in treatment was positively related
to favorable posttreatment outcomes, with clients staying in treatment for a minimum of
three months faring better than clients participating in detoxification treatment and those
who entered, but failed to continue to the three-month point. TOPS researchers also noted
that patterns of drug use had changed considerably from DARP, with less daily use of
heroin and other opiates and more polysubstance use. It appeared that client legal status,
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including pressure to enter treatment, affected the length of treatment stay as clients with
legal involvement were more likely to stay longer in treatment than those without legal
involvement (Hubbard et al., 1989; Simpson, 1993). Furthermore, pretreatment indicators
of poor social compliance and adjustment, such as criminal history, unemployment,
marital problems, and psychiatric comorbidity, were also related to higher treatment
dropout and drug-use relapse rates. Cost-effectiveness and cost-benefit investigations
carried out across modalities showed that when crime-related costs were calculated,
treatment was both cost-effective and cost-beneficial. More specifically, in the year
before treatment admission, crime-related economic costs to society were an average of
$15,262 per client and fell to $14,089, an 8% reduction, in the year after treatment
discharge. Costs to law-abiding citizens fell from $9,190 per client to $7,379, an
approximate 20% reduction (Harwood, Collins, Hubbard, Marsden, & Rachal, 1988). In
most cases, the cost of treatment was regained during treatment and further cost-benefits
accrued as a result of decreased posttreatment drug use (Harwood et al., 1988).
The 1980s witnessed several noteworthy changes within the drug abuse treatment
community. Drug use patterns eventually shifted to increased use of cocaine, the
HIV/AIDS epidemic surfaced along with concern about needle sharing, and major
modifications in the organization and structure of the treatment system materialized as
federal funding was cut and the bulk of the financial responsibility was turned over to
state governments in the form of block grants (Craddock, Rounds-Bryant, Flynn, &
Hubbard, 1997; Fletcher et al, 1997). This changeover resulted in a reduction in state
financial support and seemed to negatively affect community-based treatment programs
as they consequently experienced increased strain from excessive demand, understaffing,
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and a persistent lack of adequate resources to address the complex problems of clients
entering treatment (Fletcher et al., 1997). Such dynamic shifts within the population of
drug users and the treatment programs that served them called into question the
applicability of the previous research findings of DARP and TOPS, thus setting the stage
for a third national treatment study.
The Drug Abuse Treatment Outcome Study
The Drug Abuse Treatment Outcome Study (DATOS) was initiated by the NIDA
in 1989. Similar to its predecessors, a primary objective of this research program was to
determine drug abuse treatment effectiveness for contemporary treatment populations and
drug use patterns through the collective examination of how client factors, treatment
processes, and program structure affect outcomes (Fletcher et al., 1997; Leshner, 1997).
Data were collected on 10,010 clients in 99 programs between 1991 and 1993. As was
the case in TOPS, programs were purposely selected to represent treatment delivered in
established, stable programs across the main modalities: outpatient methadone treatment
(OMT), short-term inpatient (STI), LTR, and ODF. Extensive client-level information
was obtained in a variety of domains including demographics; alcohol and drug use;
mental and physical health; legal status; income and employment; cognitive functioning;
motivation and readiness for treatment; and engagement in AIDS risk behaviors. An
array of in-treatment variables were also collected along with information regarding
program structure and services offered. Data were collected at intake, during treatment (1
and 3 months), and after treatment (12 months) (Fletcher et al., 1997; Leshner, 1997).
In order to fully capitalize upon the wealth of data DATOS produced, a
cooperative study was eventually launched in the mid 1990s involving NIDA and three
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collaborating grantees: the National Development and Research Institutes (NDRI), the
Drug Abuse Research Center of the University of California at Los Angeles (UCLA), and
the Institute of Behavioral Research at Texas Christian University (IBR-TCU). Based
upon the expertise of the researchers at these respective institutions, each arm of the
expanded research program focused on different themes. Fletcher et al. (1997) provides a
synopsis of this breakdown. NDRI delved into health services research and investigated
issues concerning access to and use of drug treatment services such as need for services
by client subtype, access to services, service use by modality and client profile, and
factors related to treatment selection and entry. IBR-TCU concentrated their efforts on
treatment engagement and retention. This division examined client and program variables
related to retention and program adherence and the impact of motivation and treatment
readiness indicators on engagement and retention. UCLA explored the addiction and
treatment careers of treated individuals via the development and testing of models
describing the stages in the process of addiction, the interaction of program and client
variables in treatment outcomes across a client’s career, and the background and drug
history factors that relate to treatment entry and reentry. NIDA assumed responsibility for
considering the policy-relevant aspects of such a large-scale evaluation of drug abuse
treatment by developing studies that described the evolving treatment system, determined
the effectiveness of treatment as it is typically delivered for current treatment
populations, and estimated the cost-effectiveness and cost-benefits of treatment.
TOPS to DATOS
Craddock and colleagues (1997) documented the notable changes in pretreatment
behaviors and characteristics of clients entering drug abuse treatment during the period of
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TOPS data collection as compared to DATOS. The TOPS era had witnessed an increase
in the use of multiple drugs, while DATOS findings documented a decrease in the
numbers of types of drugs used. Nevertheless, reports of cocaine use since TOPS more
than doubled among clients entering LTR and ODF treatment modalities, and increased
one and one-half times among OMT clients. DATOS clients were generally older, had
higher educational attainment, less full-time employment, and more dependence on
public assistance than TOPS clients. Although there was evidence of a decrease in
involvement in predatory crime, significantly greater proportions of DATOS clients were
involved in the criminal justice system and had reported engaging in illegal activity in the
year prior to treatment to get money for drugs than TOPS clients. Additional evidence
that the clients of DATOS presented with new and difficult combinations of problems to
treat included the salience of health problems, histories of physical and sexual abuse,
needle injection practices, sexual risk behaviors, and child custody concerns. “The
changing nature of the drug treatment client population – from sociodemographics to
drug use and multiple treatment problem severities – highlights the complexity of issues
and difficulties encountered by those attempting to treat clients or plan treatment
strategies” (Craddock et al., 1997, p. 44). Such dynamic shifts underscored the
importance of continuous examination and assessment of the drug treatment-seeking
population.
Treatment Outcomes
In addition to documenting such notable changes in treatment clientele, DATOS
investigations proffered a wealth of information in an array of areas. In accordance with
its predecessors, DATOS outcome data indicated that treatment was generally effective in
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reducing drug use across all four modalities (Hubbard et al., 1997). For OMT clients,
those still engaged in treatment at the one-year follow-up point reported significantly less
weekly or daily heroin and marijuana use than clients who left treatment prior to the oneyear marker; this difference was statistically significant. A 20% reduction in weekly
cocaine use during the follow-up year was also noted for OMT treatment clients. LTR,
ODF, and STI clients reported 50% less weekly or more frequent cocaine use in the
follow-up year as compared to the year prior to admission. The overall percentage of
clients reporting weekly or more frequent use of alcohol, marijuana, and heroin during
the year prior to admission was also reduced by at least half at one-year follow-up. Longterm outcomes for a subsample of cocaine-dependent clients demonstrate sustained
treatment effects (Simpson, Joe, & Broome, 2002). Weekly cocaine use and daily alcohol
use were significantly reduced during the fifth year of follow-up as compared to the
pretreatment year and were comparable to figures reported for the year following
treatment.
Treatment duration appeared to be an important factor in producing positive
outcomes as reductions in cocaine and alcohol use were significantly greater for clients
treated for at least three months in LTR and ODF. Significant declines in marijuana use
were also noted for clients remaining in LTR for three months or more. Further logistic
regression analyses that controlled for 10 independent predictor variables chosen because
of known associations with important outcomes (e.g., gender, ethnicity, age, education)
demonstrated that a treatment stay of at least six months in LTR and ODF treatment was
associated with statistically significant reductions in cocaine, marijuana, and alcohol use
for these modalities. Hubbard et al. (1997) noted that the time-in-treatment effect related
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to reduced cocaine and marijuana use for clients enrolled in LTR programs mirrored
results obtained in TOPS. However, the additional findings of a significant decline in
alcohol use for LTR clients and substantial reductions in cocaine, marijuana, and alcohol
for ODF clients provide strong evidence for a treatment duration effect for various types
of substance use that was not identified in the TOPS research.
Measures of behavioral outcome results were more mixed (Hubbard et al., 1997).
Percentages of engagement in predatory illegal activity and high risk sexual behaviors at
follow-up were one-half the rate as compared to the preadmission year for OMT clients
(28.6% to 13.7% and 25.2% to 12.9%, respectively); however, little change was noted in
the endorsement of suicidal ideation, less than full-time employment, and health
limitations. For LTR, ODF, and STI clients, percentages in the follow-up year were
typically lower than in the preadmission year for suicidal thoughts or attempts, predatory
illegal activity, and sexual risk behavior, but little change was reported for employment
and health outcomes (Hubbard et al., 1997). Upon further examination, LTR clients
remaining in treatment for at least six months exhibited a statistically significant
reduction in illegal activity (50%) and increase in full-time employment (10%). ODF
clients staying in treatment for at least six months also displayed a small, but statistically
significant increase in full-time employment and reduction in suicidal ideation. No
statistically significant effects of stays longer than two weeks in STI were found for any
of the behaviors measured. Generally speaking, DATOS behavioral outcomes appeared
to only replicate TOPS findings within the LTR modality, as there was not a statistically
significant reduction in illegal activity for clients enrolled in OMT and ODF treatments.
Hubbard and colleagues (1997) noted that these findings were not a surprise given the
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decline in comprehensive services offered within OMT and ODF programs since TOPS
was conducted.
Programmatic Differences
Taken as a whole, the DATOS outcome data suggested that longer treatment stays
are associated with more favorable outcomes, a finding that is consistent with previous
large-scale treatment evaluation studies despite considerable changes in drug use patterns
and characteristics of clients entering treatment over time (Craddock et al., 1997;
Hubbard et al., 1997). However, multi-site treatment outcomes studies are accompanied
by a variety of complexities associated with aggregating data across a broad range of
treatment settings and clientele (Simpson, Brown, Joe, 1997; Simpson, Joe et al., 1997).
“Wide program variation may mask clinically meaningful treatment effects in large-scale
outcome studies such as DATOS and offers methodological challenges in identifying
meaningful strategies for clustering programs to account for potential impacts at the
client level” (Etheridge et al., 1997, p. 259). Thus, a comprehensive review of program
data was undertaken before programmatic differences in treatment outcome and retention
were examined. This appraisal aimed to describe the varying structures and
characteristics of the treatment programs included in DATOS and to examine treatment
and programmatic changes over time as this information compared to TOPS data
(Etheridge et al., 1997). The program-level data were derived from a self-administered
questionnaire completed by the program director or a senior counselor assessing a variety
of domains including program structure, client characteristics, staffing, job preparation,
treatment structure, treatment content, available services, treatment planning, program
policies, and indicators of success in treatment.
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Results indicated that DATOS programs typically emphasized supportive therapy
delivered in group and individual sessions, with a notable increase in the percentage of
counseling delivered in the group format as compared to TOPS. LTR and ODF programs
also tended to incorporate problem solving techniques while OMT and STF integrated
more case management approaches (Etheridge et al., 1997). Secondary treatment foci
diverged across modalities, reflecting the uniqueness of each modality. LTR programs
often included milieu therapy and 12-step strategies. STI also integrated milieu therapy
along with problem solving. In addition to 12-step approaches, ODF programs tended to
incorporate psychotherapy and cognitive-behavioral techniques into their treatment.
Treatment goals across modalities and programs focused primarily on abstinence from
illicit substances and alcohol. Consistent with these objectives, nearly all programs
employed urine monitoring and incorporated some type of relapse prevention component
into treatment, although relapse prevention was emphasized less strongly in OMT
programs (Etheridge et al., 1997). In terms of physical make-up, STI and LTR programs
were generally smaller in capacity and staff carried smaller client caseloads than OMT
and ODF programs, allowing for longer and more frequent contact with clients. The ODF
modality varied the most with regards to treatment intensity as some programs scheduled
a single one to two-hour session per week (“regular”) while others scheduled at least two
three-hour sessions per week (“intensive”).
Nearly all DATOS programs indicated that individualized treatment was
provided, at least to some clients, based on client needs. The majority of programs also
aimed to match clients to particular types of treatment or counselors, with many of these
decisions based mainly on counselor style and expertise as opposed to client
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characteristics (Etheridge et al., 1997). Almost 86% of the participating programs
reported they utilized either a general program-developed assessment or a widely used
standardized assessment to assess client needs across a variety of domains. Considering
that state and federal regulations and accrediting and licensing bodies require written
treatment plans, such plans were common across programs, and the majority of programs
involved the client in treatment plan development process (Etheridge et al., 1997). Many
programs also faced cuts in funding and resources, resulting in programmatic
reorganization and downsizing during the DATOS data collection period. Of the eight
primary services areas assessed (medical, psychological, educational, vocational,
financial, legal, family, and aftercare), nearly three-fourths of the programs were “very
much” in need of aftercare and about two-thirds were ”very much” in need of medical
services. Some of the DATOS programs appeared to be relying primarily on 12-step
groups as the continuing-care component of treatment as a trend of increased and more
widespread posttreatment 12-step participation was observed. Even though the majority
of programs reported that they referred clients for such services, the number of actual
referrals made was generally low, especially in OMT and ODF programs (Etheridge et
al., 1997). Overall, less than 10% of clients in these programs received psychological,
family, legal, educational, vocational, or financial services.
These data brought attention to an obvious reduction in number of resources and
types of services provided and accessible to clients entering drug treatment from the
TOPS era to the DATOS era. Etheridge and colleagues (1997) suggested that possible
factors that may have offset the potential negative effects of such a decline included
increased client involvement in the treatment planning process, a rise in 12-step
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participation during the posttreatment follow-up year, and higher levels of client
satisfaction with treatment. At the same time, the majority of programs had only begun to
experience the effects of cost containment strategies and managed care policies. Most
change during the DATOS data collection period was reported by STI and ODF
programs. ODF program directors accentuated challenges related to decreased lengths of
stay, the third-party authorization process, and the ability to secure appropriate levels of
care as many clients were being referred to ODF programs after being denied LTR and
STI treatment by third-party reimbursement plans (Etheridge et al., 1997). Moreover,
some programs reported feeling pressure to develop and implement brief treatment
interventions and other resource-saving strategies (e.g., substituting individual sessions
with structured, topic-oriented groups) in order to better fit with abbreviated treatment
durations. The primary concern raised by Etheridge et al. (1997) at this time related to the
apparent contradiction between research and managed care policies. In particular, third
party payers were shortening treatment stays and making it difficult for providers to
obtain authorization to secure additional sessions, while research studies continued to
generate empirical support that suggested treatment stays of at least 90 days resulted in
more positive outcomes.
Treatment Retention
Upon describing the general differences across programs within each treatment
modality, DATOS researchers proceeded to examine how these discrepancies affected
treatment retention rates. Although retention rates varied from program to program, a
consistent finding across programs was that clients regularly dropped out of treatment
long before reaching the planned length of stay. OMT programs expected clients to stay
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for least two years, though the actual median length of stay was only one year.
Recommended lengths of stay for LTR programs hovered around a minimum of nine
months and at six months for ODF programs, though actual median treatment stays for
both of these modalities was only three months (Simpson, Joe et al., 1997). Both clientlevel variables (sex, age, previous treatment, psychological problems, cocaine
dependence, alcohol dependence, legal status, and needle-sharing) and program
characteristics (counseling frequency and use of ancillary services) were examined to
further elucidate how they relate to the observed variations in treatment retention across
modalities and programs. Results indicated that LTR, ODF, and OMT programs that
treated a higher percentage of clients who met criteria for cocaine dependence tended to
have poorer retention rates, while a higher percentage of clients diagnosed with alcohol
dependence was related to higher retention rates in LTR programs and lower retention
rates in ODF and OMT programs (Simpson, Joe et al., 1997). LTR and OMT programs
with lower retention rates were also more likely to serve clients younger than 35 years of
age, while ODF programs with lower retention rates had more clients with significant
legal histories. Furthermore, OMT programs with poorer retention rates tended to have
more female clients, more previous treatment episodes, and more clients with
psychological problems (Simpson, Joe et al., 1997).
Further analyses considered whether diversity in client composition was a
sufficient explanation for the observed differences in program retention rates (Simpson,
Joe et al., 1997). Results implied that retention rates would still vary even if all programs
within the same modality would treat highly similar clientele. Thus, focus turned toward
possible program-level characteristics and treatment process variables that may account
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for the observed variations in retention, and ultimately treatment outcomes (Simpson,
Brown et al., 1997; Simpson, Joe et al., 1997). Frequency of client use of additional
treatment services was not related to retention for any of the modalities, nor was
counseling frequency in LTR and OMT programs. However, ODF programs with higher
frequency of counseling (three or more sessions per week) had significantly lower 90-day
retention rates than ODF programs that had two or fewer sessions per week (Simpson,
Joe et al., 1997). A possible explanation for this finding is that clients enrolled in ODF
programs with a high level of treatment contact may interpret this intensity as too
demanding or restrictive. Consequently, such programs may be more susceptible to
dropout, especially if clients have the option to seek treatment with a less stringent
commitment (Simpson, Joe et al., 1997). The relationship between treatment process
variables, as described by the client, and key retention thresholds – 360 days for OMT
and 90 days for LTR and ODF – (Hubbard et al., 1989; Simpson, 1981; Simpson & Sells,
1982) was also explored in a series of analyses (Simpson, Brown et al., 1997). In line
with prior research, staying in LTR treatment for at least 90 days was associated with a
constructive counselor-client relationship, client satisfaction with treatment, attendance in
education classes during treatment, and participation in continuing care programming
(e.g., 12-step meetings, other support groups). For clients enrolled in ODF programs, 90day retention was positively related to compliance with program requirements; referral
for ancillary services (e.g., vocational instruction, social services, and alcohol treatment);
and engagement in continuing care programming. For OMT, remaining in treatment
beyond the 360-day threshold was associated with treatment satisfaction, referral for
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medical or mental health services, and compliance with program policies (Simpson,
Brown et al., 1997).
Upon further examination of retention and its relationship to treatment outcome,
evidence suggested that clients remaining in LTR treatment beyond 90 days had
significantly better outcomes (e.g., reduced cocaine use and alcohol use; improved legal
status, and more employment) than those who stayed less than 90 days. In particular,
reported cocaine use dropped from 82% to 3%, daily alcohol use decreased from 23% to
1%, the arrest rate was reduced from 53% to 32%, and the employment rate increased
from 54% to 68%. Outcome comparisons for ODF clients were inconclusive due to vast
variation in pretreatment drug use between clients who continued in treatment to the 90day threshold and those who discontinued prior to this point. Simpson, Brown, et al.
(1997) noted that clients who were not retained in treatment for 90 days had more
extensive pretreatment drug use; however, the relationship between severity of drug use
and retention could not be ascertained because of program-specific disparities in client
attributes and retention rates across subsamples that could not be controlled for.
Furthermore, though results were in the predicted direction, no statistically significant
differences were found between short- and long-term retention OMT clients (Simpson,
Brown et al., 1997).
Despite these mixed findings across modalities, the identification of key client
characteristics, program attributes, and treatment process elements that relate to retention
remain imperative within drug treatment evaluation as this information can improve our
understanding of what impacts the length of stay in drug treatment, which can potentially
affect treatment outcomes. Moreover, drug use trends and the drug abuse treatment
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milieu continue to change over time and such transformations need to be documented in
order to ascertain whether prior empirical findings are applicable to contemporary
conditions.
Summary of Large-Scale Drug Treatment Research
A considerable amount of empirical evidence related to drug treatment outcomes
has been derived from large-scale, national evaluations of community-based treatment
programs representing the four main modalities of drug treatment. Over the course of
nearly four decades, DARP, TOPS, and DATOS research teams were able to develop and
refine research methodologies and quasi-experimental techniques that demonstrated the
feasibility of studying drug treatment in field settings and ultimately generated a wealth
of scientific knowledge regarding drug abuse treatment and its outcomes. More
specifically, these investigations described the characteristics of clients entering drug
abuse treatment during their respective eras and explored the features of the assorted
treatment programs included in the sample. Moreover, DARP, TOPS, and DATOS
established that drug abuse treatment is effective in reducing drug use and improving
social functioning and detected the positive relationship between length of time spent in
treatment and the achievement of positive treatment outcomes (Simpson, 1993, 2004).
At the same time, such research is not without limitations. When examining its
usefulness and applicability in the treatment of drug abuse and the programs that deliver
such services, methodological aspects of this work must be considered carefully. For
example, although the samples in DARP, TOPS, and DATOS were gathered from actual
treatment programs, they were relatively confined to individuals with a drug use disorder,
which affects the generalizability of findings (i.e., if and/or how these results pertain to
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those who abuse both alcohol and drugs or alcohol only?). Similarly, since participants
were extracted from publicly-funded drug abuse treatment programs, it is not known if
similar result patterns emerge for privately-funded agencies. Data from these large-scale,
federally-funded research projects was also collapsed across programs within the
respective treatment modalities, which can potentially conceal notable between-program
differences that might be of value to a specific treatment program that shares certain
commonalities (e.g., clientele, services offered) with a subgroup of study programs. At a
broader level, aggregating data across treatment programs and trying to detect trends
amongst the various treatment modalities has produced a myriad of results. The task of
interpreting and deciphering significance of such findings is saturated with layers of
complexity and generates innumerable additional questions. Ultimately though, DARP,
TOPS, and DATOS “comprise only part of the large body of evidence from natural and
experimental studies…that supports the general effectiveness of drug treatment”
(Simpson, 2004, p. 100). In order to maximize the value of these findings, they need to be
integrated with additional drug treatment effectiveness research.
Meta-Analytic Studies of Drug Abuse Treatment
Appraising an expanded evidence base for drug treatment effectiveness and
quantifying the diverse findings obtained via varied research methods have been possible
through the application of meta-analytic review strategies (Rosenthal, 1995). Metaanalyses conducted in the past decade have provided empirical support for the
effectiveness of particular types of drug abuse treatment including methadone
maintenance (Brewer, Catalano, Haggerty, Gainey, & Fleming, 1998; Marsch, 1998),
contingency management (Griffith, Rowan-Szal, Roark, & Simpson, 2000) and family-
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couples therapy (Stanton & Shadish, 1997). Additionally, researchers have opted to
examine variables that may influence the magnitude of effects detected. Prendergast,
Podus, Chang and Urada (2002) conducted a meta-analysis of 78 drug treatment studies
carried out between 1965 and 1996 that employed a treatment-comparison group design
where one group received an intervention and the other(s) received minimal treatment or
none at all. To calculate, combine, and analyze effect sizes, the authors utilized the
statistical methods outlined by Hedges and Olkin and Cooper and Hedges (as cited in
Prendergast et al., 2002). The overall results were first summarized in terms of
descriptive statistics using inverse-weighted techniques for combining effect sizes.
Subsequently, moderators of effect size were examined using multivariate modeling of
client characteristics and program characteristics, with effect sizes adjusted for
methodological differences across studies. Statistically significant and clinically
meaningful positive effect sizes were detected utilizing a fixed-effects model for drug use
outcomes (fixed effects weighted mean = .30) and criminal activity outcomes (fixed
effects weighted mean = .13). These figures actually increased after adjustments were
made for variations in methodological features using a random-effects model amongst the
studies (random-effects weighted means = .34 and .16, respectively). In other words,
results indicated that on average, clients who participated in drug treatment had more
favorable outcomes than those who did not receive treatment or only received nominal
treatment (Prendergast et al., 2002). Nevertheless, treatment effect sizes ranged across
individual studies, prompting further examination of methodological, client, program,
and treatment variables that may influence treatment effect sizes.
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Four methodological characteristics emerged as statistically significant predictors
of larger effect sizes. Larger effect sizes were associated with studies that had smaller
numbers of dependent variables; that detected statistically significant differences between
treatment groups at baseline; had low levels of attrition in the treatment group; and
measured drug use by means of urinalysis screens (Prendergast et al., 2002). Upon
controlling for these methodological differences, the only demographic variable that was
related to outcome was age: studies with older participants reduced crime involvement to
a greater degree than those consisting of younger adults (Prendergast, Podus, Chang, &
Urada, 2006). Consistent with previous research, there were no statistically significant
differences detected for effect size based on treatment modality, suggesting that no one
treatment modality is clearly superior to others (Prendergast et al., 2002). In examining
treatment characteristics, more favorable drug use outcomes tended to be found in studies
in which treatment was rated to be well-implemented and allegiance to the treatment
procedures was high. Surprisingly, better drug use outcomes were negatively related to
theoretical development of the treatment, drawing attention to the existence of a possible
rift between theory and practice. In this case, it could be argued that “theoretically based
interventions may not have been adequately developed for the realities of practical
application, or the application of these interventions may have diverged from what was
theoretically intended” (Prendergast et al., 2002, p. 63).
Meta-analytic studies of drug abuse treatment provide additional evidence that
treatment is effective in reducing drug use and other problematic behaviors. Such
techniques have been successful in identifying possible variables that moderate and
mediate drug treatment effects that complement the findings of the large-scale, federally-
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funded projects undertaken in the United States (Prendergast et al., 2002). Nevertheless,
the aforementioned research has concentrated on only a fraction of the available scientific
evidence within the substance abuse treatment field as the treatment of alcohol use
disorders has largely remained a separate and distinct mode of inquiry. Focus will now
shift to the concurrent national comprehensive alcohol treatment research programs that
have been undertaken.
Expansion of Alcohol Treatment Studies
In contrast to the quasi-experimental methodological approaches notably
associated with the DARP, TOPS, and DATOS initiatives, large-scale research in the
alcohol field has increasingly utilized randomized clinical trials (RCTs) in the evaluation
of alcohol treatment. Widely acknowledged as the most rigorous method to evaluate
comparative efficacy of treatments (Chambless & Hollon, 1998), RCTs employ
randomization and other procedures to assign participants to treatment conditions in order
to equate treatment groups on pretreatment characteristics that might influence outcome
(Institute of Medicine, 1990; Moyer & Finney, 2002). When properly executed, RCTs are
able to elucidate what treatment is best for a particular disorder and can consequently
assist practitioners in deciding amongst alternative treatments (Persons & Silberschatz,
1998). However, following a comprehensive review of alcohol treatment outcome
research, the Institute of Medicine (1990) proposed that basic inquiries concerning
whether or not treatment for alcohol use disorders works and which treatment(s) works
the best may not be as pertinent to the field as the expanded question: “Which kinds of
individuals, with what kinds of alcohol problems, are likely to respond to what kinds of
treatments by achieving which kinds of goals when delivered by which kinds of
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practitioners?” (p. 143). More specifically, considering the array of alcohol treatments
available, might prescribing particular types of treatment for clients possessing a certain
profile of background variables and treatment needs produce better treatment outcomes,
increase cost-effectiveness, and reduce therapeutic mismatches that may affect treatment
response or treatment dropout? (Allen & Kadden, 1995; Donovan & Mattson, 1994;
Institute of Medicine, 1990; Project MATCH Research Group, 1997a). By the late 1980s,
empirical research in support of this “matching hypothesis” was promising, though not
entirely convincing or fully understood (Longabaugh, Wirtz, DiClemente, & Litt, 1994;
Mattson et al., 1994). In response the National Institute on Alcohol Abuse and
Alcoholism (NIAAA) launched a large-scale, RCT investigation named Matching
Alcoholism Treatment to Client Heterogeneity (Project MATCH).
Project MATCH
Project MATCH aimed to test the most promising matching hypotheses to date by
determining if various subgroups of alcohol dependent clients would respond differently
to three manual-guided, individually-delivered treatments: Cognitive Behavioral Coping
Skills Therapy (CBT), Twelve-Step Facilitation Therapy (TSF) and Motivational
Enhancement Therapy (MET; Project MATCH Research Group, 1997a). In addition to
improving upon the methodological limitations of its predecessors, DiClemente (2003)
notes that Project MATCH aspired to understand treatment processes and behavioral
change components as well as drinking outcomes in its evaluation of matching
hypotheses. The three study treatments were chosen because of their diverging
conceptualizations of behavior change and the techniques they employed to influence this
process (DiClemente, 2003). CBT consisted of 12 sessions over the 12-week treatment
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period. It was derived from social learning theory wherein the focus was on the
development of coping skills that would enable clients to deal with situations that
commonly precipitate relapse. TSF was also delivered on a weekly basis throughout the
treatment period. It viewed alcoholism as a spiritual and medical disease, fostered client
acceptance of this disease, encouraged the development of a commitment to participate in
Alcoholics Anonymous (AA), and promoted the working of the 12 steps associated with
the AA paradigm. MET consisted of four treatment sessions held during the first, second,
sixth, and twelfth weeks of treatment. It employed techniques aimed at increasing
intrinsic motivation and initiating change through the mobilization of the client’s own
assets and coping resources (Project Match Research Group, 1997a; 1997b).
Project MATCH was actually comprised of two parallel, though independent,
examinations of clients recruited at nine clinical research units that were affiliated with
multiple treatment facilities. Clients were solicited directly from outpatient treatment
clinics and the community through advertisements (outpatient arm) and via inpatient or
intensive day hospital treatment programs who referred clients for aftercare (aftercare
arm). Randomization procedures, assessment instruments, treatment protocols, follow-up
evaluations, matching hypotheses, and data analyses were identical in both branches of
the study (Project MATCH Research Group, 1997a). Participants were recruited over a
two-year period using strategies to maximize sample heterogeneity. To be included in the
study, potential participants had to meet the following criteria: current diagnosis of
alcohol abuse or dependence; alcohol as the primary drug of abuse; active drinking
during the three months prior to entrance into the study; minimum age of 18; and a
minimum sixth-grade reading level. Additionally, aftercare participants had to complete
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an inpatient or intensive day hospital treatment program lasting at least seven days and be
referred for aftercare treatment. Exclusion criteria included a concurrent diagnosis of
dependence on sedatives/hypnotics, stimulants, cocaine, or opiates; intravenous drug use
in the previous six months; presently being a danger to self or others; probation/parole
requirements that may interfere with study participation; lack of clear possibilities for
stable residency; inability to identify at least one “locator” person to assist in follow-up
tracking; acute psychosis; severe organic impairment; or planned or current involvement
in alternative treatments for alcohol problems. Further general requirements were
willingness to accept randomization to any treatment condition, residence within
reasonable commuting distance with available transportation, and completion of prior
detoxification when medically advised (Project MATCH Research Group, 1997a).
The research protocol involved an initial screening to determine if a person was
eligible, followed by completion of informed consent documentation. Participants then
underwent a series of three comprehensive intake sessions that lasted a total of
approximately eight hours. These sessions consisted of personal interviews, computerassisted assessments, and self-administered questionnaires assessing an array of domains:
demographic information, alcohol and drug use history, legal status, family and social
relationships, psychological history, cognitive functioning, and motivation for treatment
(Project MATCH Research Group, 1997a). Participants were then randomly assigned to a
treatment condition and participated in treatment for 12 weeks. Follow-up assessments
were carried out at 3 (end of treatment), 6, 9, 12, and 15 months after the first therapy
session. Collateral information was collected from identified informants and laboratory
tests were carried out to substantiate the participants’ self-report of alcohol use. A
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number of procedures (e.g., standardized therapist certification, session monitoring, blind
videotape ratings of sessions) were utilized to evaluate treatment fidelity and prevent
therapist variation from the protocol (Project MATCH Research Group, 1997a). With
regards to treatment retention and compliance, outpatient participants completed 68% of
their scheduled visits while aftercare participants competed 66%. For both arms of the
study, data for over 90% of the participants were collected at all five follow-up points
during the posttreatment year (Project MATCH Research Group, 1997a).
The selection of primary and secondary a priori matching variables was based on
strength of empirical support and theoretical justification (Project MATCH Research
Group, 1997a; 1997c). Primary client-level variables utilized to test the matching
hypotheses included: severity of alcohol involvement; cognitive impairment; conceptual
level; gender; meaning seeking; motivation; psychiatric severity; social support for
drinking; sociopathy; and alcoholic typology (Project MATCH Research Group, 1997a).
Secondary variables, though they had less backing in the scientific literature, were
included to test matching hypotheses that appeared promising: severity of alcohol
dependence, anger, antisocial personality disorder, assertion of autonomy, diagnosis of an
Axis I disorder, prior engagement in AA, religiosity, self-efficacy, social functioning, and
readiness to change. The main outcome measures were percentage of abstinent days per
month and average number of drinks per drinking day, while secondary outcome
measures encompassed negative alcohol-related consequences, psychiatric status, social
behavior, days paid for working, and a category-based composite measure of client
functioning during treatment (e.g., abstinent, moderate drinking without recurrent
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problems, heaving drinking or recurrent problems, and heavy drinking and recurrent
problems) (Project MATCH Research Group, 1997a).
Treatment Outcomes
Treatment outcomes were assessed during treatment, throughout the first year
following treatment, and again three years after treatment completion. In the outpatient
arm of the study, both the CBT and TSF conditions resulted in a higher frequency of
abstinent days than MET during the 12-week treatment phase, and CBT was also
associated with fewer drinks per drinking day in the final month of treatment as
compared to MET. Furthermore, participants in the MET-condition experienced more
alcohol-related negative consequences and were more likely to be classified as drinking
heavily and/or having recurrent alcohol problems during treatment than participants in
the other treatment conditions (Project MATCH Research Group, 1997b). No treatment
main effects during treatment materialized for the aftercare arm, which may have been
the result of these participants being exposed to an intensive initial treatment (e.g.,
detoxification or day hospital) before Project MATCH randomization occurred. An
alternative explanation of this observation relates to the fact that treatment may have been
geared more towards relapse prevention in the aftercare arm because clients commenced
the study with a sustained period of abstinence, whereas more outpatient clients were
likely working to establish initial clean time. Thus, the more intensive CBT and TSF
treatments (i.e., 12 sessions over 12 weeks) may have a greater influence on the initiation
of abstinence as opposed to the maintenance of abstinence than the less intensive MET
condition (i.e., 4 sessions over 12 weeks) (Project Match Research Group, 1997b). Taken
together, it was suggested that when there is a need to quickly reduce heavy drinking and
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negative alcohol-related consequences, as is often the case in outpatient settings, there
appears to be a temporary advantage to recommending CBT or TSF over MET (Project
MATCH Research Group, 1997b).
This indication proved to be provisional because the outpatient treatment
differences initially detected faded soon after the end of treatment and were not
maintained during the follow-up year (Project MATCH Research Group 1997a; 1997b).
The three treatments had favorable and fairly similar effects on treatment outcome as
minimal discrepancies were found for drinking and related outcome measures across the
follow-up period. Consequently, the Project MATCH Research Group (1997a; 1998a)
concluded that these variations were not clinically significant and alcohol-dependent
clients appeared to respond equally well to the three treatment methods. Overall, outcome
results indicated that the percentage of abstinent days per month significantly increased
for both aftercare and outpatient participants from intake through each of the follow-up
periods. More specifically, clients were abstinent around 20% of the days in the three
months prior to participating in the study, while this rate climbed to over 85% during the
month immediately treatment. These results were sustained over the course of the year
following the completion of treatment as only a slight deterioration in abstinence rates
were reported for all participants (Project MATCH Research Group 1997a; 1998a). Even
participants who continued to drink exhibited a considerable decline in the frequency and
quantity of drinking. Prior to treatment, these clients averaged nearly 25 drinking days
per month and would usually consume approximately 15 drinks per drinking day. These
figures were reduced to 6 and 3 drinks, respectively, during the month after treatment and
were reasonably maintained throughout the one-year follow-up period (Project MATCH
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Research Group, 1997a; 1998a). In addition to improved drinking outcomes, participants
showed significant reductions in depression, use of other drugs, and alcohol-related
problems. Improvements in social functioning and liver function tests were also noted
(Project MATCH Research Group, 1997a; 1998a).
Similar drinking outcome patterns were noted at the three-year follow-up point
for the outpatients in the study. Abstinence rates paralleled those found in other long-term
treatment follow-up studies with nearly 30% of outpatient participants remaining totally
abstinent in the three months prior to the three-year follow-up assessment (Project
MATCH Research Group, 1998a; 1998b). Even participants who reported drinking
remained abstinent nearly 66% of the time at three years posttreatment, which is a 150%
improvement from baseline estimates. Furthermore, when these participants drank, they
reported consuming an average of between 6 and 7 drinks, which had decreased from a
baseline average of about 11 drinks (Project MATCH Research Group, 1998a; 1998b).
Prognostic Indicators of Outcomes
Separate analyses were conducted to examine the effects of primary and
secondary client matching attributes on drinking outcomes, regardless of the type of
treatment received. For aftercare participants, gender was associated with abstinence rates
throughout the one-year posttreatment phase with males having significantly fewer
abstinent days than females. Psychological severity also interacted with time to predict
abstinence. Near the end of the one-year follow-up phase, aftercare clients with more
severe psychological problems at intake had fewer abstinent days than those who
reported less severe psychological problems (Project MATCH Research Group, 1997a).
Primary client attributes seemed to have a greater influence on the amount of alcohol
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consumed on drinking days. Results indicated that being male, having a higher level of
alcohol involvement, reporting more severe psychological problems, and possessing
more social support for drinking was associated with more drinks per drinking during the
one-year follow-up period. Furthermore, the effects for gender (male) and psychological
severity (greater) became more pronounced over time during this posttreatment phase
(Project MATCH Research Group, 1997a). When examining secondary variables, a selfefficacy measure (i.e., difference between temptation to drink and confidence to remain
abstinent) and religiosity were related to drinking outcome. A higher discrepancy
between temptation and confidence was associated with lower abstinence rates and
higher levels of consumption, whereas a stronger religious background was positively
related to increased abstinence (Project MATCH Research Group, 1997c).
A slightly different prognostic profile emerged for outpatient participants. The
more motivated a client was prior to treatment and the less social support s/he had for
drinking, the better the drinking outcomes (i.e., higher abstinence rate and lower
consumption level) during the year following treatment. Sociopathy was also a predictor
of outcome, though it interacted with time: higher levels of sociopathy were associated
with poorer outcomes early in the follow-up phase but not in the latter stages (Project
MATCH Research Group, 1997a). In analysis of secondary attributes, two self-efficacy
measures (i.e., confidence to maintain abstinence, difference between temptation to drink
and confidence to remain abstinent) and readiness to change were related to better overall
outcomes. As in the aftercare arm, a larger gap between temptation and confidence was
associated with more frequent and larger amounts of drinking; whereas, when confidence
was considered alone, the higher the client’s confidence, the greater the amount of
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abstinence and the less alcohol consumed on drinking days (Project MATCH Research
Group, 1997c). Other prognostic indicators suggested that greater readiness to change
and higher levels of alcohol dependence were associated with increased abstinent days,
while stronger religious background was related to less heavy consumption (Project
MATCH Research Group, 1997c).
By the three-year follow-up point, several of these relationships were sustained
and a total of 11 of the 21 client matching attributes had prognostic value for the
outpatient arm of the study. It should be noted that the aftercare sample was not assessed
at three years posttreatment. The most consistent finding across these intervals was that
motivation and readiness to change continued to have a favorable main effect on both
drinking outcomes (Project MATCH Research Group, 1998b). Though the self-efficacy
variables had been related to both abstinence rates and consumption levels at the one-year
follow-up point, they remained predictive of consumption levels three years
posttreatment. The alcohol dependence and religiosity findings were sustained as well.
Additionally, outpatient participants who experienced more severe alcohol-related
problems (i.e., greater alcohol involvement, greater dependence, and type B alcoholic) or
had poorer social functioning before treatment actually had better drinking outcomes at
the three-year follow-up point (Project MATCH Research Group, 1998b). In summary,
the authors noted that these findings suggest that “the most successful predictors are
‘state’ variables (e.g., motivation, self-efficacy) that are thought to be changeable, thus
holding out the hope that treatment focusing on them can change drinking behavior”
(Project MATCH Research Group, 1998b, p. 1309).
Treatment Matching Effects
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None of the ten a priori primary matching hypotheses garnered irrefutable support
for effect on drinking outcomes during treatment and throughout the follow-up period,
though trends were detected. In the first month of treatment, outpatients who had social
networks that were more supportive of drinking prior to treatment consumed significantly
less alcohol when treated in the TSF condition as opposed to MET, though this effect
dissipated in the latter months of treatment (Project MATCH Research Group, 1997b). It
was suggested that this observation may have occurred because an initial focus in TSF is
helping clients separate themselves from the social network that supports drinking and
begin forming a new network that reinforces abstinence (Project MATCH Research
Group, 1997b). Throughout the one-year posttreatment follow-up, only three primary
matching hypotheses found support in the data, though only one of these had an effect
that was not time dependent (Project MATCH Research Group, 1997a). Outpatients who
did not report concurrent psychological problems had significantly higher rates of
abstinence when treated in TSF than those treated in CBT in 7 of the 12 follow-up
months. This divergence peaked at nine months posttreatment where TSF participants
had approximately 87% days abstinent versus 73% for CBT participants. However, as the
severity of concurrent psychological problems increased, the observed TSF advantage
disappeared. Since only a small proportion of outpatient participants fell at the high end
of the psychological severity spectrum, it was not possible to fully evaluate whether the
observed matching trend reversed itself (i.e., if CBT, as compared to TSF, led to
significantly more abstinent days for outpatients reporting more severe psychological
problems) (Project MATCH Research Group, 1997a).
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The other client attributes that interacted with treatment types as hypothesized
were meaning seeking and motivation, although statistical support was meager and was
only detected in one arm of the study. For motivation, the interaction effect changed over
time and emerged as significant only during the last month of the posttreatment period
(Project MATCH Research Group, 1997a). Outpatient MET clients who had low in
motivation to change eventually reported significantly higher abstinence rates than their
CBT counterparts one year after treatment. However, this trend had reversed itself over
time as CBT initially appeared to be superior to MET for clients low in motivation
immediately following treatment, suggesting that MET may have a delayed effect
(Project MATCH Research Group, 1997a). In the aftercare arm, the meaning seeking
hypothesis acquired some support. Participants who aspired to experience greater
meaning and felt less purpose in life at intake (i.e., high meaning seeking) were
somewhat more responsive to TSF than to other treatments as evidenced by significantly
higher rates of abstinence. However, this effect did not emerge until the latter six months
of the follow-up period (Project MATCH Research Group, 1997a).
Of the secondary matching variables selected, two results of note emerged
(Project MATCH Research Group, 1997c). Outpatient participants with greater levels of
anger who were treated in the MET condition had a significantly higher percentage of
days abstinent and consumed significantly less alcohol on drinking days than CBT
participants throughout the follow-up period. In the after care arm, degree of alcohol
dependence affected outcomes in the CBT and TSF conditions (Project MATCH
Research Group, 1997c). Clients classified as low in alcohol dependence severity had
significantly better abstinence rates when treated in CBT as opposed to TSF during the
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follow-up phase. As level of client alcohol dependence increased though, the advantage
shifted to TSF treatment. TSF clients at the high end of the dependence severity range
were abstinent significantly more days and drank significantly less amounts on drinking
days than their CBT counterparts (Project MATCH Research Group, 1997c).
In the outpatient follow-up study, only one of the initial primary and secondary
matching effects detected was sustained three years after treatment. Findings suggested
that outpatients who rated higher in anger and were treated in the MET condition
sustained superior outcome effects (i.e., higher abstinence rates and lower consumption
amounts) at the three-year follow-up than high anger clients who participated in CBT or
TSF treatment (Project MATCH Research Group, 1998b). The initial psychological
problem severity matching effect (i.e., advantage of TSF over CBT in clients without
concurrent psychological problems) found at the one-year point had disappeared by three
years posttreatment. At the same time, a primary matching hypothesis that was not
confirmed during the one-year follow-up period gained support at the three-year point. It
was originally predicted that clients whose social network was supportive of drinking
would have better outcomes if they were treated in the CBT or TSF condition as opposed
to MET because MET does emphasize coping skills or the building of a sober network
like the other treatments (Project MATCH Research Group, 1998b). Three years
following treatment, TSF clients who had greater support for drinking prior to treatment
had significantly higher abstinence and lower consumption rates than their MET
counterparts.
Project MATCH Conclusions
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The principal aim of the Project MATCH undertaking was to determine if patients
possessing particular attributes would respond differentially to three alcohol treatments.
When primary and secondary matching analyses are integrated, even though several
statistically significant results emerged, no strong evidence in support of or in opposition
to the general treatment matching hypothesis could be deduced (Project MATCH
Research Group, 1997c; 1998a). “What can be concluded with some confidence is that
matching clients on the basis of any single attribute hypothesized and tested in Project
MATCH is unlikely to markedly enhance the effectiveness of any of these three
treatments” (Project MATCH Research Group, 1998a, p. 1690). The clinical significance
and robustness of the findings are challenged by discrepancies between findings from the
outpatient and aftercare arms of the study and failure to find effects for both primary
drinking outcomes for the identified attributes. Furthermore, the Project MATCH
Research Group (1998a) reported that when comparing the difference between the top
and bottom decile of an attribute, the strongest of the hypothesized effects accounted for
no more than a 12% difference in abstinent days per month, which equates to about three
to four days, and a reduction of two drinks per drinking day. Lastly, Project MATCH did
not employ any comparison group procedures in their investigation, likely because of the
ethical dilemma of withholding beneficial treatment from participants. This limitation
introduces the possibility that just because participants demonstrated positive outcomes
across the three treatments, does not necessarily imply that the treatments “work” equally
as well; alternatively, they may not “work” at all because these outcomes were not
compared to the outcomes of a group of individuals who did not receive any of these
treatments.
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Nevertheless, the overall picture of treatment outcome was positive for
participants across the treatment conditions. High rates of compliance were documented
for both the research protocol and therapy, which preserved treatment integrity and
enhanced the quality of the data (Mattson et al., 1998). Furthermore, high rates of
participant compliance were identified (i.e., overall session attendance rate above 65%
and the completion rate of the one-year posttreatment data collection at around 90%) and
were positively related to favorable treatment outcomes. Ultimately, the Project MATCH
Research Group (1997c) purported:
Single attribute by treatment interactions alone cannot account for the complexity
of the matching findings. Further research will be needed to put the results into a
clinically useful formula that will also provide a theoretical basis for
understanding how a given treatment benefits a given client. Research is needed
to identify the common and unique active ingredients of treatments, as well as
provide a better understanding of how these treatment variables lead to different
client outcomes. Discovery of the variables and processes that mediate treatment
outcomes will enhance treatment effectiveness substantially. (p. 1695)
Project COMBINE
In accordance with the aforementioned philosophy of identifying the complex
aspects of alcohol treatment that may enhance effectiveness, NIAAA launched another
multi-center, RCT at the turn of the century entitled Combining Medications and
Behavioral Interventions (Project COMBINE). Primary aims were to examine the
efficacy of pharmacological treatments, behavioral therapies, and their combinations in
the treatment of alcohol dependence and to evaluate the placebo effects on overall
outcomes (The COMBINE Study Research Group, 2003). Study medications included
naltrexone and acomprosate. Selected behavioral treatments were medical management
(MMT), a manualized 9-session intervention that concentrated on enhancing adherence to
mediation regime and maintaining abstinence that could be adapted for primary care
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settings, and cognitive behavioral intervention (CBI), a manual-guided, individual
outpatient specialized alcohol treatment that merges a variety of methods and techniques
(The COMBINE Study Research Group, 2003). Treatment groups were comprised of
various combinations of these interventions, and participants were randomly assigned by
a stratified random block design. Eight groups (n = 1226) received MMT, while four of
these groups (n = 619) also received CBI. All of these participants were also assigned to a
medication condition (e.g., placebo, acamprosate, naltrexone, or acamprosate plus
naltrexone), yielding four medication conditions within each behavioral level (e.g., MMT
or MMT plus CBI). A ninth group (n = 157) who only received CBI was included to
assess placebo effects. The data collection period spanned from January 2001 through
January 2004 (Anton et al., 2006).
Participants were recruited from inpatient and outpatient referrals within the study
sites and from the community through media announcements. Screening assessments
were completed to determine study eligibility. Inclusion criteria included: age 18 years or
older; current diagnosis of alcohol dependence; completion of informed consent
procedures; minimum levels of drinking during the 90-day period prior to treatment
entry; at least 4 consecutive days, but no more than 21 consecutive days, of abstinence
prior to randomization; ability to identify a “locator” person; and ability to speak and
understand English. Exclusion criteria included: concurrent diagnosis of bipolar disorder,
schizophrenia, bulimia, anorexia, dementia, or another psychological disorder requiring
medication; medication regime that would pose safety issues with study medications;
concurrent diagnosis of dependence on another drug except nicotine, cannabis, and
caffeine; diagnosis of opiate dependence or abuse within the past six months; chronic
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treatment with any opiate-containing medications during the previous month; positive
urine screens for exclusionary drugs; abnormal laboratory tests; being pregnant and
nursing or potential to become pregnant; intention to engage in additional formal alcohol
treatment; more than 7 days of inpatient treatment during the 30 days prior to
randomization; and use of study medications in previous 30 days (The COMBINE Study
Research Group, 2003). Primary comprehensive assessments were conducted at intake
and then at various points following randomization: 8 weeks (during treatment), 16
weeks (conclusion of treatment), 26 weeks, 52 weeks, and 68 weeks (one-year followup). Measures of drinking and craving were also collected weekly or at each MMT
appointment. Primary drinking outcomes were percentage of abstinent days and time to
first heavy drinking day, though drinks per drinking day was also examined (The
COMBINE Study Research Group, 2003).
Treatment Outcomes
Overall, all pill-taking treatment groups exhibited significant reductions in
drinking, with percentage of abstinent days increasing from 25% during the pretreatment
period to 73% during treatment and drinks per drinking day declining from 12.6 to 7.1.
Participants in the naltrexone plus MMT; placebo plus MMT and CBI; or naltrexone plus
MMT and CBI conditions had significantly higher rates of abstinence (81%, 79%, and
77%, respectively) during the treatment phase than participants receiving placebo plus
MMT (75%). Furthermore, over time, naltrexone reduced the risk of experiencing a
heavy drinking day, an effect that was more pronounced in those also receiving MMT but
not CBI (Anton et al, 2006). Contrary to the positive findings of previous trials,
acomprosate demonstrated no significant effects on drinking as compared to placebo,
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either by itself or when combined with naltrexone, CBI, or both. Placebo effect results
indicated that participants receiving placebo plus MMT or placebo plus MMT and CBI
had significantly higher percentages of abstinent days (74% and 80%, respectively) than
their counterparts in the CBI only condition (67%). Although comparable between-group
differences were detected at the one-year follow-up point, none of them reached a level
of statistical significance, which challenges the sustainability of these treatment effects
over time (Anton et al., 2006).
Taken together, Project COMBINE results suggested that participants who
received MMT with any combination of naltrexone and CBI had more favorable drinking
outcomes than participants in other conditions. A lack of evidence was found for the
efficacy of acamprosate with or without a behavioral adjunct (CBI). With regards to
questions of comparative efficacy, MMT combined with naltrexone or CBI, but not both,
were the only treatment combinations that garnered incremental efficacy support.
Surprisingly, a placebo effect was also detected: meeting with a health care practitioner
and taking placebo pills during treatment had a positive effect on drinking outcomes
above those found for participants who only engaged in CBI (Anton et al., 2006). These
findings provide additional evidence for the general effectiveness of alcohol treatment
and delineate two combinations of pharmacological and behavioral therapies that may
produce more or less favorable results. Although the comparative efficacy results were
not as robust as researchers had hoped for, the methodological precision introduced by
Project COMBINE allowed for the investigation of both independent and combination
testing of medications with differentially intensive behavioral interventions, a new level
of design complexity that is essential to the proper evaluation of the multimodal alcohol
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treatment that is currently being delivered in treatment programs (Anton et al., 2006; The
COMBINE Study Research Group, 2003).
Despite its methodological rigor, a glaring omission from Project COMBINE
publications is a discussion of study findings as they relate to the study’s theoretical
underpinnings and hypotheses that were not supported by the results. Additionally, aside
from mentioning that naltrexone treatment delivered in a primary care setting could
extend patient access to effective alcohol dependence treatment and suggesting that the
usefulness of continued or intermittent care over the longer-term should be evaluated,
implications for clinical practice and future research directions are absent (Anton et al.,
2006). As Bergmark (2008) notes, researchers could have elaborated on potential
treatment mechanisms that could have generated improvement in the participants’
drinking practices, including participant attributes, treatment context factors, intervention
characteristics.
Meta-Analytic Reviews of Alcohol Treatment
Although RCTs are a critical source of empirical evidence regarding the
effectiveness of alcohol treatment, the value of smaller-scale randomized studies and
nonrandomized investigations cannot be discounted. Fortunately, the inception of metaanalytic techniques has made it possible for investigators to integrate alcohol treatment
research across diverse methodologies and assess the magnitude, direction, and
consistency of their respective findings (Rosenthal, 1995). Miller and Wilbourne (2002)
aimed to summarize the existing empirical support for various treatment approaches for
alcohol use disorders by evaluating controlled studies via a differential weighting system
based on the methodological precision of each study (i.e., randomization to conditions,
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quality control of treatments, follow-up length, collateral interviews, replication of
findings at multiple sites). The review included 361 investigations and 72,052 clients and
was the most recent installment in a series of three reviews. Results indicated that the
overall methodological quality of a study was significantly correlated with the reporting
of a specific effect of treatment, though this relationship was modest at best (Miller &
Wilbourne, 2002). With regard to treatment approaches, the strongest evidence of
efficacy was found for brief interventions, social skills training, the community
reinforcement approach, behavior contracting, behavioral marital therapy, and case
management. Miller and Wilbourne (2002) drew attention to the fact that it appeared that
the common themes interwoven throughout these particular approaches included selfefficacy related to stopping or reducing drinking, motivation for change, and attention to
the social context and support systems. Two pharmacotherapies, opiate antagonists
(naltrexone and nalmefene) and acamprosate, ranked fairly high on the list (3 and 4,
respectively) and did so for the first time since the inception of this methodological
review. Treatment techniques that generated the least support included those designed to
create, confront, shock or foster insight regarding the nature and causes of alcoholism
(Miller & Wilbourne, 2002).
Moyer and Finney (2002) set out to compare and contrast the participants,
methodological features, and posttreatment functioning in both randomized and
nonrandomized alcohol treatment studies conducted between 1970 and 1998. The sample
yielded an analysis of 232 randomized and 92 nonrandomized trials. Results indicated
that randomized investigations were significantly more likely to employ participant
inclusion and exclusion selection criteria, to use established diagnostic criteria to
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characterize participants, and to employ more rigorous treatment delivery and assessment
procedures (e.g., training for providers, treatment manuals, supervision) (Moyer &
Finney, 2002). Nonrandomized studies were significantly more likely to measure
outcomes in a greater proportion of participants over longer follow-up periods and to
include enough participants to ensure adequate statistical power to detect medium-sized
(p = .05) treatment effects. Types of treatments examined also diverged between the
methodologies. Randomized trials were significantly more likely to explore the effects of
behavioral or pharmacological treatment whereas nonrandomized trials tended to
examine broad or unspecified inpatient and/or outpatient treatments (Moyer & Finney,
2002). Aside from education, no evidence was detected of baseline differences in primary
demographic characteristics including sex, ethnicity, marital status, employment status,
history of alcohol use, and education. Participants in randomized studies completed
significantly more years of education than their nonrandomized counterparts. With
regards to treatment outcomes, even when differences in study features was controlled
for, abstinence rates and the proportion of participants who improved following treatment
were similar for both types of investigations. Despite the contrasting strengths and
weaknesses of randomized and nonrandomized trials, Moyer and Finney (2002) advise
that it would behoove the field to consider them as complementary forms of treatment
evaluation.
Descriptive review approaches have also been utilized to examine the nature of
alcohol treatment research itself and provide more qualitative information about what
types of studies have been undertaken in the field and what changes have occurred over
time. Swearington, Moyer, and Finney (2003) reviewed 701 multiple-group (n=404) and
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single-group alcohol (n=297) treatment outcomes studies reported between 1970 and
1998. Findings indicated that males continued to make up the majority of research
participants, with the percentage of women included in research (15%) not corresponding
to the actual approximate percentage of female clients in alcohol treatment programs
(31%) (Swearington et al., 2003). Although single- and multiple-group studies were fairly
similar with respect to participant characteristics, there were observed differences in
terms of treatment type, setting, and outcome assessment. Multiple-group studies
investigated behavioral (33%) and pharmacological (23%) treatments more often than
single-group studies (7% and 6%, respectively). On the other hand, single-group studies
tended to focus more on multimodal or unspecified treatment (61%) as compared to their
multiple-group counterparts (23%) (Swearington et al., 2003). Multi-group research was
more often evaluated in outpatient settings (52% vs. 31%), while single-group research
was more concentrated in inpatient and residential centers (53% vs. 32%). Single-group
investigations also tended to track participants for a longer period of time for follow-up,
nearly 20 months, as compared to just over 12 months for multiple-group investigations
(Swearington et al., 2003). The observed methodological differences between multipleand single-group designs are not surprising considering the divergent purposes of each:
Whereas single-group studies tend to be conducted by treatment practitioners
within existing treatment programs in an effort to discover how patients fare
following a particular treatment program, multiple-group studies are typically
undertaken by academic researchers interested in exploring theory-driven models
of alcohol treatment to identify efficacious treatments and the relative effects of
different treatment approaches. These findings point to a schism between research
conducted in real-world settings and research-based investigations. Closing the
gap will require comparative investigations of the effects of theory-based
treatments in more “real-world” settings as a follow-up to efficacy studies.”
(Swearington et al., 2003, p.432)

58
Regardless of this divide, researchers have refined statistical techniques to
combine data from both randomized and nonrandomized investigations to determine
average outcomes for a person who is treated for an alcohol use disorder. Miller, Walters,
and Bennett (2001) examined over 8000 clients who participated in four RCTs (e.g., the
VA collaborative trial of lithium, the VA collaborative study of disulfiram, two Project
MATCH studies) and three uncontrolled studies (e.g., the Relapse Replication and
Extension Project, the VA study of treatment for substance use disorders, the Rand
corporation reports) of treatment as usual and converted outcome findings to derive
estimates of average effectiveness for alcohol treatment.
Results indicated that after a single treatment episode, approximately one in four
clients will maintain abstinence from alcohol during the year following treatment;
moreover, another one in ten clients will moderate the frequency and quantity of their
drinking to a point where no alcohol-related problems are experienced in the
posttreatment year. Taken together, approximately one third of clients have relatively
clear-cut positive outcomes following treatment (Miller et al., 2001). Substantial
improvements are also noted for the remaining two thirds of treated clients who continue
to have some periods of heavy drinking during the year after treatment. Findings
indicated that the frequency of drinking is reduced, as prior to treatment they were
drinking about two out of three days whereas after treatment they drink approximately
one out of four days (Miller et al., 2001). The amount of consumption also decreases. The
average number of drinks per drinking day is less than half what it was prior to treatment,
and the average number of drinks per week is reduced by more than 87% (i.e., 77
standard drinks per week to 10). Moreover, the number of alcohol-related problems
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decreases by 60% following treatment for these clients (Miller et al., 2001). Overall,
these results highlight the substantial improvements made by treatment clients who do
not necessarily maintain complete abstinence or moderation following treatment.
Unfortunately, such progress is often masked by simplistic, dichotomous posttreatment
classification of “successful” (i.e., complete abstinence) or “relapsed” (Miller et al., 2001,
p. 218). Ultimately, the execution of such an investigation provides additional empirical
support for the effectiveness of alcohol treatment and a unique perspective on the
assessment of treatment outcomes.
Summary of Large-Scale Alcohol Treatment Research
Despite embedded limitations including the recruitment of homogeneous
treatment samples and utilization of tightly-controlled treatment conditions, which both
affect the generalizability of results to actual treatment settings characterized by complex
clientele and variability in treatment delivery, a substantial amount of empirical evidence
related to alcohol treatment outcomes has been derived from large-scale, RCTs. Studies
such as Project MATCH and COMBINE aimed to determine absolute and relative
efficacy of assorted alcohol abuse treatment approaches, and in accomplishing this feat,
produced manualized treatment protocols that can be used in the field and demonstrated
the cost-effectiveness of treatment. Meta-analyses of specific interventions and reviews
of the nature of the study of alcohol treatment effectiveness have bolstered this scientific
research base as well. Consequently, simple questions such as “Is treatment effective?”
and “Which treatment is the best?” have often been answered with a relatively
convincing, “yes, and they all work about equally as well” (Miller, 1992, p. 99). Similar
responses to such questions would likely be proffered in the drug abuse treatment field as
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well, because positive outcomes continue to be detected across a multitude of modalities
and programs. At the same time, diversity across treatment programs with regards to
clientele, approaches, and services offered necessitates a further examination of these
rather broad sweeping generalizations regarding treatment efficacy and effectiveness,
with a particular focus on attending to the inherent complexities of studying substance
abuse treatment at a micro-level.
Translating Large-Scale Treatment Research to Small-Scale Settings
The Gap Between Research and Practice in Substance Abuse Treatment
Generally speaking, despite the strong scientific underpinnings of psychotherapy
outcome research, the discrepancy between clinical practice and research continues to be
large (Godfried & Wolfe, 1996). This gap also exists within substance abuse treatment
field as the integration of science-based treatment into clinical practice remains the
exception, not the rule, even though pressure from a variety of sources (e.g., increased
consumer demand for treatment options, greater accountability for expenditures, high
value placed on the scientific method as the basis for developing effective treatments)
continues to mount in favor of enhanced integration (Lamb, Greenlick, & McCarty, 1998;
Marinelli-Casey, Domier, & Rawson, 2002). Explanations for this rift have often been
attributed to a lack of communication and cooperation between clinicians and
researchers; divergent perspectives on the relevance and utilization of each other’s
knowledge and methods of dissemination of this knowledge; and a lack of emphasis on
the transfer and implementation stages initiatives designed to blend research and practice
(Marinelli-Casey, Domier, & Rawson, 2002). In examining how the exchange of science
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and information between drug abuse treatment providers and researchers can be more
bidirectional, Bowser (1998) outlines a number of conditions that must be met:
First, treatment research has to be produced for practitioners and must be useful to
them. Second, practitioners must want to work with and provide information to
researchers. Third, researchers must be interested in what practitioners know and
want to know. And fourth, we assume that better information exchanges between
practitioners and researchers will improve client outcomes. (p. 136)
Clinicians and researchers who choose to engage in efforts to narrow the science-practice
gap through collaborative endeavors need to acknowledge that these circumstances are
met to varying degrees across research and treatment programs and should incorporate
assessment procedures to appraise these aspects of the partnership. The need for
collaborations amongst researchers and treatment programs within the field of substance
use disorders is great and the potential value of these ventures is yet to be fully realized.
One step individual substance abuse treatment programs can take in an effort to
strengthen their scientific foundation is to evaluate the utility of extant substance abuse
treatment literature as it relates to their particular program and the clients they serve.
Impetus for Applying Large-Scale Research Findings to Individual Programs
Why is it not only important, but critical to the advancement of the field, to determine
whether or not the aforementioned substance abuse treatment outcome and retention
findings can be applied at the local level of individual treatment programs? The reasons
are three-fold. Such knowledge is critical for the sake of treatment itself. Treatment
programs ultimately aim to serve clients and help them achieve favorable results as
defined by both the treatment program and the individual client. Learning more about
behavioral change processes and the variables related to “successes” (i.e., reduced
frequency of use, decreases problems related to substance use, improved relationships)
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and “failures” (i.e., inability to maintain abstinence, treatment dropout, increased
substance use-related problems) within a particular treatment program will enhance the
general knowledge base regarding the treatment of substance use disorders through the
substantiation or refutation of existing empirical evidence. Moreover, “treatment
practices are best driven by the cumulative evidence from a variety of studies over time”
(Project MATCH Research Group, 1998a, p. 599). Thus, such program-level
investigations are necessary to inform and shape general treatment practices, which will
contribute to diminishing the observed science-practice gap that exists within the field.
The study of substance abuse treatment and treatment processes at the local level
is also critical for the sake of the treatment program itself. Such findings can inform
programs and their providers about the particular aspects of their services and practices
that may facilitate or impede treatment progress and eventual outcomes. In essence, being
equipped with this information can assist programs and providers in making decisions
related to the allocation of resources, including time and money, in order to become more
efficient and cost-effective (Etheridge et al., 1997). In a similar vein, program-level
evaluation is critical for the sake of managed care policy. Providing data regarding
treatment retention and treatment outcomes and their relationship to client variables is
essential to informing managed care guidelines. As third-party payers continue shaping
the treatment delivery system and enforcing policies that may not be in the best interest
of the client, empirical evidence will be a key factor in effectively countering such
practices and providing education about what factors should be considered when such
decisions are made (Etheridge et al., 1997; Godfried & Wolfe, 1996). More specifically,
despite the fact that one of the most consistent findings in the drug abuse treatment
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literature is that length of treatment stay is a reliable predictor of favorable outcomes
(Hubbard et al., 1989; Hubbard et al., 1997; Simpson & Sells, 1982), it is this aspect of
treatment that is often been impinged upon by managed care and third-party payers. From
a structural standpoint, Etheridge and colleagues (1997) underscore why substance abuse
treatment programs need to attend to empirical evidence and critically evaluate how it
pertains to their respective programs:
A necessary ingredient for efficiency of program operation and for program
stability, treatment quality, and effectiveness is program-level control and
regulatory authority over the types and volume of clients coming to treatment and
control over the type of treatment delivered. This control seems essential for
program planning, resource allocation, staffing, and, ultimately, treatment
effectiveness. Larger system-level factors such as changes in treatment financing
and other system-level policy changes appear to be eroding program control over
the types of clients served, length of stay, treatment and services provided, and
other clinically relevant dimensions of treatment. In the absence of researchinformed treatment policy development, there is a danger that these system-level
forces will limit the options available for matching treatment intensity and type of
counseling and services to the nature and severity of clients’ presenting
conditions. (p. 259)
These motives for examining research findings and determining their applicability
at the local level are bolstered by the Stage Model of Behavioral Therapies Research put
forth by Onken, Blaine, and Battjes (1997) and later revised by Rounsaville, Carroll, and
Onken (2001). In this model, Stage Ia consists of the preliminary work that needs to be
carried out prior to the execution of a well-designed, controlled clinical trial: identifying
potential behavioral and psychosocial research and clinical findings related to treatment,
devising new therapies, operationally defining therapies in treatment manuals, developing
reliable and valid competence and adherence measures, and refining therapies based on
clinician and client feedback. Stage Ib is where this work undergoes pilot testing (Onken
et al., 1997; Rounsaville et al., 1997). Stage II involves establishing the efficacy of
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therapies and its components and has historically been the phase that has received the
majority of federal funding. It encompasses clinical trials examining the promising
therapies identified in Stage I, investigations to determine the mechanism(s) of action of
such therapies, and replication studies. It is Stage III that closely coincides with the
impetus for carrying out program-level research, as it aims to determine the
transferability and usefulness of the established efficacious treatment. It is at this
juncture, between research and practice, where a range of questions are examined and
evaluated: will the treatment work with real clients, therapists, and treatment settings;
what kind of training is required for practitioners to execute the new treatment skillfully
and safely; how should such training be delivered; and what are the costs and benefits of
employing such a treatment for a particular program(s) (Rounsaville & Carroll, 2001).
Such investigations are crucial to maintaining a sound scientific basis within the
substance abuse treatment delivery system, but are often accompanied by assorted
challenges in determining if an efficacious treatment is indeed effective in a real-world
setting.
Inherent Challenges of Applying Large-Scale Research Findings to Individual Programs
A noteworthy debate within the field of psychological treatment is if and how
results from RCTs are useful to practitioners. RCT proponents argue that clinicians
cannot truly provide the best quality care to patients if they disregard the findings of
research that determines the absolute and comparative efficacy of interventions.
Moreover, clinicians have an ethical responsibility to inform patients about treatment
options, make treatment recommendations, and eventually carry out treatment
interventions based on the best available scientific evidence, which ought to encompass
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RCTs (Persons & Silberschatz, 1998). On the contrary, there are numerous reasons why
RCT findings may not generalize to typical treatment settings. In order to establish
efficacy and detect “true” effects of an intervention, RCTs require a high level of
experimental control to curb the number of confounding variables and the extent of their
impact on outcomes. However, the maximization of internal validity comes at a price:
reduced external validity. Randomization procedures, strict inclusion and exclusion
criteria to ensure homogeneity within samples, and manualized treatment interventions
restrict the ability of RCT findings to inform science-practice linkages because these
conditions do not reflect “real world” clients and treatment delivery systems (Borkovec,
1997; Carroll & Rounsaville, 2003; Persons & Silberschatz, 1998; Tucker & Roth, 2006).
“While such speculative concerns do not diminish the unique strengths of randomized
trials, it is reasonable to ask (and study) whether patterns of outcomes observed in
ordinary practice settings parallel those from carefully controlled clinical research”
(Miller & Wilbourne, 2002, p. 276).
Although the DARP, TOPS, and DATOS research programs aimed to evaluate how
drug treatment was typically delivered and utilized a naturalistic methodology, they too
restricted participants to primarily drug users and carried out comprehensive assessment
procedures that may not be feasible for an individual treatment program. Particularly in
substance abuse treatment settings, the case mix is highly diverse, and clients often
present with multiple problems and/or diagnoses, including concurrent alcohol and drug
abuse or dependence (Carroll & Rounsaville, 2003; Persons & Silberschatz, 1998; Tucker
& Roth, 2006). In light of the merged substance abuse treatment systems predominantly
found in the U.S. private sector, which drew more from the alcohol treatment field
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(Institute of Medicine, 1990), combined alcohol and drug treatment may not provide
specific enough treatment for the range of substance use diagnoses present amongst
clientele in any given treatment program. This observation may suggest that different
factors may affect dropout and various corresponding approaches may be needed to
improve retention and, ultimately, outcomes for those who meet criteria for only an
alcohol use disorder, only a drug use disorder, or a polysubstance use disorder (Mertens
& Weisner, 2000).
At the same time, diversity in client composition alone is not an adequate explanation
for observed differences in treatment program retention rates. As a subset of DATOS
analyses implied, retention rates would still vary even if all programs within the same
modality would treat highly similar clientele (Simpson, Joe et al., 1997). Shifting focus to
the programs themselves, treatment interventions often markedly differ from the
randomized and highly specified interventions (i.e., certain number of sessions, particular
techniques used, timing of interventions, emphasis on uniformity and fidelity to the
protocol) evaluated in RCTs as clinicians tend to favor flexibility and attempt to tailor
interventions to meet the individual treatment needs of each client. Generally speaking,
substance abuse treatment is becoming more multi-modal and integrative, making it
increasingly difficult to operationalize within the confines of RCT investigations and
quasiexperimental or single group research designs (Persons & Silberschatz, 1998;
Tucker & Roth, 2006).
At a broader level, RCT and other large-scale research (e.g., DATOS) often combine
data across modalities and sites, which can ultimately conceal clinically significant
programmatic disparities that may be of value to individual treatment programs that are
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fairly comparable to certain study programs but not to others or not to the “typical” one
upon which results represent (Etheridge et al., 1997). Likewise, since DARP, TOPS, and
DATOS were carried out in community-based, publicly-funded treatment programs,
privately-funded agencies likely encounter difficulties in determining the applicability of
such research findings because disparities likely exist in clientele served, services
offered, and structure of treatment entry and delivery. The diversity within the research
itself, including varied questions of interest, methodologies, population(s) studied, and
variables examined, also makes it difficult for programs to determine the extent of
applicability of empirical findings because the likelihood that all of these characteristics
will match up with a particular program is highly unlikely. Plus, the dynamic quality of
clientele, treatment delivery processes, and managed care policies necessitates constant
evaluation as prior findings may become obsolete or less germane to a particular program
as it evolves and changes. Despite the aforementioned challenges associated with
ascertaining if and how empirical treatment findings filter down to the individual
program level, the ability of a program to answer these questions can impact the
treatment delivery system and ultimately improve treatment outcomes. Fortunately, a
constructive offshoot from the wealth of evidence derived from large-scale treatment
efficacy and effectiveness studies and specialized treatment evaluations is that this
information has been organized into a variety of comprehensive treatment models
designed to assist researchers and practitioners conceptualize the complex processes of
substance abuse treatment, describe how it works, and effectively evaluate it. Attention
will now shift to one such model.
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A Conceptual Framework for Substance Abuse Treatment Processes and Outcomes
The Texas Christian University Treatment Model
As Simpson (2004) noted, “psychotherapy, counseling psychology, and drug
treatment research has identified important therapeutic issues and domains, but these
finding have not been integrated efficiently into a conceptual scheme to guide clinical
application and improvements” (p. 102). Hence, Simpson’s drug treatment process and
outcome research program at Texas Christian University (TCU) aimed to incorporate
contributions from psychology and other addiction treatment and adopt both conceptual
and methodological approaches designed to capture the dynamic, complex, and
sequential nature of the treatment process over time (Simpson, 2001, 2004). TCU studies
over the past 20 years have spanned various populations and settings, though they
adopted corresponding assessment procedures and longitudinal data collection strategies
in both experimental and naturalistic investigations to allow for the compilation of
findings across projects to form a general treatment model (Simpson, 2001, 2004). The
TCU Treatment Model “focuses attention on sequential phases of the recovery process
and how therapeutic interventions link together over time to help sustain engagement and
retention, thereby improving patient functioning during treatment and after discharge”
(Simpson, 2004, p. 102). The primary features of the TCU Treatment Model are
illustrated in Figure 1.
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Figure 1. The TCU Treatment Model, representing sequential influences of patient
attributes, stages of treatment, and evidence-based interventions on post-treatment
outcomes. From “A Conceptual Framework for Drug Treatment Process and Outcomes,”
by D. D. Simpson, 2004, Journal of Substance Abuse Treatment, 27, p. 103.

The leftmost portion of the diagram identifies contextual influences on treatment
outcomes. Patient attributes including background characteristics, problem severity at
intake, motivation for change, and readiness for treatment are all factors deemed
important in making treatment placement and planning decisions. Historically, patient
sociodemographic variables have been fairly weak, inconsistent predictors of
posttreatment outcomes. Although the amount of variance accounted for by any one
client attribute tends to be fairly small, to the extent that a substance use disorder is
“viewed as a multidimensional dysfunction, no single variable should be expected to
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account for a large portion of variance” (Project MATCH Research Group, 1998b, p.
1309). Consequently, more empirical attention has been paid to exploring the complex
sociodemographic profiles of clients entering substance abuse treatment. With increased
measurement precision and better analytic techniques, investigators are better able to
identify the extent to which patient factors and their combinations mediate and moderate
treatment processes, retention, and eventual outcomes (Simpson, 2004). Indicators of
problem severity such as substance use history, legal status, social resources, and
psychological dysfunction, also affect early treatment experiences (i.e., program
participation, the development of rapport, satisfaction with treatment) and may serve as
gauges for identifying clients with specific treatment needs and others who may be at a
greater risk for disengaging and dropping out of treatment.
Simpson (2004) further elucidates two complementary, yet distinct, patient
attributes that contribute to early treatment processes: motivation for change and
readiness for change. The motivation for change concept is grounded in Prochaska and
DiClemente’s Transtheoretical Model, wherein the client’s position along the behavioral
change continuum is examined (Prochaska & DiClemente, 1992; Prochaska, DiClemente,
& Norcross, 1992), and Miller and Rollnick’s (2002) corresponding Motivational
Interviewing method, wherein the client’s intrinsic motivation to change is enhanced
through the exploration and resolution of ambivalence. On the other hand, readiness for
change refers to both a global readiness for personal change and a more specific readiness
for commencing a treatment program that involves particular treatment interventions. It
encompasses patient attributes such as motivation level, skills/resources, and
confidence/self-efficacy (Simpson 2001, 2004). Considering the dynamic quality of these
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motivational concepts, along with the fluctuating nature of treatment needs, the
aforementioned patient attributes need to be evaluated at the outset of treatment,
periodically during treatment, and following treatment. “Patient assessment is crucial not
only for the purposes of understanding treatment effectiveness, but also for developing
and maintaining treatment plans and measuring progress” (Joe, Broome, Rowan-Szal, &
Simpson, 2002, p. 183). Information regarding how pretreatment characteristics,
psychosocial functioning, and motivation factors affect one another and change over time
to impact treatment engagement, participation, rapport, satisfaction, and retention is
critical to deconstructing substance abuse treatment, understanding how treatment
enhances outcomes, and ultimately improving treatment delivery systems (Joe et al.,
2002; Simpson, 2004).
Simpson (2001, 2004) acknowledges the fact that client elements are only one
piece of the therapeutic puzzle as specific programs also possess preexisting
characteristics that impact how substance abuse treatment unfolds for their clients.
Although not depicted in Figure1, program attributes such as resources, staff skills,
climate, and clinical and program information management procedures have been
identified as factors to consider when examining treatment experiences and therapeutic
effectiveness, and thus need to be documented and evaluated regularly. Furthermore,
client characteristics and treatment retention rates vary widely across modalities and
therapeutic orientations. Even after controlling for these client differences, similar types
of programs still exhibit differential effectiveness, necessitating a closer examination of
how client attributes and program features interact at the individual program level to
influence treatment processes and outcomes (Broome, Simpson, & Joe, 1999; Simpson,
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Joe et al., 1997). In particular, Simpson (2004) outlines evidence-based interventions
designed to enhance specific aspects of treatment and recovery processes such as
improving patient readiness for treatment, program participation, therapeutic
relationships, early recovery, retention, and transition out of treatment, and posttreatment
outcomes. These interventions vary depending on the targeted action and are sequential
in nature (Figure 1).
Empirical Examination of the TCU Treatment Model
A critical component in evaluating the TCU Treatment Model’s potential utility at
the individual program level is to examine the findings of scientific evidence across
modalities, programs, treatment approaches, and client populations. The early
engagement portion of the hypothesized treatment model was tested with a subset of
DATOS data from clients enrolled in LTR (n=1,362), ODF (n=866), and OMT (n=981)
treatment programs (Joe et al., 1999). The structural equation modeling analyses
consisted of two stages. The first phase examined the relationships among treatment
readiness and three treatment process components: session attributes (i.e., frequency of
counseling session attendance, number of health topics discussed in session, and number
of other topics discussed); therapeutic involvement (counsel-patient rapport, patient
ratings of confidence in treatment that is effective, and patient feelings of commitment to
treatment); and time in treatment (i.e., 90 days for LTR and ODF clients and 360 days for
OMT clients). The model proposed that a reciprocal relationship between session
attributes and therapeutic involvement would emerge, with both of these components
positively influencing treatment retention. Moreover, treatment readiness was
hypothesized to positively impact therapeutic involvement (Joe et al., 1999). As
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expected, all of the hypothesized paths were statistically significant, and treatment
readiness was a strong positive predictor of therapeutic involvement for the LTR and
ODF modalities. For the OMT modality, all paths were significant except for the path
from session attributes to retention. However, the overall amount of variance in retention
explained by the hypothesized model was low across modalities: LTR (2%), ODF (6%),
and OMT (2%) (Joe et al., 1999).
The second phase of the analyses incorporated the impact of additional patient
pretreatment characteristics on both retention and the treatment process components. The
reciprocal relationship between session attributes and therapeutic involvement was
detected again, with both of these components having significant positive effects on
treatment retention for LTR, ODF, and OMT clients. Treatment readiness was also
positively related to therapeutic involvement across modalities (Joe et al., 1999).
Discrepancies emerged among client characteristics, however. For LTR clients,
depressive symptoms were positively related to session attributes and retention, while
hostility negatively impacted therapeutic involvement and retention. Other factors
positively related to treatment retention were alcohol dependence, legal pressure, and
being a minority, while cocaine use had a negative impact on retention. Furthermore,
being female and a minority was positively related to therapeutic involvement, suggesting
that such clients may have fared better in the LTR modality. Approximately 6% of the
overall variance in LTR retention could be explained by the model (Joe et al., 1999).
Some similar relationships emerged for ODF clients. Depression was positively related to
session attributes, while hostility negatively affected both therapeutic involvement and
retention. Males, Caucasians, and those who used cocaine also did not stay as long in
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ODF treatment as their respective counterparts. In contrast to LTR clients, alcohol
dependence was negatively related to treatment retention, and legal pressure had a
positive effect on session attributes and retention, but a negative effect on therapeutic
involvement. Approximately 12% of the overall variance in ODF retention could be
explained by the model (Joe et al., 1999). Negative influences on OMT tenure included
crack use and legal pressure. White clients also tended to have lower therapeutic
involvement. Approximately 4% of total retention variance in the OMT modality could
be explained by the model. Overall, these findings reinforce the hypothesized
relationships amongst session attributes, therapeutic involvement, treatment readiness,
and treatment retention and provide general support for the early engagement
components of the TCU Treatment Model.
Simpson and Joe (2004) employed more advanced structural equation modeling
techniques to examine the TCU Treatment Model from a new perspective. Specifically,
this investigation explored the sequential relationships of the early engagement treatment
process components (i.e., participation and therapeutic relationship) and the early
recovery treatment process components (i.e., psychosocial and behavioral changes) that
contribute to treatment retention and posttreatment outcomes (Simpson & Joe, 2004).
Participants were patients (n=711) admitted to three not-for-profit, community-based
OMT programs. Assessments were conducted at intake, throughout treatment, and one
year after intake. According to the model, it was expected that higher treatment readiness
would positively affect session attendance and that the cognitive mapping technique
would positively impact counseling rapport. Reciprocal positive relationships would
likely be detected between session attendance and counseling rapport (measured at month
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2), which would be related to lower opiate and cocaine use (measured at month 3).
Furthermore, it was hypothesized that greater counseling rapport would have direct
effects on lowered drug use during treatment and indirect effects on in treatment drug use
via improved psychological and social functioning (Simpson & Joe, 2004). With regards
to treatment retention, the model suggested that lower drug use during treatment and
treatment session attendance would positively impact 360-day treatment retention.
Increased time in treatment and lower in treatment drug use would reduce drug use at the
one-year follow-up point. Results provided support for the core components and
suggested sequential pathways of the TCU Treatment Model as all hypothesized
relationships were statistically significant and in the expected directions (Simpson & Joe,
2004).
Drug use following treatment was predicted not only by the time in treatment but
more importantly by a more detailed picture of dynamic elements that define
treatment process…Systematic measurement of these elements therefore offers a
way to monitor patient needs and progress in treatment, including responses to
interventions and better treatment management. (Simpson & Joe, 2004, p. 94)
Additional empirical investigations have directly and indirectly evaluated the TCU
Treatment Model and its respective components. Treatment retention, completion, and
outcomes have been examined in light of client attributes including various
sociodemographic characteristics (e.g., gender, age, race/ethnicity, education, income),
substance use severity variables, psychiatric symptoms, motivational factors, and social
support indicators. Treatment factors such as the therapeutic relationship and service
delivery elements have also been explored. Please refer to Tables 1 and 2 for a review of
the empirical findings pertaining to the features of the TCU Treatment Model and their
relationship to treatment retention/completion and treatment outcomes.
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Table 1.
TCU Treatment Model Factors Related to Substance Abuse Treatment
Retention/Completion Identified in the Empirical Literature
Author(s)

Sample

Major Finding(s)
Patient Attributes

Arfken et
al. (2001)

2,471 individuals
referred to publicly
funded treatment:
LTR, IOP, or
standard outpatient

Women comprised 27% of the sample and had sig. greater
problem severity at intake (lower income, more previous
treatments, more primary crack use, and higher ASI
composite scores in all domains except legal); women also
had sig. lower 30-day retention and treatment completion
rates across drugs of use and treatment settings

Bride
(2001)

305 men and 102
women treated in
either a mixed- or
single-gender
treatment settings

Treatment provided in single-gender settings did not
significantly increase treatment retention or completion
rates for either men or women.

Chou et al.
(1998)

Subset of 907 in
MM, 673 clients in
LTR, and 2,184 in
ODF treatment
programs from the
California Alcohol
and Drug Data
System

Program funding source interacted with gender for the
ODF modality: female clients had sig. lower retention
rates in programs only accepting public funding than those
that accepted both public and private funding; male clients
remained in treatment an average of 25 fewer days than
female clients in programs that only accepted public
funding, though had roughly the same length of stay in
programs receiving both public and private funding

Claus &
Kindleberg
er (2002)

260 clients referred
for residential or
outpatient
treatment
following an
central intake unit
assessment

Probation status and a history of physical or sexual abuse
predicted treatment dropout after 1 or 2 sessions, as clients
who were on probation were three times more likely to
drop out of treatment than those not on probation;
likewise, clients with an abuse history were also three
times more likely to drop out
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Author(s)

Sample

Major Finding(s)
Patient Attributes

Hser et al.
(2005)

1,073
methamphetamineabusing
individuals in
community-based
residential and
outpatient
treatment
programs

Treatment retention and completion rates were similar for
women and men across modalities; improvements from
baseline to 9-month follow-up were observed across ASI
domains for both women and men across modalities (with
only one exception, there was no change observed in
medical severity for men); women demonstrated sig.
greater improvements in family relationships and medical
problems than men, despite the fact that more of them
were unemployed, had childcare responsibilities, were
living with someone who used alcohol or drugs, had been
abused, and reported more psychological symptoms

McCaul et
al. (2001)

268 individuals in
a publicly-funded
substance abuse
treatment clinic
with residential,
IOP, and standard
outpatient services

Sig. predictors of more session attendance and longer
treatment duration included being Caucasian, being male,
and having a high employment ASI composite score;
substance use status (alcohol-only, drug-only, or alcohol +
drug) was not predictive of session attendance or
treatment duration

McKellar
et al.
(2006)

3,649 male
patients entering a
28-day VA
residential
treatment program

Individuals who were younger, reported more frequent
drug use, reported fewer symptoms of alcohol
dependence, and had poorer cognitive functioning were at
sig. greater risk for treatment drop-out; treatment
environment variables including perceiving less support
and more staff control sig. increased the odds of drop-out

Maglione
et al.
(2000a)

2,337
methamphetamine
users in publiclyfunded outpatient
treatment
programs in
California

Sig. predictors of 180-day treatment retention include age
(being 40+ years old), gender (female), a criminal justice
referral, and less severe drug use (used less than daily and
did not inject)

Maglione
et al.
(2000b)

2,570
methamphetamine
users in publiclyfunded residential
treatment

Sig. predictors of 90-day treatment retention include age
(being 25+ years old), gender (female), a criminal justice
referral, prior drug treatment, and less severe drug use
(used less than daily and did not inject)
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Author(s)

Sample

Major Finding(s)
Patient Attributes

Mammo &
Weinbaum
(1993)

12,697 outpatients
and intensive
outpatient
admissions for the
state of New
Jersey

Likelihood of not completing treatment was sig. higher for
females, those who are less educated, those employed in
less-skilled occupations, and the young

Mertens &
Weisner
(2000)

317 women and
599 men in an
HMO’s outpatient
alcohol and drug
treatment program

Fewer and less severe drug problems were sig. predictors
of retention for both men and women; for women, higher
retention was also predicted by having higher incomes
($20,000+), belonging to ethnic categories other than
African American, being unemployed, and having lower
levels of psychiatric severity; for men, predictors, higher
retention was also predicted by being older (40+ years
old), receiving employer suggestion to enter treatment,
and having abstinence goals

Mulligan et 111 individuals
from each of two
al. (2004)
trials randomly
assigned to
different
behavioral and
pharmacotherapies

Few differences were found between African American
and White participants in terms of demographic
characteristics and cocaine use outcomes; African
Americans completed sig. fewer days of treatment than
Whites; African Americans who received disulfiram
remained in treatment sig. longer than African Americans
who did not receive disulfiram

Roffman et
al. (1993)

Early dropouts (did not attend treatment after fourth
session) were younger, earned less income, and had a
higher level of psychological distress at intake than
completers (attended at least 7 sessions, including one of
the last two); late dropouts (attended treatment past the
fourth session but did not meet completion criteria) and
completers were of similar age, income, psychological
stress level, and confidence in maintaining future
abstinence; completers had sig. higher abstinence rates at
1-, 3-, and 6-month follow-up than the dropout groups

212 marijuanadependent
individuals
engaged in
outpatient
treatment
consisting of 10 2hour group
sessions spaced
over 12 weeks and
“booster” sessions
at 3- and 6-months
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Author(s)

Sample

Major Finding(s)
Patient Attributes

Satre et al.
(2004)

65 patients aged
55-77, 296 patients
aged 40-54, and
564 patients aged
18-39 who
participated in a
managed care
outpatient
treatment program

Older adults (55+ group) had sig. longer retention in
treatment than younger adults (18-39 group); older adults
were sig. more likely than younger adults to report
abstinence from alcohol and drugs during the preceding
month and preceding year at the 5-year follow-up point;
sig. predictors of abstinence for the preceding month at the
5-year follow-up were female gender, greater treatment
retention, and having no close family or friends who
encouraged alcohol or drug use at 5 years (age was not
significant)

Sayre et al.
(2002)

165 individuals
enrolled in a 12week/20-session
outpatient
treatment study of
Relapse Prevention
for the treatment of
cocaine
dependence

Classified as completers – attended all 20 sessions (35%),
late dropouts – attended 10-19 sessions (15%), or early
dropouts – attended less than 10 sessions (50%); sig.
predictors of dropout were being separated from spouse,
having less education, having more family/social
problems, and having a less extensive legal history; late
dropouts had sig. more years of education and poorer
psychiatric functioning as compared to early dropouts

Siqueland
et al.
(2002)

487 cocaine
dependent patients
randomized to 4
psychosocial
treatments
spanning across 9
months

Younger, African American, unemployed, and less
educated patients stayed in treatment for less time; higher
psychiatric severity kept men in treatment longer but put
women at risk for dropping out; unemployed males had
higher retention than unemployed females; employed
females had higher retention than employed males

White et al. 138 patients in an
(1998)
outpatient
substance abuse
program

Discriminant function analyses suggested that ASI
composite scores and severity ratings were not useful
predictors of treatment attrition, though individual items
identified as sig. predictors included: Hispanic ethnicity,
absence of a professional skill, shorter time since last
hospitalization, cocaine or cannabis use in the previous 30
days, total number of family members with drug
problems, presence of emotional abuse in previous 30
days, and concern with family problems
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Author(s)

Sample

Major Finding(s)
Patient Attributes

Wickizer et 5,827 client
al. (1994)
records from statefunded alcohol and
drug treatment
programs in 4
treatment
modalities

Completion rates were highest for intensive inpatient
alcohol treatment (75%) and lowest for intensive
outpatient drug programs (18%); variables most
consistently related to treatment completion were age and
education, as older clients and clients with more education
were more likely to complete inpatient as well as
outpatient treatment
Substance Use Severity

Alterman
et al.
(1996)

95 low SES
cocaine-dependent
veteran men from
a 4-week day
hospital treatment
program

Cocaine use in 30 days prior to treatment and a positive
initial cocaine toxicology screen were sig. predictors of
dropout; recent and lifetime ASI indices were not sig.
predictors of dropout

De Leon et
al. (1997)

1,398 primarily
African American
(66%) men (70%)
entering an LTR
treatment program

30-day and 10-month retention rates for groups based on
primary drug of use (cocaine, opiate, marijuana, and
alcohol) are similar, except the primary alcohol group had
sig. higher retention rates than the primary opiate and
marijuana users;

Heil et al.
(2001)

302 cocainedependent
individuals
admitted to a
university-based,
outpatient research
clinic for the
treatment of
cocaine
dependence via
one of two
treatment
conditions

No sig. differences emerged for average number of weeks
retained in treatment between clients with concurrent
alcohol dependence (alcoholics) and those without
(nonalcoholics), despite the fact that alcoholics had greater
problem severity in several domains at intake; a sig.
interaction was noted between alcohol-dependence status
and type of treatment received – alcoholics tended to
remain in treatment longer than nonalcoholics when
treated with intensive behavioral counseling plus
incentives, but the reverse was true when treated in control
conditions
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Sample

Major Finding(s)
Substance Use Severity

Patkar et
al. (2004)

140 substancedependent
volunteers
recruited from a
publicly-funded
12-week outpatient
substance abuse
treatment program

Participants were categorized based on primary
substance(s) o f use: alcohol, cocaine, or multisubstance;
multisubstance group reported sig. greater drug, alcohol,
and psychiatric problems on the ASI, displayed sig. higher
impulsivity and anxiety scores, and provided a sig. higher
proportion of dirty urines at admission than other groups;
overall, 3 groups had equivalent improvements on the
majority of the during treatment and follow-up outcomes
at 9 months – substance use, dirty urines, days in
treatment, session attendance, dropout, symptom
reduction, benefit ratings

Rawson et
al. (2000)

Stimulant users
(500
methamphetamine,
224 cocaine)
entering outpatient
an treatment clinic

No sig. differences in retention rates between
methamphetamine and cocaine users, despite sig.
differences in pretreatment characteristics including
gender, ethnicity, age, education, marital status,
employment status, and legal history; most sig. predictor
of retention was reported years of heavy drug use, with
each year of use resulting in a longer stay

RowanSzal et al.
(2000)

900 cocainedependent clients
from DATOS in
LTR treatment

Clients who preferred crack cocaine were sig. more likely
to be female and African American and sig. less likely to
have a legal history and use alcohol or marijuana on a
weekly basis; crack preference was a sig. predictor of 90day retention as crack users were only about 2/3 as likely
to stay in treatment for 90 days as were non-crack users

Veach et
al. (2000)

509 individuals
admitted to an
outpatient
substance abuse
treatment program

Those retained in treatment, as compared to those who
dropped out, were more likely to be alcohol-dependent,
were less likely to be cocaine-dependent, were more likely
to be employed, and had sig. more problems on their
treatment plans
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Sample

Major Finding(s)
Psychiatric Symptom Severity

Broome et
al. (1999)

DATOS subset of
2,362 LTR clients,
1,896 ODF clients,
and 1,011 OMT
clients

LTR clients with current depressive symptoms were sig.
more likely to stay in treatment for at least 90 days, while
those with more hostility were more likely to drop out
prior to this point; OMT clients with a lifetime Axis I
depression or anxiety disorder diagnosis were sig. more
likely to drop out of treatment prior to 360 days; in ODF,
no consistent or statistically significant predictive pattern
emerged across programs

Castel et
al. (2006)

2,784 clients of the
outpatient
programs at a
comprehensive
addictions
treatment facility
in Canada

Overall, 69% of clients screened positive for at least one
cluster of psychiatric symptoms (depression, anxiety,
mania, schizophrenia-like, eating, conduct disorder) –
27% scored positive for one cluster, 19% were positive for
two clusters, and 22% were positive for three or more
clusters; multimorbidity (2+ clusters and 2+ substance use
disorders) was positively associated with being female,
unemployment, fewer legal problems, less social support,
and drug use; these clients also attended more visits and
had a lower attrition rate

Curran et
al. (2002)

126 consecutively
admitted males to
a 3-week VA IOP
treatment program

BDI scores emerged as a sig. predictor of early attrition
(within first 5 days/visits); clients scoring 33+ were more
likely to drop out of treatment early as compared to those
who scored < 22; polysubstance users had the highest
mean BDIs; age, race, education, marital status, number of
prior treatments, severity of use, employment status,
PTSD symptoms, and a dichotomous measure of meeting
DSM-IV criteria for major depression were not sig.
predictors of attrition

Daughters
et al.
(2005)

122 primarily
African-American
(95%) men (71%)
entering an LTR
treatment facility

Early dropouts (completed < 30 days) were sig. less likely
to persist on psychological stressors than 30-day
completers; no differences between these groups were
noted for persistence on physical stressors; lower levels of
psychological distress tolerance were predictive of
dropping out prior to 30 days, though were not predictive
after this point; no sig. differences were noted between 30day completers and dropouts on demographic variables,
legal status, psychiatric status including previous
diagnoses and current symptomology
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Major Finding(s)
Psychiatric Symptom Severity

Haller et
al. (2002)

78 drug-dependent
women in a
gender-specific
day treatment
program
categorized into 3
groups based on
cluster analysis of
MCMI-II scores

Justus et al. 596 primarily male
(2006)
(96%) veterans
enrolled in a
homeless
rehabilitation
program
Ross et al.
(1997)

308 male and 106
female with
moderate-severe
substance
dependence
referred for
outpatient and
inpatient treatment
programs

Group 2 (n = 28) evidenced severe addiction, psychiatric
(Axis I), and personality (Axis II) problems and had the
worst treatment completion rate (26%); Group 3 (n = 29)
was characterized by fewer Axis I problems and
prominent addiction and externalizing (Cluster B)
personality deficits and had the highest completion rate
(76%); Group 1 (n = 21) presented with less severe
addiction and personality problems and minimal distress
had an attrition rate between the other two groups (56%)
Clients who were younger, female, and currently
diagnosed with a depressive disorder demonstrated sig.
higher rates of treatment retention and completion;
diagnosis of a current personality disorder or history of
psychiatric treatment was related to sig. poorer rates of
retention and completion
Somatization scale scores on the SCL-90-R emerged as
the only sig. predictor of treatment completion, with
higher levels of somatization being associated with a
poorer completion rate; tendency noted for clients
reported more severe symptomatology to not start
treatment programs to which they had been referred,
though once clients entered treatment, there was a modest
positive correlation between length of stay and symptom
severity
Motivation/Readiness

Ball et al.
(2006)

24 individuals who
reported reasons
for prematurely
dropping out of
outpatient
treatment

Loss of motivation/hope and interpersonal problems with
staff were most common reasons cited for dropping out;
problem severity and logistical conflicts with treatments
were least often reported
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Motivation/Readiness

Carrol et
al. (2006)

423 substance
abusers entering
outpatient
treatment in 5
community-based
settings

Participants were randomized to receive either the
standard intake session or the same session in which
motivational interviewing (MI) techniques were
integrated; MI group had sig. better retention and attended
more sessions at the 28-day follow-up point, though sig.
differences had dissipated by the 84-day follow-up; no sig.
differences were found between groups on substance use
outcomes at either follow-up point

Carroll et
al. (2001)

60 adults referred
for substance
abuse evaluation
by a child welfare
worker

Participants were randomized to receive either the
standard intake session or the same session in which MI
techniques were integrated; rate of participants attending
at least one treatment session following the evaluation was
sig. higher for the MI group; no sig. differences were
detected between groups for percentage of participants
attending 3+ sessions

De Leon et
al. (1997)

1,398 primarily
African American
(66%) men (70%)
entering an LTR
treatment program

Motivation scores were the most consistent predictors of
short-term (30-day) and long-term (10-month) retention
for primary cocaine users and opiate users, less consistent
among primary marijuana users, and not apparent for
primary alcohol users; demographic variables (age,
gender, race/ethnicity, legal status) were inconsistently
related to retention depending on primary drug use
category and retention length

Demmel et
al. (2004)

51 patients who
started a 6-week,
CBT-focused IOP
alcohol treatment
program

Patients were randomly assigned to a motivational (n=24)
or educational (n=27) procedure at the outset of treatment;
motivational group had sig. higher Recognition and
Taking Steps and lower Ambivalence (on the
SOCRATES) after the intervention (2 weeks) and sig.
higher Recognition at the end of treatment than the
education group; no sig. between-group differences were
noted between for engagement in treatment (attendance)
or dropout; for the entire sample, low Ambivalence was
associated with dropout
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Motivation/Readiness

Donovan et 654 individuals
al. (2001)
awaiting publicly
funded drug
treatment

Motivational attrition prevention intervention designed to
increase commitment to and motivation for treatment
while awaiting treatment admission did not have a
differential effect on treatment entry, completion, or
outcomes compared to the standard waiting list

Joe et al.
(1998)

DATOS subset of
2,265 LTR clients,
1,791 ODF clients,
and 981 OMT
clients

Treatment readiness (i.e., degree of commitment to active
change process through participation in a treatment
program) was a sig. predictor of 90-day retention for LTR
clients and 360-day retention for OMT clients; problem
recognition (i.e., level of personal acknowledgement of
drug use problems) was a sig. predictor of 90-day
retention for ODF clients; these motivation factors were
more important than socio-demographic, drug use, and
other background variables

Mullins et
al. (2004)

71 pregnant
women referred for
outpatient drug
treatment by child
welfare due to
prenatal drug use

Participants were randomly assigned to receive 3 MI
sessions or watch two educational videos and have a home
visit in addition to treatment as usual; treatment retention,
group attendance (weekly psychoeducational and
substance abuse groups), and urinalysis results were not
sig. different amongst these groups during 8 weeks of
treatment

Simpson,
Joe, &
RowanSzal (1997)

435 OMT patients
who completed an
interview 12
months after
treatment
discharge

Sig. predictors of more favorable outcomes (i.e., reduced
drug use, alcohol use, and criminal involvement) included
being over 35, having lower injection frequency prior to
admission, having higher motivation for treatment (i.e.,
desire for help), and being retained in treatment for at least
360 days; length of treatment stay was predicted by higher
patient motivation at intake and early program
involvement (i.e., greater session attendance and higher
counselor ratings of performance during treatment)
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Social Support

Broome et
al. (2002)

748 patients from
DATOS in shortterm inpatient
programs

After controlling for pretreatment use, posttreatment
social support networks were the most consistent
correlates of outcomes; patients in a deviant peer network
or who lived with a drug or alcohol user during the
follow-up year had 3 times the odds of weekly cocaine use
and 2 ½ times the odds of frequent (3+ times per week)
drinking

Dobkin et
al. (2002)

Consecutive
admissions to a
Canadian
outpatient
substance abuse
treatment program
assessed at intake
(n=206) and at 6month follow-up
(n=172)

High and low social support groups demonstrated sig.
declines in negative affect and severity of substance
abuse, though symptoms of depression and psychological
stress were sig. higher at intake and at follow-up for the
low social support group; low social support patients
reported sig. higher alcohol and drug abuse severity at
follow-up; after controlling for time in treatment, higher
levels of social support were a modest predictor (6% of
variance) of more favorable alcohol-related outcomes (not
drug),; drop-out rates were sig. higher for patients with
low social support

Griffith et
al. (1998)

960 opiod drug
users admitted to
three publicly
funded methadone
clinics
participating in the
DATAR project

Hypothesized model examining how perceived family and
peer relationships are related to specific treatment process
variables (motivation and engagement) found support; a
history of poor family relations was related to perceived
family dysfunction and peer deviance at treatment entry;
these 2 factors in turn predicted poor psychosocial
function, whish was related to higher levels of motivation;
higher motivation was associated with greater treatment
engagement, which was associated with reduced opiod use
and criminality at follow-up (12 months after leaving
treatment)

Westreich
et al.
(1997)

66 patients
enrolled in a 21day, inpatient
program

Homeless status and low initial perceived social support
from family scores were sig. predictors of completion
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Treatment Factors

Hser et al.
(2004)

1,939 patients
from communitybased residential
and outpatient
treatment
programs

Path analysis results indicated that greater service
intensity and satisfaction were positively related to either
treatment completion or longer treatment retention, which
in turn was related to favorable treatment outcomes (30day abstinence period, ASI drug score of 0, no criminal
activity, and lived in the community) at the 9-month
follow-up point

Meier et al. Review of the
(2005)
impact of the
therapeutic
alliance on drug
treatment retention
and outcomes

Early therapeutic alliance appears to be a consistent
predictor of engagement (session attendance) and
retention in drug treatment and seems to influence early
improvements during treatment, though is an inconsistent
predictor of posttreatment drug use and other outcomes

Simpson et
al. (1995)

557 clients from
DATAR who
completed at least
3 months of
outpatient MM
treatment and
attended at least
one session per
month

Higher session attendance was sig. related to less frequent
drug use and positive perceptions of therapeutic
interactions by both counselors and clients; being white,
being perceived by counselors as having higher treatment
motivation and better rapport in month 1, and receiving
counseling that emphasized problem-solving applications
in month 1 were sig. predictors of higher overall session
attendance in the first 3 months of treatment

Simpson,
Joe,
RowanSzal, &
Greener
(1997)

527 daily opiod
users who
remained in
outpatient MM
treatment for a
minimum of 3
months

Participants were randomly assigned to a cognitively
enhanced (i.e., utilized node-link mapping, a tool for
improving communication and problem solving) or
standard treatment condition; counseling enhancement
was positively related to a stronger therapeutic
relationship between counselor and patient, which had a
positive reciprocal relationship with session attendance;
better therapeutic relationships and higher session
attendance were sig. predictors of longer retention; better
treatment relationships was also related to less drug use
during treatment, which in turn was also a sig. predictor of
longer retention
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Table 2.
TCU Treatment Model Factors Related to Substance Abuse Treatment Outcomes
Identified in the Empirical Literature
Author(s)

Sample

Major Finding(s)
Patient Attributes

Fiorentine
302 clients who
et al. (1999) entered outpatient
drug treatment
programs in the
Los Angeles
metropolitan area

For female clients, 9% of variance in treatment
engagement (average weekly sessions X weeks in
treatment) was related to client variables with
increased engagement related to more pretreatment
arrests, higher pretreatment alcohol use, and less
problems with memory and concentration; 21% of
this variance was attributable to treatment
experiences including perceived helpfulness of life
skills and medical services and belief that counselors
“cared a lot about them”; for men, no pretreatment
characteristics were associated with engagement
while 27% of the variance could be accounted for by
perceived helpfulness of medical and transportation
services and relapse prevention training

Hser et al.
(2003)

511 patients
enrolled in MM,
residential,
inpatient, and
outpatient
treatment
programs

No sig. differences between men and women in
measures of drug and alcohol use at the 1-year
follow-up point; sig. positive predictors of drug
abstinence for women included greater readiness for
treatment and longer time in treatment, and sig.
negative predictors included being in MM programs
and multiple drug use; for men, positive predictors
included being in residential programs (as opposed to
outpatient) and longer treatment retention, and
negative predictors included being in MM programs
and having a spouse who also used drugs

Jarvis
(1992)

Meta-analysis
examining the
magnitude and
direction of trends
of sex difference
in outcomes

Women appear to have better results in the first year
of follow-up, while men have better results after the
first follow-up year; however, estimated differences
were small and derived from a heterogeneous sample
of studies
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Substance Use Severity

Booth et al.
(1991)

255 consecutive
admissions to a
21-day inpatient
VA alcohol
treatment program

For 98 patients readmitted at least once for alcoholrelated problems within 15 months of discharge,
variables related to chronicity and severity of alcohol
use were positively related to time to readmission,
while polysubstance use and other psychiatric
variables (depression, antisocial personality traits)
were not predictive

Flannery et
al. (2004)

Symposium
examining
differences in
demographic
characteristics and
treatment
outcomes in
alcohol and
cocaine dependent
individuals

Individuals with primary cocaine-dependence (CD)
are more likely to be younger, African American, and
have experienced more negative consequences than
those with alcohol-only dependence (AD); CD
persons responded as well as AD persons to a
community 12-step oriented outpatient treatment, a
standardized CBT approach, and a less standardized
CBT program; individuals dependent on both alcohol
and cocaine (CAD) experienced more psychological,
interpersonal, and social problems than those with
CD only; CAD individuals who participated in an
aftercare program following 1 month of IOP
treatment had similar drinking outcomes during the
aftercare program and at follow-up (9 months) than
those with AD only, despite seeming more impaired
before treatment
Psychiatric Symptom Severity

Charney et
al. (2005)

326 consecutively
recruited patients
entering outpatient
addiction
treatment in
Canada

Majority of the sample (63%) presented with
comorbid psychiatric symptoms – 15% depressive,
16% anxiety, and 32% combined depressive and
anxiety; these 3 groups were more likely to abuse
alcohol and other drugs, than the no psychopathology
group, who was more likely to abuse alcohol only;
depression-anxiety group had lowest rate of
abstinence (40%) at 6 month follow-up; concurrent
depression-anxiety symptoms at intake had a sig. but
small effect on outcomes beyond factors that known
to influence outcome: days in treatment, primary
drug of abuse, and frequency of use
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Psychiatric Symptom Severity

Chen et al.
(2006)

230 mostly male
patients (97%)
with dual
substance use and
psychiatric
disorders who
received high or
low serviceintensity care at a
residential
substance abuse
program

43% rated in high-severity category (baseline
substance use and psychiatric symptoms) while 57%
were classified as moderate severity; high-severity
patients treated in high-intensity programs had sig.
better alcohol use, drug use, and psychiatric
outcomes, higher service utilization, and greater costs
by the 1-year follow-up than counterparts treated in
low-intensity programs; for moderate-severity
patients, high-intensity programs improved outcomes
for drug use only and exhibited higher service
utilization, but did not have greater health care costs

McKay &
Weiss
(2001)

Review of alcohol
and drug treatment
studies with
follow-ups of 2+
years

Psychiatric severity at baseline was a sig. predictor of
substance use outcomes in the highest percentage of
studies, although the nature of the relationship varied;
stronger motivation and coping at baseline
consistently predicted better drinking outcomes

Pirard et al.
(2005)

700 uninsured or
Medicaid insured
substance abusers
in residential or
day treatment

Abused participants were sig. more likely to be
women and were more impaired at baseline on ASI
family/social and psychiatric severity; abuse group
used heroin and cocaine sig. less frequently in favor
of alcohol or polydrug abuse: abuse history was not a
sig. predictor of completion of the intake session; at
1-year follow-up, abuse group had sig. worse
psychiatric status and more psychiatric
hospitalizations and outpatient treatments than the
nonabused group, though similar alcohol and drug
severity
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Motivation/Readiness

Demmel et
al. (2004)

350 alcoholdependent
German inpatients

Readiness to change, as measured by the Taking
Steps and Recognition SOCRATES subscales, were
significant predictors of whether a client relapsed
within the 3-month follow-up period; these measures
accounted for 9.4% of the variance while background
variables and severity of use explained only 6%;
Taking Steps was also positively related to
pretreatment self-efficacy

Hewes &
Janikowski
(1998)

Nonrandom
sample of 31
individuals with
primary alcohol
problems who
completed
treatment at an
inpatient or
outpatient
program

Participants were categorized into 3 stages of
readiness for change (Recognition, Ambivalence,
Taking Steps); all participants showed sig. reductions
in alcohol use problem severity across a range of
ASI domains at the 30-day follow-up; no sig.
differences were noted between these groups for any
outcome measure

Social Support
Booth et al.
(1992)

61 consecutive
admissions to a
21-day inpatient
VA alcohol
treatment program

Patients who received high levels of “Reassurance of
Worth” from family and friends while in treatment
were less likely to be readmitted (20%) in the
subsequent year than patients reporting moderate
(25%) or low levels (61%)
Treatment Factors

Dearing et
al. (2005)

208 clients
voluntarily
seeking outpatient
treatment for
alcohol problems

Positive expectations about therapy, greater session
attendance, and positive perception of the working
alliance appeared to predict greater client satisfaction
and, in turn, more positive 6-month posttreatment
drinking-related outcomes: abstinent days, drinks per
drinking day, and drinking-related consequences
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Fiorentine
& Anglin
(1996)

330 clients who
entered outpatient
drug treatment
programs in the
Los Angeles
metropolitan area

Counseling frequency predicts relapse above what is
predicted by treatment completion status, with more
frequent group and individual sessions (as opposed to
family sessions or 12-step meetings) being associated
with lower levels of posttreatment relapse (drug use
during the 6 months prior to follow-up interview);
frequent participants of group and individual
counseling in treatment who continued to be frequent
participants in 12-step meetings posttreatment had
the lowest rates of relapse

Joe et al.
(2001)

2 cohorts of
outpatients being
treated for
methadone (354
patients in
community-based
nonprofit
programs and 223
patients from a
private for-profit
program)

During treatment ratings made by counselors of
therapeutic involvement and relationships with
patients (i.e., counseling rapport) was a more
consistent predictor of 1-year treatment outcomes; a
lower level of rapport was a sig. predictor of more
cocaine use and criminality, both by itself and after
adjusting for treatment retention, satisfaction with
treatment, and post-treatment self-report of drug use,
illegal activity, and arrests during the prior 6 months

Long et al.
(2000)

188 consecutive
admissions to a
cognitive
behavioral
addiction unit
therapy program

Classification of drinking outcomes included remitted
drinking (abstinent or nonproblem drinking) and
relapsed drinking (drinking but improved or
unimproved); sig. predictors of more favorable
outcome included higher self-efficacy in positive
social situations, reduction in psychological
symptoms during treatment, greater program
involvement, lower perception of staff control, and a
greater perception of treatment as helpful

Utilizing Taxonomic Methods to Narrow the Research-Practice Gap
Value of Taxonomic Methods
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Despite the range of research questions and methodologies targeting assorted
treatment modalities and clientele outlined in Tables 1 and 2, results of these inquiries
have not produced consistent, reliable profiles of clients who are retained in substance
abuse treatment and achieve a positive treatment outcome and profiles for those who drop
out of treatment prematurely (McClellan & McKay, 1998; Stark, 1992). As Carise and
Gurel (2003) note:
There is no ongoing, generalizable, descriptive information on such basic
characteristics as demographics; types and amounts of substances used prior to
treatment entry; or the nature and severity of addiction-related problems in the
areas of medical health, employment, criminal activity, family relationships, or
psychiatric status. The gaps created by this lack of information on the population
of substance abusing or dependent individuals in our nation’s treatment system, as
well as limited information at state and local levels on the treatment provided, has
been recognized as a problem by the Office of National Drug Control Policy. (p.
181)
Instead, substance abuse treatment research results often merely delineate lists of
differences between men and women, between older clients and younger clients, between
clients who primarily use alcohol and those who primarily use other drugs, between those
who are motivated for treatment and those who are less motivated for treatment, and the
list can go on (Luke et al., 1996). Consequently, there is a clear need for more
comprehensive descriptions of clients and their respective attributes, particularly at the
individual program level, in order for researchers, clinicians, and other key stakeholders
gain a better understanding of who is participating in substance abuse treatment programs
across the country. Questions remain regarding what methods would be most suitable and
valuable for such an endeavor. Particularly in the behavioral health field, where pressure
exists to individually tailor treatment depending on the distinct needs of clients, clinicians
often aim to identify groups of individuals that will respond well to similar treatment
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modalities, approaches, and interventions (Rapkin & Dumont, 2000). Likewise, research
methods that seek to ascertain the group composition of a heterogeneous sample based on
the characteristics of the individual cases that comprise it (i.e., taxonomic methods) could
potentially assist treatment programs in determining if retention rates and outcomes
systematically vary amongst clients, while also expanding the descriptive knowledge
base about the characteristics of those presenting for treatment. “The goal is to form
meaningful systems of classification that can be used to distinguish members of a
population on important features” (Rapkin & Dumont, 2000, p. S404). In this instance,
the “important features” would consist of the dimensions of identity and behavior that
have been linked to substance abuse treatment retention and outcomes.
There are several reasons why taxonomic methods are appropriate tools to utilize
in the study of heterogeneous groups, such as clients in a particular substance abuse
treatment program. Instead of emphasizing relatively linear associations among variables
within an aggregated dataset, such methods focus more on the prevalence of occurrence
of different patterns of variables, which can potentially provide insight into and deeper
exploration of the complex relationships among these variables (Rapkin & Dumont,
2000). Additional questions and hypotheses about these groups and the connections
among variables (i.e., identifying which ones are predictors, covariates, and/or mediators)
within them may also be raised and tested after the groups are detected. “Ideally,
taxonomic research may involve a complementary relationship between theory and
empirical description” (Rapkin & Dumont, 2000, p. S406). Through the application of
taxonomic methods within theoretical frameworks, the value of such research is enhanced
because a direct link between science and practice is created.
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Consequently, in addition to exploring how clients who complete an intensive
outpatient chemical dependency treatment program at a nonprofit, freestanding mental
health clinic differ from clients who do not complete treatment on pretreatment variables
(e.g., sociodemographic characteristics, substance use history, psychiatric symptoms,
motivation for treatment, social functioning), this study will determine if meaningful
subgroups of this client population be identified. Such analyses are better able to
accurately capture and describe the composition of a sample because they do not merely
determine the presence distinct variables, but rather detect the prevalence of patterns of
variables, which are more representative of the complexity of individuals that comprise
the sample. Moreover, it is critical for treatment programs to understand how group
characteristics may relate to successful completion of programs because “group
composition may play a role in determining participation and treatment outcomes,
especially if members who are in some regard ‘outsiders’ prove to be more likely to drop
out (Rapkin & Dumont, 2000, p. S413). At the micro-level, such information regarding
the presence of a certain pattern(s) of pretreatment characteristics could be used to
quickly identify clients that may be at risk for dropout, so the treatment team can
intervene to reduce this risk. At the macro-level, identifying groups of clients that share
certain commonalities (e.g., sociodemographic characteristics, substance use history,
motivation for treatment) may help programs identify clientele who may be more or less
suitable for their program based upon the treatment program’s values, approaches, and
interventions.
Taxonomic Research in Alcohol Use Disorders
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Research has been undertaken examining potential subtypes of substance abusing
or dependent individuals, with much work being focused on alcoholism and based upon a
wide range of dimensions, symptoms, and characteristics. Babor (1997) noted:
The search for alcoholic subtypes has had a long and varied history, with little to
guide its progress but clinical intuition during the pre-Jellinek years leading up to the
modern era of alcohol studies. With the development of multivariate techniques and
improvement in clinical assessment technology, typology research has experienced a
renaissance. (pg. 1665-1666).
Characteristics that have been examined include drinking history, pattern(s) of drinking,
severity of dependence, gender, personality traits, comorbid psychiatric symptoms,
cognitive impairment, sociopathy, and familial history (Bohn & Meyer, 1999). From
these inquiries have emerged a variety of subclassifications of individuals with alcohol
problems.
Early typology investigations of individuals with alcohol use disorders tended to
focus on a single, defining characteristic. Babor, Dolinsky, and associates (1992)
reviewed five unidimensional typologies that had received the majority of attention in the
empirical literature up to that point in time: gender comparisons, primary vs. secondary
psychopathology associated with alcoholism, the gamma-delta distinction, familial
alcoholism, and subtyping by various personality factors. Cumulative gender research
suggested that female alcoholics tended to have a later onset of alcohol dependence and a
more rapid course of symptom development as compared to their male counterparts.
Female alcoholics also generally had a higher prevalence of comorbid psychiatric
disorders, particularly depression, while male alcoholics were more likely to exhibit
antisocial personality traits. Additional classification efforts suggested categorizing
female alcoholics based on if and when comorbid psychopathology developed. Primary
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alcoholism was a term used to describe individuals who did not experience comorbid
psychopathology or who began to experience psychiatric symptoms following the onset
of alcohol dependence, whereas individuals who fall into the secondary alcoholism
category were persons who experienced psychiatric symptoms prior to the onset of
alcohol dependence (Schuckit, Pitts, Reich, King, & Winokur, 1969).
Babor, Dolinsky, et al. (1992) also described Jellinek’s gamma-delta distinction
which was based on three delineating characteristics in alcohol dependent individuals:
etiological elements, dependence process, and types of drinking consequences.
Psychological vulnerability was an underlying factor in the development of dependence
in gamma alcoholics. Even though gamma alcoholics were generally abstinent between
drinking episodes, their drinking was characterized by a loss of control and inability to
stop drinking and often resulted in severe damage to their health and interpersonal
relationships. On the contrary, delta alcoholics were able to generally limit their
consumption, but were unable to abstain for even short periods of time. Sociocultural
elements including ease of access to alcohol and societal encouragement to drink
regularly were purported as the etiological factors in delta alcohol dependence.
Familial/genetic theories and personality influences were also reviewed by Babor,
Dolinsky, and colleagues (1992). In general, alcohol-dependent individuals with a family
history of alcoholism in first-degree relatives tended to have an earlier onset of problem
drinking, more intrapersonal and interpersonal problems associated with their drinking, a
faster course of symptom development, and higher degree of physiological dependence
than alcohol-dependent individuals without a family history of alcohol problems in firstdegree relatives. Antisocial personality disorder has been considered a cardinal trait of a
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certain subtype of alcoholic and is associated with earlier age of onset, quicker
progression to problem drinking, and more severe problems stemming from drinking.
Poorer treatment prognosis and outcomes have also been linked to antisocial behavioral
traits. The Minnesota Multiphasic Personality Inventory (MMPI) has also been used to
classify alcoholics into three subgroups: neurotic, psychotic, and psychopathic.
Babor, Dolinsky, et al. (1992) subsequently evaluated the discriminative power
and predictive validity of these five classification schemes with a heterogeneous sample
of inpatients in three different residential treatment programs. Multiple classification
analysis, survival analysis, and discriminant function analysis were employed to compare
the relative discriminative power and predictive validity of these typologies. Results
encapsulated the shortcomings of unidimensional categorical systems. There was a high
degree of overlap among certain subtypes across models (i.e., familial alcoholism,
antisocial personality traits, and impulsivity tended to cluster in men). When significant
discriminations were detected for a particular typology, they were generally limited to
areas closely related to the defining characteristics of that particular typology (i.e., the
gamma-delta typology differentiated significantly on measures of alcohol consumption
and consequences of drinking). Ultimately, none of the single factors emerged as a strong
predictor of treatment outcomes including future alcohol consumption, psychological
functioning, alcohol dependence, and medical status, which is the missing link in the
study of alcohol typologies that can have the largest impact clinical practice and
treatment policy. The authors also advocated for the use of empirical grouping strategies
to explore naturally occurring commonalities, as opposed to theoretically-constructed
ones, in samples of alcoholics and to identify homogeneous subgroups of this population.
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Armed with progressively more sophisticated methodological techniques, newer
generation typology studies of persons with alcohol use disorders have moved beyond
examining a single defining dimension, such as personality or gender, to exploring
multifaceted schemes comprised of pluralistic characteristics (Babor, Dolinsky et al.,
1992). Cloninger and his associates (1987, 1988, 1989, as cited in Bohn & Meyer, 1999)
utilized methods of genetic epidemiology to identify subtypes of alcoholics and longterm alcohol-related outcomes with a group of Swedish adoptees. Type 1 or milieulimited alcoholism affected both men and women, had an onset after the age of 25 years,
and had a variable course of alcohol-related symptoms and problems. Environmental
factors, including the atmosphere in which one was raised, usually affected the severity
of the alcoholism in Type 1 alcoholics. On the other hand, Type 2 or male-limited
alcoholism transpired only in men, commenced before age 25 years, appeared highly
heritable, and was characterized by heavy amounts of consumption, an inability to abstain
from alcohol, and recurrent experience of negative medical and social consequences.
Cloninger also explored personality features of these individuals, with Type 1 alcoholics
tending to score high on reward dependence and harm avoidance and low on novelty
seeking, whereas Type 2 alcoholics generally had low levels of reward dependence and
harm avoidance and high levels of novelty seeking.
Similarly, von Knorring and colleagues (von Knorring, Palm, & Anderson, 1985)
examined a sample comprised of male alcoholics currently in treatment and those in
remission and classified them into groups based on the age of alcohol onset. Clients with
onset prior to age 25 were categorized as Type II alcoholics and those whose age of onset
was after age 25 were classified as Type I alcoholics. Results paralleled Clonginger’s
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findings in many ways. Type II, or early onset, alcoholics had higher rates of
aggressiveness, criminality, drug abuse, and familial alcoholism than their Type I
counterparts. In terms of personality functioning (von Knorring et al., 1987, although
Type II individuals were more extraverted and tended to score higher on impulsiveness
and adventure-seeking measures, they also endorsed a greater degree of guilt and anxiety
as compared to Type I individuals.
Adding to the girth of empirical evidence related to alcoholism typologies, Babor,
Hofmann, and colleagues (1992) examined 17 characteristics across 4 domains (e.g.,
premorbid risk factors, use of alcohol and other substances, chronicity and consequences
of drinking, and psychiatric symptoms) in a sample of alcohol-dependent individuals.
The clustering solution produced two categories. The Type A cluster was characterized by
fewer childhood risk factors, later age of onset, less severe dependence, and fewer
previous treatment episodes. Members of this cluster also exhibited fewer alcohol-related
physical and social problems, less psychopathological dysfunction, and lower levels of
distress in the areas of work and family, and responded better to standard treatment. On
the other hand, Type B alcoholics had more familial risk factors, an earlier age of onset,
greater severity of dependence, increased levels of polydrug use, and more treatment
episodes. This group also experienced more serious consequences, a greater level of
psychopathological dysfunction, and more life stress. Not surprisingly, these clients
demonstrated poorer treatment outcomes.
At the same time some researchers were describing and defining two subtypes of
alcoholism, others were questioning if two subtypes sufficiently captured the
heterogeneity of alcoholics. In an early study, Morey, Skinner, and Blashfield (1984)
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proposed an alternative classification scheme in a large sample of individuals seeking
treatment for alcohol problems. Three types of drinkers were identified and were
distinguishable on measures related to alcohol use, as well as on measures of personality,
psychopathology, intellectual functioning, and demographic variables. Type A or earlystage problem drinkers represented a fairly heterogeneous group who showed evidence
of drinking problems but did not exhibit major symptoms of alcohol dependence. Type B
or affiliative drinkers were more socially-oriented, tended to drink on a daily basis, and
displayed moderate levels of alcohol dependence. Type C or schizoid drinkers were more
socially isolative, tended to drink in binges, and reported the most severe symptoms of
alcohol dependence. There were consistent differences in symptom severity among the
three types on measures of psychopathology, cognitive functioning, and social
adjustment, with Type C exhibiting the highest levels of dysfunction. In the end, the
authors propose a hybrid model of alcohol abuse that integrates both categorical and
dimensional elements and superimposes the three identified subtypes of clients on an
underlying continuum of alcohol dependence.
Del Boca & Hesselbrock (1996) were particularly interested in gender differences
and proceeded to reanalyze the data reported by Babor, Hofmann, and colleagues (1992)
to see if gender-related subtype would emerge. Results suggested that although the twocluster solution (i.e., Type A – Type B) effectively represented the sample in terms of risk
and severity, a functional four-cluster solution could also be derived: low risk–low
severity (few problems at low levels), internalizing (moderate risk, high depression and
anxiety), externalizing (moderate risk, high antisocial behavior), and high risk–high
severity (multiple problems at high levels). In terms of gender dispersion, the low and the
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high risk subgroups had a relative balance in gender composition, while the two
intermediate, moderate risk subgroups appeared to be more gender-specific. The
internalizing group was comprised of 32% of the women in the study and only 11% of
the men, whereas the externalizing group included 38% of the men versus 7% of the
women. Etiological implications of these findings suggest that the development and the
expression of alcohol problems in the two moderate risk, gender-related groups, likely is
more strongly influenced by sociocultural factors (i.e., differing behavioral expectations
and emotional expressions), as opposed to an inherited disposition.
More recently, Windle and Scheidt (2004) evaluated the adequacy of a range of
cluster analytical solutions in a large, heterogeneous in terms of gender and ethnicity,
group of inpatients from five alcohol treatment centers in both rural and urban areas.
Based on comparison across the two-, three-, and four-cluster solutions, the four-cluster
solution appeared to represent the data most effectively. The mild course typology was
characterized by a later age of onset; fewer years of drinking; lower levels of
consumption, impairment, and withdrawal symptoms; few childhood conduct problems;
and low rates of familial history of alcoholism. High levels of polydrug use and
benzodiazepine use demarcated the polydrug subtype, while the negative affect subgroup
was distinguished by symptoms of depression and anxiety and high characterological
vulnerability to a substance use disorder. The chronic/antisocial typology was
distinguished by high levels of alcohol consumption and impairment, a longer duration of
drinking, and high levels of adult antisocial behaviors. Generally speaking, this foursolution model is consistent with Del Boca and Hesselbrock’s (1996) classification
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scheme and provides further evidence that two-solution typologies may not fully the
capture the diversity of behavior observed in alcohol use disorders.
In addition to cluster analytic techniques, other statistical grouping methods have
been used in alcohol typology research. Peters (1997) employed non-metric multidimensional scaling to explore 102 symptoms linked to various aspects of alcoholism to
classify individuals voluntarily seeking in- and outpatient alcohol abuse treatment in the
Netherlands. Results indicated the presence of a three-dimensional spatial solution. The
first dimension represented the alcohol dependence syndrome and consisted of symptoms
related to withdrawal, drinking throughout the day, irresistible urges to drink, and
drinking to avoid withdrawal symptoms. At one end of the spectrum of the second
dimension detected was the male-dominated, early onset, antisocial drinker and at the
other end of the spectrum of this dimension was the female-dominated, isolated home
drinker. The main pole of the third dimension was comprised of symptoms indicative of
chronic alcoholism, while the antipole referred to “young persons raised in troubled
families” (p. 1658). Taken together, these results suggest that severity, gender, and age
seem to be principal continuums clients seeking treatment for alcohol problems can be
positioned along.
Taxonomic Research in Drug Use Disorders
Substance use history, pattern of use, familial traits, personality factors,
psychosocial characteristics, and sociocultural backgrounds have also been examined to
identify subtypes of drug users. Ball and colleagues (1997) were interested in
determining whether individuals with a cocaine use disorder could be subtyped according
to the important characteristics that had already gained empirical support in alcoholism
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typology research. In particular, this study examined the evidence for the Type A – Type
B distinction (Babor, Hofmann, et al., 1992) that had emerged with persons with alcohol
use disorders in a diverse sample of cocaine users (i.e., inpatients, outpatients, and nontreatment-seeking individuals). Results supported this classification scheme as
participants in the Type B category exhibited higher heritability, more childhood behavior
problems, an earlier age of onset, more severe drug and alcohol dependence, a higher
degree of addiction-related functional impairment, more antisocial behavior, higher
sensation seeking, and more comorbid psychiatric problems than their Type A
counterparts. Type B individuals also had poorer treatment outcomes. Adequate construct,
concurrent, and predictive validity of the Type A – Type B distinction in this sample was
also demonstrated. However, the authors noted that this typology model seemed to
portray the inpatient sample more effectively than the outpatient and non-treatment
seeking participants, suggesting the existence of variability in typology schemes among
subpopulations of individuals who use cocaine. It should also be noted that the inpatient
sample had a relatively equal number of participants fall into each subtype, whereas the
outpatient and community samples had a majority of participants classified as Type A
(75%).
Garcia and colleagues (2006) outlined commonalities of Type A and Type B drug
addicts in a sample of participants receiving outpatient treatment. Type A individuals, or
functional drug-addicts, tended to report using drugs for fewer years, having more
alcohol-related problems, and having higher employment rates than their counterparts.
Conversely, Type B individuals or chronic drug-addicts, tended to report being older,
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consuming drugs more frequently, and having more medical, employment, legal, family,
and psychiatric problems than Type A persons.
Fals-Stewart (1992) examined the personality characteristics of recreational drug
users treated in a long-term, inpatient, drug-free therapeutic community and how they
relate to length of stay in treatment and one-year posttreatment outcomes. A hierarchical
agglomerative cluster analysis was performed on the scale scores of the Millon Multiaxial
Clinical Inventory (MCMI). Five cluster types cluster emerged, and although this
investigation neglected to fully describe cluster the characteristics of cluster membership,
it noted that clusters distinguished by elevations on the avoidant, schizoid, and antisocial
scales were associated with fewer days in treatment, less abstinence during the one-year
follow-up period, and earlier time to relapse. Antisocial tendencies were also positively
related to more major rule violations and avoidant and schizoid tendencies were
associated with leaving treatment against medical advice. These major findings
confirmed the hypotheses that suggested that clients who exhibited higher interpersonal
discomfort and difficulties with authority would likely fare the worst in a therapeutic
community as this modality of treatment place emphasizes interpersonal interactions and
a high degree of structure. Along the same lines, forms of antisociality were explored in a
sample of clients engaged in methadone maintenance treatment (Alterman et al., 1998).
Results yielded six replicable and temporally stable cluster groups comprised of varied
degrees of antisociality, configuration of antisociality, and associated psychiatric,
psychological, and criminal characteristics. Types included early onset, high
antisociality; late onset, high antisociality; emotionally unstable, moderate antisociality;
nonantisocial, drug-related antisocial behavior; psychopathic criminal, moderate
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antisociality, and low antisociality. The diversity in the expression of antisocial
tendencies in this study further exemplifies the complexity of investigating personality
traits in substance abusing populations.
Taxonomic Research in Dual Diagnosis
The heterogeneity of a dual diagnosis population (i.e., persons diagnosed with a
substance use disorder and a comorbid Axis I psychological disorder) has been explored
using cluster analysis (Luke et al., 1996). With hopes of facilitating the planning and
implementation of individualized treatment programs, this project examined the
Addiction Severity Index (ASI) severity ratings of dually-diagnosed persons admitted to
a state psychiatric hospital. The ASI assesses a client’s status in seven domains: medical,
employment, alcohol, drug, legal, family/social, and psychiatric. Severity ratings are
subjective ratings given by the interviewer that are based on both objective and subjective
self-report information provider by the participant. They range from 0 to 9 and reflect the
degree of the problem and as well as the perceived need for treatment (i.e., no real
problem, treatment not indicated; extreme problem, treatment absolutely necessary).
Cluster analysis results produced seven subgroups that were labeled and interpreted based
on the pattern of severity rating means across ASI domains. It should be noted that these
subgroups were reliable and had adequate concurrent and predictive validity according to
longitudinal measures of clinical and community functioning.
The best functioning cluster had low to moderate severity for each of the ASI
domains and appeared to have relatively adequate levels of functioning compared to the
remaining groups. The unhealthy and functioning alcohol abuse groups exhibited high
alcohol and low drug ratings; however, the unhealthy alcohol abuse cluster demonstrated

107
higher severity ratings in the medical, employment, legal, and social relationship areas
than those in the functioning alcohol abuse group. The drug abuse cluster showed a high
drug severity and low alcohol severity pattern, with considerable psychiatric,
employment, and family problems. Members of the remaining three clusters
demonstrated high levels of both alcohol and drug problems, but levels of severity varied
across the remaining domains. The functioning polyabuse group had relatively few
medical and legal problems. Members of the criminal polyabuse cluster showed the
highest level of legal problems amongst all clusters and had high problems ratings in all
of the remaining domains except for medical. The unhealthy polyabuse group had the
highest psychiatric problem rating, with substantial problems in the medical and
employment domains and moderate legal and social difficulties. In addition to delineating
the seven clusters of dually diagnosed individuals, Luke and colleagues (1996) noted that
the identified groups could be arranged, at a broader level, along the dimensions of level
of functioning (e.g., good, moderate, poor) and pattern of substance use (alcohol, drug,
alcohol and drug). Based on where a client exists along these continuums, the authors
suggest more effective individualized treatment services can be designed and delivered to
homogeneous subgroups of substance abuse treatment-seeking populations.
Summary of Taxonomic Research in Substance Use Disorders
The range of typology studies carried out with substance abusing populations is
quite broad, as are the classification schemes deduced from these investigations.
Extensive lists of subgroup attributes and correlates, as opposed to more cohesive
depictions, often comprise the results sections and are in stark contrast to the fundamental
goal of these studies: delineating parsimonious subgroups within a certain sample. Such
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variability in findings can be attributed to diversity in sample characteristics, variables of
interest, operational definitions of these variables, and the statistical analyses employed.
At the same time, there exists substantial overlap in much of the research reviewed here.
Barring the exact label attached (i.e., Type I vs. Type II; Type A vs. Type B; low risk-low
severity vs. high risk-high severity; functioning vs. unhealthy), individuals with a
substance use disorder appear to travel different developmental paths that lead to a
diagnosis of abuse and/or dependence, to engage in different patterns of substance use,
and to exhibit different types and degrees of consequences related to their substance use.
There also appears to be some empirical typology evidence that suggests particular
individuals with a substance use disorder commonly experience symptoms of both Axis I
(e.g., major depression, anxiety) and Axis II (e.g., antisocial personality disorder)
psychopathology. At the same time, this apparent redundancy has not been adequately
investigated and the overlap in the various typologies is unclear – “do these schemas
represent different methods and labels of describing the (alcohol and drug abusing)
population in an essentially similar fashion, or do the schemas truly break up the universe
of (substance abusers) differently” (Epstein, Labouvie, McCrady, Jensen, & Hayaki,
2002). The answer to this question not only has potential theoretical value in further
illuminating the etiology and expression of substance abuse disorders, but it also has
prospective value in refining and tailoring assessment and treatment techniques to align
with the different types of clients presenting to treatment.
Applied Utility of Taxonomic Methods
Essentially, such typology research within the substance abuse field aims to not
only accurately describe the individuals under study, but to fuse science and practice and
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identify potential treatment implications. “Regardless of our ability to replicate subtypes,
the real test of a typological classification lies within its external validity and its
usefulness for theory development and clinical practice” (Babor, 1997, p. 1666). At the
individual treatment program level, clients share at least one fundamental commonality:
they are seeking treatment at the same facility. However, these clients enter treatment
with divergent backgrounds and possess assorted characteristics that can influence how
they respond to treatment and how well the treatment program can meet their needs. It
should be the goal of the treatment program to gain knowledge about their clientele and,
when possible, detect similarities across clients that may positively or negatively impact
treatment. With this information, clinicians and researchers alike can begin to postulate
why certain individuals, or groups of individuals, tend to fare better or worse in their
particular treatment program. These assumptions can then be empirically tested and
results can ultimately provide a framework for organizing service delivery and inform
programmatic decisions regarding admission criteria, treatment planning, interventions,
and resource allocation, all crucial aspects of improving substance abuse treatment
outcomes and helping to alleviate the societal strain that substance use disorders
engender.
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Chapter III: Method

Overview
The primary purpose of this chapter is to describe the methodology employed in
this study of characteristics of clients entering an intensive outpatient chemical
dependency treatment program and their relationship to treatment retention. Descriptions
of the participants, assessment procedures, assessment instruments, variables of interest,
and the data analysis plan are provided. This project was retrospective in nature as data
collection has been completed. It was carried out as part of research collaboration with a
local substance abuse treatment program that was interested in implementing a
standardized assessment battery into their intake procedures for a variety of reasons.
Firstly, as proposed by the TCU Treatment Model, gathering detailed information
regarding pretreatment client characteristics including problem severity at intake,
motivation for change, and readiness for treatment is critical for clinicians and clients in
identifying and clarifying problems, determining treatment needs, making treatment
planning decisions, and measuring treatment effectiveness as these data serve as a
baseline measurement of functioning (Simpson 2001; 2004). Secondly, it was anticipated
that the comprehensive nature of this evaluation process would facilitate the exploration
of how patient factors and their combinations mediate and moderate treatment processes,
retention, and eventual outcomes in this particular treatment program (Simpson, 2004).
Thirdly, standardizing the intake data collection process provided clinicians and
researchers with a “common language” to speak about and compare clients entering this
particular program.

111
Participants
Participants (N = 273) were a sample of clients who entered the intensive
outpatient chemical dependency program at Rogers Memorial Hospital, a nonprofit,
freestanding mental health hospital in West Allis, Wisconsin. The assessment protocol
aimed to evaluate all new clients to the program. However, a variety of practicalities,
which are detailed later, interfered with the successful accomplishment of this endeavor
and ultimately produced a sample of convenience. The data collection period spanned
from January 2005 – November 2006. All participants were 18 years of age or older and
competent to give consent.
Program
The intensive outpatient chemical dependency program at Rogers Memorial
Hospital – West Allis utilizes a Minnesota treatment model (Owen, 2003) and
incorporates components of the 12-step philosophy to provide a framework for clients to
learn about the nature of substance use disorders and to begin or recommence their
recovery process. It primarily serves clients who are insured or able to pay out of pocket
for services. Maintaining abstinence is a chief treatment objective, thus the program
performs random urine screens for drugs and/or breathalyzer tests for alcohol. Clients are
expected to comply with these screens, as missed screens are considered “positive”
screens and refusals could result in discharge from the program. Group therapy is the
primary method of treatment, which allows clients to receive feedback from both their
peers and clinicians. Group sessions are held daily from 9:00-12:00, and on Monday,
Tuesday, and Thursday evenings from 6:00-9:00. Group sessions are augmented with
weekly individual sessions with a clinician as well as a separate session with the
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attending physician. Ancillary contact with family members, employers, and others may
be scheduled. The treatment team consists of a physician/addictionologist, a manager,
and two primary clinicians. Decisions regarding treatment frequency and duration are
made collaboratively between the treatment team and the client depending on a variety of
factors including recommended level of care, treatment goals, scheduling availability,
and insurance benefits.
Assessment Procedures
Assessment Training
Approximately 14 masters and 2 doctoral students (i.e., this author and a fellow
senior assessor familiar with the assessment instruments and related procedures) from the
Department of Counseling and Educational Psychology at Marquette University
comprised the primary assessment team and administered the standardized assessment
battery over the course of the data collection period. All assessors received training in
basic counseling skills, ethical and professional issues, and instruction on the assessment
battery. More specifically, assessor trainees were provided with reading materials about
specific policies and procedures related to conducting the intake sessions and the
assessment battery instruments (i.e., general overview, administration procedures, and
scoring instructions). Subsequently, trainees attended a minimum of eight hours of formal
training and completed at least one practice administration and observation. These
activities were coordinated by this author and the fellow senior assessor under the
supervision of Todd C. Campbell, Ph.D., licensed psychologist, chair of this project. The
initial training session presented an overview of the purpose of the intake assessment
project, reviewed policies and procedures, and discussed ethical issues (i.e.,
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confidentiality, informed consent, suicide protocol, and supervision). The second training
session focused on the assessment instruments. Administration and scoring procedures of
each measure were explained and demonstrated, and trainees had the opportunity to ask
questions and carry out practice administrations.
Upon completion of these formal training sessions, trainees administered the
entire assessment battery to this author or the fellow senior assessor and received
feedback. Prior to having contact with clients, assessors were required to attend a Rogers
Memorial Hospital orientation that familiarized them with the organization and its
policies and provided CPR and self-defense training. Following orientation completion,
the trainee observed this author or the fellow senior assessor conduct the assessment
battery with an actual participant. Then, the trainee administered a minimum of two
assessment batteries with actual participants under the live supervision of this author or
the fellow senior assessor. A discussion about the trainee’s comfort level and proficiency
in administering the assessments was then undertaken to determine if s/he was ready to
administer the battery on her/his own. This process was repeated until the trainee, this
author and the fellow senior assessor, and Todd C. Campbell were in agreement about the
trainee’s readiness to perform the assessments without live supervision. Ongoing
individual and group supervision was provided for the assessors by this author and the
fellow senior assessor under the direction of Todd C. Campbell. In addition to the
administration-specific training, the Institutional Review Board at Marquette University
required trainees to complete an online tutorial about conducting research with human
participants.
Administration of Assessment Battery
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Both treatment providers and researchers are concerned about the appropriate
timing for the administration of assessment measures. “Demands for quick turnaround to
aid in triage and treatment planning compete with the clients’ ability to provide accurate
and reliable information after detoxification. Drastic reductions in clients’ length of stay
imposed by managed care decisions further complicate the dilemma” (Allen, 2003, p. 9).
Considering the scant amount of research examining optimal assessment administration
times (Allen, 2003), the primary investigators consulted with the treatment program and
determined that the assessment battery was to be administered to the participants within
48 hours of being admitted to the program. Upon entry into the intensive outpatient
program, clients should have completed a sufficient amount of detoxification to provide
reliable information. Thus, immediate assessment completion would not be problematic
for this reason and would actually aid in the treatment planning process if done at the
outset. It was also decided that the assessment session would take place during the group
session time, as potential participants were easily accessed during this period and
additional scheduling conflicts would not interfere with data collection. Notification and
referral procedures were as follows. When a new client entered the program, the primary
clinician called the assessment office and left a message providing the client’s name and
admission date. This referral information was subsequently recorded on a cumulative
admissions log kept in a locked filing cabinet. When assessors reported to the research
office, they consulted the admissions log to see there was a client to be tested. In the
event that there were numerous clients to be tested, the client with the oldest admission
date was given precedence. Prior to the beginning of the group treatment session,
assessors reported to the clinician to inquire whether or not the preferred testing client
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was in attendance. If the preferred client was available, the clinician introduced the
assessor to the client, and the assessor proceeded to briefly explain the purpose of the
assessment session. In the event that the preferred client was not in attendance, the
assessor inquired about the subsequent client(s) on the admission log until a client was
available for testing.
Despite the aforementioned notification and referral procedures, a range of
practical difficulties interfered with the assessment team’s ability to evaluate each client
entering the program. Space constraints allowed for the testing of only one individual per
group session. In particular, intermittent census increases in the program reduced the
ability of the assessment team to efficiently (i.e., within the target 48 hours following
admission) complete testing procedures on all clients. Additionally, the assessment team
was comprised of graduate student volunteers; thus, unforeseen circumstances
occasionally prevented them from covering for their scheduled assessment slots and
impeded evaluation efficiency. Timely notification was also an area of concern at various
points during the data collection period, as clinicians failed to inform the assessment team
of new clients entering the program. Moreover, poor client attendance and early attrition
from the program limited access to clients who needed to be tested, further hindering the
assessment team’s ability to complete all intake evaluations. Such obstacles are not
unusual when carrying research in applied treatment settings (Joe et al., 1999; Simpson,
Brown et a, 1997). In recognition of the fact that the obtained sample may not be
representative of the actual substance abuse treatment-seeking population at Rogers
Memorial Hospital – West Allis, demographics (e.g., sex, race, and age) and treatment
information (e.g., treatment completion status, treatment duration, number of treatment
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days) were obtained for those clients who were not assessed at intake and subsequently
excluded from the study (N = 171). Comparative analyses were conducted in order to
determine the equivalency of the obtained sample to the overall population from which it
was drawn. These results will help determine the external validity or generalizability of
study findings.
The treatment program required that all new clients admitted to the program
complete the assessment battery for clinical purposes, though the client could decide
whether or not her/his data would be further deidentified and utilized for research
purposes. An informed consent document outlining these dual objectives was created to
explicate the procedures (Appendix A). Prior to the administration of the assessment
battery, a copy of the informed consent was provided to each participant. It contained an
explanation about why the information was being collected and how it was going to be
collected. Furthermore, it assured participants that they had the right to refuse
participation and doing so would not affect their treatment. The informed consent
document was read to the participants verbatim, and participants were given the
opportunity to have their questions answered. They initialed the bottom of every page and
signed the final page to indicate they agreed to participate in the study. They were given a
copy of the informed consent for their reference.
The length of the assessment session generally ranged from 90 to 150 minutes.
Assessors read both the instructions and individual items to the participant and recorded
all responses on her/his behalf. Data were collected in a variety of mediums as more
sophisticated methods became available. The computer-assisted Addiction Severity Index
(ASI) was utilized throughout the data collection period. These data were directly
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exported from the program into an SPSS file where all identifying client information was
removed and replaced with an arbitrary client identification number. The paper-pencil
version of the Mini-International Neuropsychiatric Interview (M.I.N.I.) was used until a
computerized version of this instrument became available and was purchased (February
2006). Since the computerized version of the M.I.N.I. did not have a fully-functioning
export option, this information, along with the paper-pencil data, was de-identified and
manually entered into an SPSS file by the senior assessors. Paper-pencil versions of the
Form 90 Drinking Assessment Interview (Form 90), Inventory of Drug Use
Consequences (InDUC), and Stages of Change Readiness and Treatment Eagerness Scale
(SOCRATES) were initially utilized, though electronic forms of these assessments were
eventually created and implemented (February 2006). The electronic versions allowed
assessors to access the password-protected forms via the Center for Addiction and
Behavioral Health Research website. Assessors proceeded to input client answers during
the interview, which were subsequently directly exported into an SPSS file. Paper-pencil
Form 90, InDUC, and SOCRATES data were retrospectively entered into the electronic
forms, as opposed to manually being entered in SPSS, to expedite the data entry process.
The assessment battery also contained the Alcohol Abstinence Self-Efficacy Scale,
though data from this measure will not be included in further analyses as it was
incorporated into the protocol in the middle of the data collection period and data were
only collected for clients who primarily used alcohol.
Upon completion of the assessment battery, the assessor filled out a personalized
feedback report for the client (Appendix B) containing summary assessment information.
This report was given to the primary clinician, along with a computer-generated ASI
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narrative report, for clinical use and became part of the treatment record. All hard copies
of paper-pencil instruments, scoring sheets, ASI narrative report copies, and personalized
feedback report copies were deidentified and placed in separate folders arranged by client
identification number. These files are being kept in a locked filing cabinet at Rogers
Memorial Hospital in the assessment office. Informed consent documents are being kept
in a locked filing cabinet at Marquette University. All data will be kept for approximately
seven years and will then be destroyed.
Assessment Instruments
Accurate client assessment is essential to both treatment of and research on
substance use disorders. As Allen (2003) notes:
Although each of these activities is advanced by informed use of psychometric
instruments, the needs of professionals in the two endeavors differ. Most notably,
the practitioner is primarily concerned with the clinical utility of the measure,
particularly how well it identifies the needs of a given client and guides treatment
planning. The researcher is likely to explore a broader range of variables that may
quantify and explain the overall impact of an intervention. (p. 1)
These perspectives, along with the administration ease and acceptability of the measures
to clients, were taken into account in the selection of the instruments that would comprise
the assessment battery. Efforts were made to maximize both clinical and research utility
through the use of reliable and valid assessment tools. In the end, a comprehensive
battery with a variety of measures evaluating symptoms, diagnosis, risk behaviors (e.g.,
suicidal ideation), functional impairment, problem severity, subjective distress,
motivation, and self-efficacy was selected. Psychometric properties of each instrument
are evaluated and reported below.
Unfortunately, there is a lack of consensus on what constitutes acceptable
reliability standards within research and practice settings, and such guidelines often differ
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depending upon what the instrument is being used for. For instance, Nunnally and
Bernstein (1994) purport that increasing reliabilities beyond .80 in basic research (i.e.,
exploring the difference between groups) may waste valuable resources including time
and money. In contrast, they indicate that when making important decisions based upon a
particular test score(s), a reliability of .80 is likely not rigorous enough, since much
weight is placed on the specific score that is obtained (e.g., determining if a child should
be placed in special education classes based on IQ). In such instances, Nunnally and
Bernstein (1994) advise that the reliability should be at least .90, though .95 would be
considered ideal. Along the same lines, Aiken (2003) and Rosenthal and Rosnow (2008)
recommended reliability estimates of .85 or higher when scores are used in making
clinical decisions, while Sternberg (1994) asserted that reliability estimates above .80 are
desirable and above .90 are preferred when using a tool for screening or diagnostic
purposes. Assuming a more liberal stance, Cicchetti (1994) suggested that reliability
coefficients (r) below .70 were unacceptable, between .70 and .79 were fair, between .80
and .89 were good, and those equal to or greater than .90 were excellent. At the same
time, his interrater reliability standards have been criticized as far too lenient (i.e., κ < .40
= poor; .40 ≤ κ ≤.59 = fair; .60 ≤ κ ≤ .74 = good; .75 ≤ κ ≤ 1.00 = excellent).
Fairly consistent with the suggested guidelines, when selecting instruments to be
included in this particular assessment battery, efforts were made to choose measures with
reliability estimates of .80 or higher, though values of .70 or higher were considered
acceptable. Nonetheless, such decisions were impacted by additional factors (i.e., the
ability of the instrument to provide clinically useful information; administration time),
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thus there were instances where a measure was selected, despite reliability estimates that
fell below the preferred level (r < .70).
Addiction Severity Index, Fifth Edition (ASI)
The ASI was developed over 25 years ago by a team of researchers lead by A.
Thomas McLellan at the University of Pennsylvania’s Center for the Studies of
Addiction. It is currently in its fifth revision and has emerged as one of the most
frequently used measures in the substance abuse treatment field due to its usefulness in
identifying areas of treatment need and measuring treatment outcomes within a
multidimensional framework (McLellan et al., 1992; McLellan, Luborsky, Woody, &
O’Brien, 1980; Donovan, 2003). The ASI is a semi-structured interview that can be
administered in about 50-60 minutes by a trained assessor. Two-day, intensive training
sessions on administration and scoring procedures are offered by the Treatment Research
Institute (TRI). These workshops are supplemented with manuals, practice materials,
quizzes, scripted role plays, videotapes, and vignettes to assist interviewers derive more
accurate interviewer severity ratings, reduce errors, and improve overall consistency in
administration and scoring (McLellan et al., 2006; TRI, n.d.). For this project, the fellow
senior assessor attended the TRI training sessions and subsequently provided training to
the remaining assessors based on the instruction she received. It is critical that the ASI
interviewer is able to rephrase questions, adequately summarize responses, and probe for
more complete information to ensure that the client understands all of the questions and
provides answers that correspond to the intent of the questions; thus, the ASI training
employed in this study tended to focus on these particular areas (McLellan et al., 1992).
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The ASI was designed to measure patient functioning in seven domains: alcohol
and drug use, medical and psychiatric health, employment and self support, family and
social relationships, and illegal activity. Within each of these areas, two time frames are
examined. Lifetime information aims to assess the duration and severity of each problem,
while knowledge about the frequency and intensity of problems within the past 30 days
supplements this data and assists in the identification of current treatment needs
(McLellan, Cacciola, Alterman, Rikoon, & Carise, 2006). Structurally, the ASI is
comprised of separate modules of domain-related questions. At the end of each module,
clients are asked to rate how troubled or bothered they have been by problems in a
particular area and then indicate how important treatment for these problems is to them at
the present time. Responses are chosen from a 5-point Likert scale ranging from “not at
all” to “extremely.” The interviewer also has a chance to rate severity of problems in each
domain on a 10-point scale ranging from “no real problem, treatment not needed” to
“extreme problem, treatment absolutely necessary” and indicate his or her level of
confidence that the client has understood and answered the questions truthfully. In
addition to these subjective ratings, domain-specific composite scores representing
weighted mathematical combinations of a defined set of items in each area are computed
to provide a more objective measure of problem severity in the past 30 days. Composite
scores are only made up of items that are subject to change, making them an ideal method
for examining change over time (i.e., pretreatment versus posttreatment scores)
(Donovan, 2003; McLellan et al., 1980; 1992). According to McLellan and colleagues
(1992) it is often advantageous to create summary measures (i.e., composite scores) to
aggregate multiple indicators of patient characteristics when conducting research and
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evaluating treatment outcomes because such scores offer distinct statistical advantages
such as greater reliability of measurement and increased statistical power when
measuring change.
ASI Psychometrics
The ASI has been utilized across a range of substance abuse treatment-seeking
populations including different gender and ethnic groups (Brown, Alterman, Rutherford,
Cacciola, & Zaballero, 1993), clients with various primary substances of use across
treatment settings (McLellan, Luborsky, Cacciola, & Griffin, 1985; McLellan et al.
1994), clients with psychiatric disorders (Appleby, Dyson, Altman, & Luchins, 1997;
Carey, Cocco, & Correia, 1997; Zanis, McLellan, & Corse, 1997), and homeless
individuals with a substance use disorder (Zanis, McLellan, Cnaan, & Randall, 1994).
Considering the diversity within the population being examined for this project and a lack
of descriptive information documented about it, a review of such studies involving
assorted treatment-seeking subgroups is pertinent. Psychometric properties have varied
considerably depending on the population tested, variables examined, and statistical tests
executed, making it difficult at times to compare values across studies and determine if
adequate reliability and validity evidence exists (Makela, 2004).
All new items that were added to the Fifth Edition of the ASI exhibited
satisfactory test-retest reliabilities as Cohen’s kappa values were .83 or higher (McLellan
et al., 1992). These results were consistent with similar studies conducted with previous
editions of the ASI (McLellan et al. 1985) and another longer-term investigation of the
test-retest reliability of the ASI lifetime items (Cacciola, Kippenhaver, McKay, &
Alterman, 1999). In a review of studies examining the test-retest reliability of composite
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scores, Makela (2004) reported that values ranged from satisfactory to unsatisfactory,
with most of the deficient values emerging from studies of special subpopulations like
those who are homeless, in prison, or have comorbid disorders.
Interrater reliability coefficients for severity ratings were fairly high (above .80)
in initial and subsequent investigations among clients entering substance abuse treatment
(McLellan et al., 1980, 1985; Stoffelmayr, Bertram, Mavis, Brian, & Kasim, 1994).
Lower levels of interrater consistency have been found in clients with concurrent severe
and persistent mental illness and substance use disorders; ICCs for severity ratings in this
sample averaged .66 and ranged from .55 (employment) to .91 (legal) (Zanis et al., 1997).
In reference to interrater reliability of composite scores, Makela (2004) indicated that
they have been consistently higher than those found for severity ratings, likely due to the
fact that they involve less subjective judgment and more objective recording of reported
information. This observation is corroborated by higher average interrater reliability
coefficients for composite score as compared to severity ratings in various studies (Carey
et al., 1997; McLellan et al., 1985; Zanis et al., 1997).
According to Makela (2004), composite scores for medical status, alcohol use,
and psychiatric status generally have acceptable internal consistencies (α > .70), whereas
the composite scores for employment status, drug use, legal status, and family/social
relationships tend to have lower consistencies (.60 < α < .70). As with test-retest and
interrater reliability, it is not unusual to detect low internal consistency estimates with
particular subpopulations such as those with primary psychiatric disorders (Carey et al.,
1997) and homeless individuals with a substance use disorder (Zanis et al., 1994). In this
study, the seven ASI composite scores showed generally acceptable internal consistency:
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medical (α = .85); employment (α = .67); alcohol (α = .89); drug (α = .77); legal (α =
.68); family/social (α = .75); and psychiatric (α = .83). However, consistent with previous
research, the internal consistency estimates in the employment and legal domains fellow
below the desired value of α > .70.
ASI validity studies have also examined multiple populations and used diverse
methodologies to decipher how well the ASI measures what it intends to measure. The
first independent validation study of the ASI found that within a sample of opiate users,
the ASI psychiatric, family/social relationships, legal, and employment severity ratings
had poor to fair concurrent validity with self-report measures of psychological problems,
social adjustment difficulties, legal trouble, and employment problems (r = .39 – 59, p <
.001). Furthermore, the combined alcohol and drug severity rating showed limited
concurrent validity (r = .17, p = .02) and no measures of physical health were available
for comparison with the medical severity rating (Kosten, Rounsaville, & Kleber, 1983).
Subsequent comparisons of ASI severity ratings and composite scores among a substance
abuse treatment-seeking population exhibited evidence of adequate concurrent and
discriminant validity with a battery of previously validated tests (McLellan et al, 1985).
The concurrent and discriminant validity of the alcohol, drug, and psychiatric composite
scores has also been studied in a sample of homeless substance users. Satisfactory
evidence was detected as these scores were correlated with the Michigan Alcohol
Screening Test (r = .31), Risk for AIDS Behavior (r = .54), and the Symptom Checklist90 (r = .66), respectively, and did not display significant relationships with unrelated
measures (Zanis et al., 1994). Furthermore, in a sample of persons with severe and
persistent mental illness and a low degree of current comorbidity, combined validity
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evidence for both severity ratings and composite scores was acceptable for the alcohol
and drug domains, weak for the employment and family/social domains, and mixed for
the psychiatric, medical, and legal domains (Carey et al., 1997).
Criterion validity has also been explored. Appleby and colleagues (1997) found
strong relationships between the alcohol and drug composite scores and related measures
(r = .50 - .73) among substance abusing clients with comorbid psychiatric disorders.
Sensitivity and specificity analyses have provided further evidence for the predictive
utility of the ASI as results have compared favorably with related measures. A minimum
alcohol severity rating of one (i.e., mere recognition of a problem) had a sensitivity of
93% and corresponding specificity of 59% with respect to a current alcohol use disorder
as measured by the Structured Clinical Interview for the DSM-III-R (SCID). Similar
results were found for the drug severity rating, which had a sensitivity of 93% and
specificity of 55% with respect to a current drug use disorder (Appleby et al., 1997).
More recently, Rikoon, Cacciola, Carise, Alterman, and McLellan (2006) investigated if
ASI composite scores could serve as an effective screening tool for DSM-IV substance
dependence in two separate samples utilizing different diagnostic tools (i.e., ASI
including the DSM-IV questions and the SCID-DSM-IV). Results indicated that ASI
alcohol and drug composite scores identified dependent clients with approximately 85%
sensitivity and 80% specificity. The psychiatric subscale has also been explored. Kosten
et al. (1983) found that a psychiatric status severity rating of three or greater had a
sensitivity of 89% and specificity of 67% when identifying depression by research
diagnostic criteria (RDC), which compared favorably to the Beck Depression Inventory.
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Considering the breadth of psychometric studies carried out on the ASI, there is
sufficient evidence to suggest that it is a reliable and valid instrument for the evaluation
of general populations entering substance abuse treatment. It should be noted though that
it appears that caution needs to be exercised when using the ASI with other
subpopulations, as the reliability and validity evidence has not been as strong in such
investigations. For this particular project, the sample was drawn from a population of
clients entering an outpatient chemical dependency program, making the ASI an
appropriate measure for inclusion. Furthermore, in providing reliable and valid
information across a range of domains that assisted in the identification of treatment
needs at the outset of treatment, it met the needs of both practitioners and researchers,
another aim in the construction of this assessment battery.
Mini-International Neuropsychiatric Interview (M.I.N.I.)\
The M.I.N.I. was developed by psychiatrists and clinicians in the United States
and Europe in response to the need for a brief, structured diagnostic interview that
primarily assessed for Axis I psychiatric disorders in the DSM-IV and International
Classification of Diseases (ICD-10). More specifically, it was designed as a short, but
accurate psychiatric interview for use in multi-center clinical trials and epidemiology
studies and as an initial outcome tracking measure in nonresearch clinical settings
(Sheehan et al., 1998). From the outset, the M.I.N.I.’s creators “wanted an instrument to
have the ability to detect a substantial portion of patients without incorrectly labeling a
disproportionate number of patients without disorders” (Sheehan et al., 1998, p. 23).
M.I.N.I. Psychometrics
Validation and reliability studies were executed comparing the M.I.N.I. to the
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diagnostic standards for the DSM-IV (SCID) and for the ICD-10 (Composite International
Diagnostic Interview [CIDI]). Concordance rates were characterized by good to very
good kappa values for the M.I.N.I. – SCID comparison, with only one value (current drug
dependence) below .50. Kappa values were also good to very good for the M.I.N.I. –
CIDI comparison, with only two values (simple phobia and generalized anxiety disorder)
below .50. Moreover, the operating characteristics (e.g., sensitivity, specificity, positive
predictive values, and negative predictive values) for the majority of the diagnoses were
adequate to very good (Sheehan et al, 1998). Mean administration time for the M.I.N.I.
was about half that of the SCID (18.7 ± 11.6 minutes vs. 43 ± 30.6 minutes) and about
one fourth that of the CIDI (21 ± 7.7 minutes vs. 92 ± 29.8 minutes) (Sheehan et al.,
1998). Reliability estimates were also satisfactory. All kappa values measuring interrater
reliability for each diagnosis were above .75, with 70% of them being .90 or higher. Testretest reliability was relatively adequate, with 61% of the values being above .75 and only
one value (current mania) below .45.
Based on this reliability and validity data, the authors made adjustments to the
original instrument. Several questions were strengthened, improvements to enhance the
operating characteristics were made, and all diagnostic modules were updated to reflect
the DSM-IV and its time frames. A computerized version was also created to ease the
process of administration The M.I.N.I. can be used by clinicians, after a brief training
session, though lay interviewers require more extensive training to familiarize themselves
with diagnostic criteria and procedures (Sheehan et al., 1998). In light its satisfactory
psychometric properties and practical advantages (i.e., fully-structured, administration
time, electronic version, brief training), the M.I.N.I. was selected as the primary
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diagnostic tool in this battery of assessments. According to Maisto, McKay, and Tiffany
(2003), diagnostic information is not only important in delineating severity of substance
use (i.e., determining if criteria is met for abuse or dependence), but it is also critical in
the identification of concurrent psychiatric disorders because this information has a
profound impact on the treatment planning process and often necessitates targeted
interventions and/or additional services. Furthermore, the M.I.N.I. suicidality module was
utilized as a supplementary gauge of suicidal ideation and assisted the treatment team in
providing appropriate care to clients who were potentially in danger of harming
themselves. A suicide prevention protocol was created, and assessors were instructed
about what action to take in the event that a client presented with low, moderate, or high
suicide risk. The primary clinician was notified of the situation assessed in all instances,
while the attending physician was also informed when clients presented with moderate to
high risk.
Form 90 Drinking Assessment Interview (Form 90)
A primary concern in the study of alcohol and drug treatment is the employment
of self-report measures to evaluate the extent of use. Sobell and Sobell (2003) reported
that a number of comprehensive reviews have explored the reliability and validity of
alcohol users’ self-reports and concluded that this data can be used with confidence,
particularly when it is gathered under certain conditions: the client is alcohol-free at the
time of interview, the setting encourages honest reporting, the questions are clearly
worded and objective, and memory aids are provided. Furthermore, questions about
heavy and atypical drinking should be included to accurately capture a client’s total
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alcohol consumption. Considering this information, the Form 90 was selected as the
primary assessment tool utilized to gather substance use data.
The family of Form 90 instruments was originally developed for Project MATCH
and aimed to combine the strengths of prior methodologies used to measure use:
quantity-frequency questionnaires, average consumption grids, timeline follow-back
calendars, and self-monitoring diaries. All versions are structured, intervieweradministered, retrospective assessments that yield quantitative data (Miller & Del Boca,
1994). The Form 90 Drinking Assessment Interview, the one selected for the current
project, was part of the Project MATCH in-person intake protocol. In addition to
collecting daily drinking information for the 90 days prior to the last drink, the Form 90
examines other aspects of client functioning including drug use, participation in medical
and psychological treatment, institutionalization periods, work activity, school
involvement, and religious participation (Sobell & Sobell, 2003). Calendars showing all
the days in the assessment window are used to aid client recall. The identification of
abstinent periods, drinking patterns, and idiosyncratic drinking episodes also help
promote accurate reporting.
Drinking behavior is quantified by estimating daily alcohol consumption (i.e.,
standard drink unit as measured by standard ethanol content [SEC]) and intoxication level
(i.e., blood alcohol concentration [BAC]) These values are deduced from the amount and
type of alcohol consumed and drinking episode duration. Supporting software systems
employed to execute the complex SEC and BAC calculations include the Blood Alcohol
Concentration Computation System and the updated, more user-friendly, Center on
Alcoholism, Substance Abuse, and Addiction’s (CASAA) Liquor Database and
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SEC/BAC Calculator. Both of these programs are in the public domain and can be
downloaded from CASAA’s website, along with the instrument itself (CASAA, n.d.;
Miller & Del Boca, 1994). Percentiles indicating where a client ranks in relation to other
women and men in United States for average SECs per week and frequency of drug use
are available to bolster the clinical utility of the instrument. This information, along with
peak BAC levels, can be used within a motivational structure to provide feedback to the
client regarding the severity of their alcohol and drug use problems. Average
administration time for the Form 90 is 40 to 60 minutes and scoring time is 20 minutes. It
is a complex procedure that is subject to numerous errors and distortions if interviewers
are not properly trained. Thus, in addition to reviewing the Form 90 manual instructions,
specialized training is advised (Miller & Del Boca, 1994). For this particular project, two
individuals from a local clinical trials site familiar with Form 90 procedures from their
participation in Project MATCH conducted a formal Form 90 training session that was
embedded within the aforementioned assessment training sessions.
Form 90 Psychometrics
Sobell and Sobell (2003) reported that there is evidence supporting the stability,
criterion validity, and construct validity of the Form 90. In reference to reliability, a study
of 70 treatment-seeking men and women found that the agreement for daily self-report of
drinking (i.e., yes or no) between the test interview and the retest interview (i.e., 2 days
later), as measured by kappa coefficients, ranged from .48 to .97 with an average of .77
(Rice, 2007). Agreement for test-retest was further stratified by gender and assessment
window (days 1-30, 31-60, 61-88). Results indicated that test-retest agreement was higher
for women as compared to men, and was best for the most recent period (days 1-30) as
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compared to more than 31 days prior to testing. In a more comprehensive review,
Tonigan, Miller, and Brown (1997) several approaches were used to evaluate reliability.
ICCs and r calculations were carried out for test-retest comparisons, while kappa
coefficients were used to determine interviewer agreement regarding the presence or
absence of specific drug use. Results indicated that the Form 90 yielded relatively
consistent measures of drinking, drug use, and psychosocial functioning as evidenced by
r ≥ .90 in a large majority of comparisons (57 of 81 variables examined). The more
conservative standard of reliability (ICC) yielded less consistent reliability estimates,
though the majority of them fell within the acceptable range (Tonigan et al., 1997). With
a few exceptions, kappa coefficients of interrater agreement concerning lifetime drug use
were satisfactory. Grant, Tonigan, and Miller (1995) reported relatively adequate
convergent validity for the timeline followback calendar approach utilized by the Form
90. Correlations with similar methods of gathering retrospective drinking information
yielded values ranging from .59 to .80 for key variables (e.g., drinking days, total SEC,
peak BAC).
When selecting alcohol and drug use measures, decisions need to be made about
the type of information to be collected (e.g., level of precision, assessment period,
administration length) (Sobell & Sobell, 2003). Since research and clinical utility were at
the forefront in this project, the Form 90 emerged as a reliable, valid, and valuable
measure to assess the frequency and intensity of alcohol use, along with the rate of drug
use and other activities during the period leading up to treatment entry. The ability to
provide clients feedback regarding their level of substance use as it compares to others
was a favorable aspect of the instrument that the clinicians particularly liked because they
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felt it gave them objective information they could relay to clients and often initiated a
conversation regarding problem recognition and severity.
Inventory of Drug Use Consequences (InDUC)
Exploring the consequences individuals experience in relation to their alcohol and
drug use is not only useful for diagnostic determinations, but it can also illuminate
connections between substance use and negative physical and psychosocial consequences
that clients are not always able to recognize (Maisto et al., 2003). Furthermore, such data
has proven to be particularly useful in informing motivational and behavioral
interventions and helping clients move through the stages associated with the behavioral
change process (Miller & Rollnick, 2002). Nevertheless, there is a paucity of
standardized measures assessing adverse consequences of substance use. The
development of the Drinker Inventory of Consequences (DrInC) in 1995 was an initial
advance in filling this gap (Blanchard, Morgenstern, Morgan, Labouvie, & Bux, 2003).
This 50-item instrument was designed to evaluate alcohol-related consequences in five
domains: Physical, Social, Interpersonal, Impulse Control, and Interpersonal. Considering
the fact that a majority of individuals with substance use disorders have both alcohol and
drug problems, the DrInC was revised to incorporate consequences of drinking and using
drugs and the Inventory of Drug Use Consequences (InDUC) was created (Blanchard et
al., 2003).
The InDUC is available in two general formats. The lifetime version assesses
lifetime consequences and utilizes a dichotomous “yes/no” response scale to indicate
whether or not the respondent has ever experienced a particular event. This version was
selected for use in this project as it seemed more relevant to gather a more comprehensive
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history of consequences at the outset of treatment. The recent version inquires about how
frequently consequences that have been experienced during a particular time period (i.e.,
since treatment entry, in the previous 30 days), making it a suitable instrument to
examine changes over time. Respondents answer on a 4-point Likert scale ranging from
“never” to “daily or almost daily” (Blanchard et al., 2003). Scores are summed for each
subscale and across subscales to produce a total score, with higher scores reflecting more
severe consequences. The InDUC also employs a control scale comprised of five reversescaled items designed to detect careless or perseverative responding (Blanchard et al.,
2003). Endorsement of at least one of these items suggests that the respondent was
relatively prudent in their responding. Administration time is approximately 10 minutes,
and minimal training is required. The instrument is available free of charge and can be
downloaded from the CASAA website (CASAA, n.d.).
InDUC Psychometrics
Since the lifetime version of the InDUC was utilized in this project, the
subsequent evidence relates to this form. In a sample of outpatient drug treatment clients,
Tonigan and Miller (2002) found that three out of the five subscales had acceptable testretest stability. ICCs were .92 for Impulse Control, .88 for Social Responsibility, and .73
for Interpersonal. In contrast, the Physical and Intrapersonal scales had reliabilities falling
below the preferred level (ICC = .68, ICC = .33, respectively). In a more recent study of
outpatient clients, Gillaspy and Campbell (2006) reported higher test-retest reliability for
the entire scale (ICC = .94) and adequate temporal stability for nearly all five subscales:
Intrapersonal (ICC = .86); Social Responsibility (ICC = .83); Interpersonal (ICC = .82);
Physical (ICC = .71), and Impulse Control (ICC = .64).
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Tonigan and Miller (2002) also recruited a larger clinical sample from both
inpatient and outpatient settings to examine construct validity. A confirmatory factor
analysis produced a single common factor, which contrasted the proposed structure of the
InDUC containing five subscales (Tonigan & Miller, 2002). In a sample of outpatient
substance abuse treatment clients, Blanchard and colleagues (2003) also found support
for a one-factor solution, and reported high internal consistency for the entire measure (α
= .96). Gillaspy and Campbell (2006) reported additional internal consistency estimates:
entire scale (α = .96); Intrapersonal (α = .89); Interpersonal (α = .86); Physical (α = .85);
Social Responsibility (α = .84); and Impulse Control (α = .84). These authors also note
high intercorrelations among the five subscales, further challenging the construct validity
of the InDUC as there seems to be much overlap and redundancy. InDUC scores
demonstrated positive, yet modest, convergent validity with measures of psychological
distress, depression, and alcohol and drug use (Gillaspy & Campbell, 2006).
Although the evidence for construct validity of the InDUC’s five-factor structure
is lacking, this instrument appears to be a reasonably reliable and valid assessment of
consequences related to alcohol and drug use. In this study the InDUC demonstrated
acceptable internal consistency: Total (α = .92); Intrapersonal (α = .80); Interpersonal (α
= .78); Physical (α = .70); Social Responsibility (α = .76); and Impulse Control (α = .78).
Its clinical applicability in increasing client awareness and recognition of how substance
use has affected her/his life and gauging substance abuse/dependence severity further
supported the selection of this instrument. Ease of access, administration, and scoring
were also benefits to including this tool in the assessment battery.
Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES)
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The SOCRATES (Miller & Tonigan, 1996) is an instrument designed to assess
the stage of readiness to change drinking behavior. It is based on the transtheoretical
model of change (Prochaska & DiClemente, 1992; Prochaska et al., 1992), which
proposes that people progress through a sequence of stages as they initiate and maintain
behavior change. Precontemplation is characterized by a state of unawareness of a
problem or a need for change. As awareness of a problem increases, the person
progresses to a state of ambivalence or contemplation. At this point, the person often
weighs the pros and cons of behavior change. Eventually, the decisional balance may tip
in favor of change, as adverse consequences (cons) of maintaining the status quo
outweigh the perceived advantages (pros). Once this happens, the person is thought to
have entered the preparation stage, which involves making and strengthening a
commitment to change and developing a plan of action. Once these objectives are
achieved, the person attempts to execute the plan and makes necessary revisions to
manage difficulties in the action stage. If these initial efforts are successful, the person
proceeds to the maintenance stage where the focus is primarily on relapse prevention
(DiClemente, 2003; Prochaska & DiCLemente, 1992; Prochaska et al., 1992).
The SOCRATES is available in a long version (39 items) and an abbreviated
version (19 items). The authors recommended the use of the short form because it
generates scores that converge well with the longer version, and demonstrates greater
simplicity and clearer factor structure. In accordance with this advice, the 19-item version
was selected for use in this project (Miller & Tonigan, 1996). Clients are instructed to
indicate the degree to which they agree or disagree with statements worded specifically
about changing drinking behavior. Response options are on a 5-point Likert scale ranging
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from strongly disagree to strongly agree. Administration time is approximately 5 to 10
minutes, and training is minimal. The SOCRATES and accompanying materials
including an overview of the instrument and interpretation guidelines can be downloaded
from the CASAA website (CASAA, n.d.).
SOCRATES Psychometrics
Factor analyses yielded a 3-factor solution amongst responses of a sample of
1,672 Project MATCH participants seeking treatment for alcohol problems. The first
factor, Taking Steps (to change drinking behavior), accounted for 27% of the item
response variance and consisted of eight items (e.g., I am working hard to change my
drinking; I want help to keep from going back to the drinking problems that I had before).
The second factor, Recognition (that an alcohol problem exists), explained an additional
11% of the variance and contained seven items (e.g., I have serious problems with
drinking; my drinking is causing a lot of harm). The third factor, Ambivalence (about
whether an alcohol problem exists or not) accounted for a further 7% and consisted of
four items (e.g., There are times when I wonder if I drink too much; Sometimes I wonder
if I am in control of my drinking) (Miller & Tonigan, 1996). In light of these findings, it
appears that the SOCRATES does not fit perfectly within Prochaska and DiClemente’s
stages of change model, but the scales may be “better understood as continuously
distributed motivational processes that may underlie stages of change” (Miller &
Tonigan, 1996, p. 84). Scores are summed according to subscales, and deciles for each
scale are provided to determine how individuals compare to other people presenting for
alcohol treatment (i.e., low, average, high). Descriptive interpretation guidelines are also
provided to further delineate what the scores might signify.
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The relationship between these motivational dimensions and measures of problem
severity (e.g., various consumption variables, problem scales derived from the Alcohol
Use Inventory) was also examined. The strongest correlations, reflecting up to 15%
common variance, indicate a positive relationship between Recognition and problem
severity (Miller & Tonigan, 1996). Internal consistency estimates were generally
acceptable: Taking Steps (α = .83), Recognition (α = .85) and Ambivalence (α = .60).
Test-retest reliabilities were sound: Taking Steps (α = .96), Recognition (α = .95) and
Ambivalence (α = .87) (Miller & Tonigan, 1996). In addition to possessing fairly sound
psychometric properties, the ease of administration and scoring, simplicity of
interpretation, and fit within a motivational framework (Miller & Rollnick, 2002) made
the SOCRATES a suitable motivational measure to include in the battery. As Miller and
Tonigan (1996) noted, the SOCRATES also has clinical utility as a client feedback tool
that can help initiate a discussion about motivation and readiness for change and provide
a common language to talk about such topics. Alternative versions of the SOCRATES
have also been created, included one examining drug use (SOCRATES-D). The items are
worded exactly the same except for the references to alcohol are substituted with
references to drugs. Although the drug version has not received adequate attention in the
literature regarding its psychometric properties, the decision was made to incorporate this
measure into the battery for clinical purposes. Again, it was anticipated that such
information would assist clinicians in engaging clients into conversations about their
level of motivation and readiness for change. Both of the versions of the SOCRATES
exhibited excellent reliability in this study: Alcohol Recognition (α = .99); Alcohol
Taking Steps (α = .99); Alcohol Ambivalence (α = .88); Alcohol Total (α = .98); Drug
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Recognition (α = .99); Drug Taking Steps (α = .99); Drug Ambivalence (α = .91) Drug
Total (α = .99). These high internal consistency estimates may be the byproduct of how
face valid the SOCRATES questionnaire is. Anecdotally speaking, participants tended to
answer in a consistent manner that reflected high treatment eagerness/motivation if they
endorsed problems with alcohol and/or drugs (i.e., strongly agree with statements) or low
treatment eagerness/motivation if they did not use that particular substance (i.e., strongly
disagree with statements).
Pretreatment Variables
Table 3 outlines the primary variables that were explored in this study, the
assessment instruments they were obtained from, and their respective levels of
measurement. Pretreatment characteristics of interest were selected based on those
identified in the TCU Treatment Model (Simpson, 2001, 2004). The ASI domain
composite scores were also included as they represent more global indicators of overall
functioning that may be defining characteristics of this sample.

Table 3.
Pretreatment Characteristics
Variable

Instrument

Level of Measurement

Age

ASI

Continuous

Gender

ASI

Categorical

Ethnicity

ASI

Categorical

Marital Status

ASI

Categorical

Patient Attributes
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Variable

Instrument

Level of Measurement

Education

ASI

Categorical

Recent Monthly Employment Income

ASI

Continuous

Substance Use in Past 30 days

ASI

Continuous

Previous AODA Treatment

ASI

Categorical

SUD Diagnosis

M.I.N.I.

Categorical

Total Drinking Days in Past 90

Form 90

Continuous

Average Weekly SEC

Form 90

Continuous

Peak BAC for Assessment Window

Form 90

Continuous

Physical Consequences

InDUC

Continuous

Interpersonal Consequences

InDUC

Continuous

Intrapersonal Consequences

InDUC

Continuous

Impulse Control Consequences

InDUC

Continuous

Social Responsibility Consequences

InDUC

Continuous

M.I.N.I.

Categorical

Previous Psychiatric Treatment

ASI

Categorical

Been Prescribed Psychotropic(s)

ASI

Categorical

History of Abuse

ASI

Categorical

Patient Attributes

Substance Use Severity

Psychiatric Symptom Severity
Dual Diagnosis
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Variable

Instrument

Level of Measurement

Recognition

SOCRATES-A

Continuous

Ambivalence

SOCRATES-A

Continuous

Taking Steps

SOCRATES-A

Continuous

Recognition

SOCRATES-D

Continuous

Ambivalence

SOCRATES-D

Continuous

Taking Steps

SOCRATES-D

Continuous

Medical Composite Score

ASI

Continuous

Employment Composite Score

ASI

Continuous

Alcohol Composite Score

ASI

Continuous

Drug Composite Score

ASI

Continuous

Legal Composite Score

ASI

Continuous

Family/Social Composite Score

ASI

Continuous

Psychiatric Composite Score

ASI

Continuous

Motivation – Alcohol Use

Motivation – Drug Use

General Functioning

Treatment Variables
The primary treatment variable of interest is treatment completion status.
Treatment status completion was determined through a variety of methods. Clinicians
were encouraged to record whether or not clients successfully completed treatment in the
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program’s census log. However, this data was only available for approximately half of
the participants. In the event that treatment completion status was not available, the two
senior assessors accessed the client’s chart and examined the most recent treatment
progress note(s) to determine treatment status. A client was considered a treatment
completer if s/he met the majority of treatment goals, as identified by the treatment team,
was discharged from the program with staff approval, and/or was transferred to a more or
less intensive level of care. Examples of statements indicating treatment completion
include: “patient completed treatment assignments and was given a medallion for
completion of treatment;” “patient was discharged today with staff approval and is seen
as reaching maximum benefit in treatment;” and “patient discussed her discharge plans
with group, received feedback from peers, and received her medallion.” On the contrary,
a client was considered a treatment dropout if s/he did not complete the majority of
treatment goals and/or was discharged from the program without staff approval.
Examples of statements indicating treatment dropout include: “patient needs to complete
the last two assignments in the group and also needs to obtain a temporary sponsor;”
“patient was discharged due to noncompliance;” and “patient seems disinterested in the
group, coming in late, on the phone during breaks and away from peers, no meeting
attendance, and no assignment completion.” Clinicians were also consulted to review
client charts (n = 12) in situations where the two senior assessors were unable to
determine if a client successfully completed treatment based on the outlined criteria. The
treatment status criteria in this study were similar to those outlined in previous treatment
retention research (Mammo & Weinbaum, 1993; Veach et al., 2000).
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In accordance with efforts to accurately and adequately describe the treatment
characteristics of the current sample, the dichotomous treatment status variable was
expanded to include two additional classifications: treatment stopouts (i.e., treatment
dropouts who returned for subsequent treatment at the same facility) and treatment
repeaters (i.e., treatment completers who returned for subsequent treatment at the same
facility). To determine whether or not clients were stopouts or repeaters, the two senior
assessors accessed client charts and checked if they were readmitted to the treatment
facility for inpatient and/or outpatient treatment following their discharge from the main
treatment episode examined in this study. The designated period that stopouts and
repeaters were identified was the day following discharge through September, 15, 2007.
Number of treatment sessions and duration of treatment (i.e., number of days between
admission and discharge) were also examined to further depict the nature of treatment
participants received. Treatment characteristics of interest were selected based on
treatment information available to the researchers.
Data Analyses
Sample Characteristics
All statistical analyses were performed with the Statistical Package for the Social
Sciences (SPSS). Descriptive statistics (e.g., frequencies, modes, means, and standard
deviations) were conducted on identified pretreatment and treatment variables to describe
the basic characteristics of this sample of clients entering an intensive outpatient chemical
dependency treatment program at Roger Memorial Hospital – West Allis. Considering
the aforementioned data collection obstacles that were encountered while carrying out
this research project, the obtained sample may not be representative of the actual
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chemical dependency treatment-seeking population at this facility. Thus, demographic
variables and treatment information were obtained for those clients who were not tested
at intake and subsequently excluded from the investigation (N = 171). Comparative
analyses were conducted between these persons and the study participants in order to
determine the equivalency of the obtained sample to the overall population from which it
was drawn. These results will help to ascertain the generalizability of study findings.
Treatment Completers vs. Treatment Dropouts
In order to determine how clients who completed this treatment program differ
from clients who dropped out prematurely on identified pretreatment variables (research
question 1), comparative analyses between treatment completers and dropouts were
performed. Analyses were selected based on the level of measurement of the variables.
Chi-square analyses were carried out on the categorical variables, and continuous ASI
variables were examined using independent samples t-tests. Considering the mixed
evidence regarding how pretreatment characteristics relate to treatment completion status,
the null hypothesis in each of these tests was that the measure of central tendency (e.g.,
mode, median) is equivalent for treatment completers and dropouts. Groups were
considered to be significantly different if p < .05. Standardized expected cell residuals
greater than 1 or less than -1 were used to detect significant cell effects for chi-square
analyses.
Continuous variables deduced from the InDUC, Form 90, SOCRATES-A, and
SOCRATES-D and previous 30-day use of alcohol, opiates, cocaine, and marijuana, the
most used substances in this sample, were explored using profile analysis. Variables were
grouped together based on the assessment instrument they were derived from and a
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separate profile analysis was conducted on each group of instrument variables. By
grouping the variables in this manner, the clinical utility of this project was enhanced
because the results of the analyses could potentially be used to assist the treatment
program in determining if and how the assessment instruments are able to differentiate
between clients who go on to complete the treatment program and those who drop out of
the program prematurely. Utilizing such empirically-based methods in adapting the
intake evaluation process and selecting assessment instruments can aide treatment
program improvement efforts and, in the end, enhance the program’s retention rates and
positive treatment outcomes. Raw scores on the InDUC, Form 90, SOCRATES-A, and
SOCRATES-D were first converted to standardized z scores and then transformed into T
scores (10z + 50). Outliers were subsequently recoded. Scores deviating from the mean
by more than 3 standard deviations were recoded to be either 3 standard deviations above
(T = 80) or below (T = 20) the mean (n = 16). Responses on the ASI previous 30-day use
variables were all on the same scale (i.e., 0 – 30 days), thus no transformation was
necessary.
Identification of Subgroups
Cluster analysis was conducted to determine if meaningful subgroups of this
sample could be identified based on important pretreatment characteristics and treatment
variables (research question 2). Cluster analysis is the general term used to describe a
class of multivariate techniques whose primary purpose is to assemble objects (e.g.,
participants) based on the characteristics they possess with respect to predetermined
selection criterion. If classification is successful, the clusters should exhibit high withincluster homogeneity and high between-cluster heterogeneity. The three primary
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objectives of cluster analysis include taxonomy description, data simplification, and
relationship identification, making it an appropriate technique for use in this study based
on the identified research questions (Hair & Black, 2000). Dennis, Perl, Huebner, and
McLellan (2000) indicated that cluster analysis is a recommended analytical method for
exploring questions regarding who is being served and identifying major client
subgroups, one of the primary aims of this investigation.
The cluster analysis in the present study was exploratory in nature. The selection
of variables, as opposed to the actual methods utilized, may have the strongest impact on
the results of a classification study, thus careful consideration was undertaken in the
selection process (Peters, 1997). In addition to appraising the available empirical
evidence, the utility of the potential interpretation of results in comprehensively capturing
the complexity of the sample was heavily weighted. Ultimately, age, ASI composite
scores, and InDUC subscale scores were chosen as the variables to be included in the
cluster analysis. It was deemed that these characteristics appeared to be an adequate
snapshot of participant functioning across multiple domains and had potential to produce
a parsimonious grouping scheme with applied value in the treatment process (i.e.,
identification of treatment needs at the outset of treatment).
The specific clustering procedure employed in this study was Ward's method
(Ward, 1963). Ward’s method is a hierarchical agglomerative clustering technique
wherein each case starts as its own cluster, and similar clusters are sequentially merged
until all cases are in one cluster. For each cluster, the means of all variables are calculated
and then the squared Euclidean distance (i.e., the geometric proximity between two
cases) to the cluster means is calculated. These distances are then summed for all of the
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cases within the hypothetical cluster. At each step, the two clusters that merge are those
that result in the smallest increase in the overall sum of the squared Euclidean distances.
In other words, clusters are merged so as to minimize the variability within the cluster
(Borgen & Barnett, 1985; Norusis, 2006). The agglomeration schedule, the dendogram,
and interpretability of identified clusters were considered in determining the adequacy of
potential cluster solutions (Clatworthy, Buick, Hankins, Weinman, & Horne, 2005;
Norusis, 2006). More specifically, the agglomeration coefficient is a dissimilarity
measure wherein small values suggest that the clusters being combined are fairly
homogeneous, whereas larger values indicate that fairly dissimilar clusters are being
combined. The dendogram is a visual representation of how clusters are combined. It is
read from left to right, with vertical lines demarcating joined clusters. A large distance
between sequential vertical lines is used to determine at what stage the distances between
the combined clusters is large (Norusis, 2006). Concurrent and predictive validation
procedures (e.g., ANOVA, chi-square test) were also completed to demonstrate how the
identified clusters relate to a range of variables (i.e., demographic characteristics,
substance use history, psychiatric status, motivation, treatment attributes) that were not
included in the cluster analysis.
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Chapter IV: Results

Overview
This chapter details the results of statistical analyses completed. It begins with a
discussion of how missing data was handled and then delineates how the obtained sample
compares to the larger population from which is was drawn. Sample characteristics are
then described, along with significant differences between treatment completers and
treatment dropouts on these characteristics. Finally, results of the cluster analysis are
outlined.
Missing Data
How to handle missing data is a common dilemma a researcher encounters as the
improper handling of missing values can distort statistical analyses and produce a
remaining data set that is biased. Completing a missing value analysis can help address
such concerns, thus a qualitative analysis of the missing data was conducted. The data set
in this study originally contained a total of 298 cases. Upon further examination, 13 cases
evidenced missing data points due to computer problems wherein responses on the
InDUC or SOCRATES were lost electronically and could not be retrieved. An additional
11 cases evidenced missing data points due to incomplete data gathering wherein the
information collected was not sufficient to make a diagnosis on the M.I.N.I. or to
compute summary Form 90 statistics (e.g., days of drinking, weekly SEC, Peak BAC) on
the Form 90. One more case had the race/ethnicity response missing from the ASI. These
missing data points were spread out across time, variables, and assessors. Taken
together, these observations provide evidence to support the decision to classify it as
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missing completely at random (Allison, 2002). Consequently, listwise deletion, as
opposed to an imputation method, was chosen to handle the missing data in this study.
Furthermore, listwise deletion produced a relatively small drop in sample size (8.4%), so
although statistical power was slightly reduced, the estimated parameters were likely not
biased by the absence of this data.
Generalizability
As previously mentioned, a variety of practical difficulties interfered with the
assessment team’s ability to evaluate each new client in the treatment program (e.g.,
timing of new client notification, space constraints, inconsistent client attendance at
treatment groups). In recognition of the fact that the obtained sample (N = 273) may not
be representative of the actual substance abuse treatment-seeking population at this
facility, demographics and treatment information were obtained for those clients who
were not assessed at intake and consequently excluded from the study (N = 171). The
average age of the entire population (N = 444) was 38.78 years (SD = 12.00). A majority
were males (62.4%). With regards to ethnicity and race, 84.5% identified as Caucasian,
9.2% identified as African, 3.5% identified as Hispanic, 1.6% identified as a Native
American or Alaska Native, and 1.1% identified as Asian or Pacific Islander. The overall
treatment completion rate was 49%. On average, individuals attended 12.18 group
treatment sessions (SD = 6.64) and stayed in treatment for just over 3 weeks (M = 22.67
days, SD = 13.95).
Comparative analyses were conducted in order to determine the equivalency of
the obtained sample to the overall population from which it was drawn to help inform the
generalizability of study findings. Results indicated that study participants and excluded
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individuals did not significantly differ on sociodemographic characteristics including
gender, χ2(1, N = 444) = 0.00, p = .95, and race, χ2(1, N = 444) = 4.71, p = .32;
however, treatment participants were significantly older (M = 39.77, SD = 11.80) than
those who did not participate in the study (M = 37.20, SD = 12.18), t(442) = -2.21, p =
.03. Significant differences were also detected on all three treatment variables. Study
participants were more likely to complete treatment as compared to individuals who were
not evaluated, χ2(1, N = 444) = 28.94, p < .001. They also attended more treatment
groups on average (M = 14.19, SD = 5.06) than individuals who were not included in the
study (M = 8.99, SD = 7.56), t(442) = -7.95, p < .001, and generally stayed in treatment
for more days (M = 27.05, SD = 11.39) than nonparticipants (M = 15.68, SD = 14.83),
t(442) = -8.56, p < .001.
Sample Characteristics
See Table 4 for sample characteristics. Of the total sample (N = 273), 62.3% were
male, 86.4% were Caucasian, 44.7% were married, and 91.6% had at least 12 years of
education. The mean age of the sample was 39.77 years (SD = 11.80). The average
amount of money earned from employment in the past month was $1977 (SD = 2948).
This estimate appeared to be impacted by a few participants (n = 6) who earned more
than $10,000 in the past month. The median monthly income for was $1200. Of the total
sample, 68.1% had participated in prior substance abuse treatment, 58.1% had received
previous treatment for psychological problems, and 64.5% had been prescribed
psychotropic medications. Furthermore, 60.8% of the sample had experienced some type
of physical, emotional, and/or sexual abuse. Fifty-nine percent of the sample completed
the treatment program, while 41.0% dropped out prematurely. Again, this estimate
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represents higher estimate than was found for the population from which the sample was
drawn (49%). Of the treatment dropouts in the study sample, 25.0% returned for a
subsequent treatment episode (i.e., treatment stopout), while 18.6% of treatment
completers also returned for additional treatment at a later date (i.e., treatment repeater).
Altogether, just over 20% of the study sample returned for a subsequent treatment
episode in the same program. The number of treatment days for the study sample ranged
from 2 to 27 days, with an average of 14.2 (SD = 5.1). Total treatment duration for the
study sample ranged from 1 day to 78 days, with an average of 27.1 (SD = 11.4).

Table 4.
Participant Characteristics by Treatment Completion Status
Treatment Completion Status

Characteristic

Completer
(n = 161)

Age (M ± SD)

42.32 ± 11.00

Dropout
(n = 112)

Total Sample
(N = 273)

36.10 ± 11.98** 39.77 ± 11.80

Gender (%)
Male
Female

63.4
36.6

60.7
39.3

62.3
37.7

Ethnicity (%)
Caucasian
African American
Native American/Alaska Native
Hispanic
Asian/Pacific Islander

87.6
8.7
1.2
2.5
0.0

84.8
8.0
1.8
4.5
0.9

86.4
8.4
1.5
3.3
0.4

Marital Status (%)
Married
Widowed
Separated
Divorced
Never Married

52.8
1.9
1.9
17.4
26.1

33.0*
0.0
4.5
17.9
44.6*

44.7
1.1
2.9
17.6
33.7
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Completer
(n = 161)

Dropout
(n = 112)

Total Sample
(N = 273)

6.8
32.9
60.2

10.7
42.0
47.3

8.4
36.6
54.9

$2298 ± 3483

$1517 ± 1856*

$1977 ± 2948

Previous AODA Treatment (%)

67.7

68.8

68.1

Previous Psych Treatment (%)

53.4

66.1*

58.6

Been Prescribed Psychotropic(s) (%)

61.5

68.8

64.5

Been Emotionally, Psychologically,
or Sexually Abused (%)

59.6

62.5

60.8

Characteristic
Education (%)
Less than HS
HS
More than HS
Recent Monthly Employment Income

* p < .05. ** p < .001.

In the 30 days prior to the day the assessment was conducted, nearly 80% of the
sample had used alcohol, 30.8% had used marijuana, almost one-fourth had used a form
of cocaine, 20.2% had used opiates (e.g., Percocet, Vicadin), 10.3% had used sedatives
(e.g., Xanax, Valium), 5.9% had used heroin, 2.2% had used amphetamines (e.g.,
Methamphetamine, Ritalin), 2.2% had used a hallucinogen (e.g., LSD, mushrooms), and
1.5% used barbiturates (e.g., Phenobarbital, Nembutal). It should be noted that
prescription drug use was only counted above if participants did not use them as
prescribed (i.e., took twice as much pain medication as was advised).
Nearly the entire sample (97.4%) met criteria for at least one substance use
disorder: 48.4% met criteria for only an alcohol use disorder, 23.4% met criteria for only
a drug use disorder(s), and 25.6% met criteria for both an alcohol and a drug use
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disorder(s). This diagnostic information was gathered from a self-report instrument
(M.I.N.I.), thus participants may not have endorsed questions that would qualify for a
substance abuse or dependence diagnosis, despite seeking treatment for substance use
problems. With reference to comorbid psychological problems, over half of the sample
met criteria for at least one substance use disorder and at least one comorbid
psychological disorder (51.6%). See Table 5 for a breakdown of the most common Axis I
diagnostic categories that participants met criteria for. It should be noted that one-third of
the sample also reported having suicidal thoughts.

Table 5.
Prevalence of Axis I Disorders by Treatment Completion Status (%)
Treatment Completion Status
Completer
(n = 161)

Dropout
(n = 112)

Total Sample
(N = 273)

Depression

37.9

49.1

42.5

Anxiety (PTSD, OCD, Panic, Social)

21.1

39.3*

28.6

Alcohol

76.4

70.5

74.0

Marijuana

13.0

17.0

14.7

Opiate

15.5

25.9*

19.8

Cocaine

14.9

32.1*

22.0

SUD Diagnosis
No Diagnosis
Alcohol Only
Drug(s) Only
Alcohol and Drug(s)

3.1
57.1
20.5
19.3

1.8
35.7*
27.7
34.8*

2.6
48.4
23.4
25.6

Diagnostic Category
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Diagnostic Category
Dual Diagnosis
No Diagnosis
SUD Only
Dual Diagnosis
* p < .05.

Completer
(n = 161)

Dropout
(n = 112)

Total Sample
(N = 273)

3.7
51.6
44.7

1.8
36.6*
61.6*

2.9
45.4
51.6

Treatment Completers vs. Dropouts
Consult Table 4 and Table 5 for results of comparative analyses between
participants who completed treatment and those who dropped out of treatment
prematurely. Standardized expected cell residuals greater than 1 or less than -1 were used
to detect significant cell effects for chi-square analyses. Treatment completers (M =
42.32, SD = 11.00) were significantly older than treatment dropouts (M = 36.10, SD =
11.98), t(271) = -4.37, p < .001, and earned significantly more income from employment
in the past 30 days (M = 2298, SD = 3483) than treatment dropouts (M = 1517, SD =
1856), t(271) = -2.40, p = .017. Treatment completers were more likely to be married
(52.8%) than their counterparts (30.0%), while treatment dropouts were more likely to
never have been married (44.6%) as compared to treatment completers (26.1%), χ2(4, N
= 273) = 16.14, p = .003.
Treatment dropouts were significantly more likely to have participated in previous
psychological treatment (66.1%) than participants who completed treatment (53.4%),
χ2(1, N = 273) = 4.36, p = .037. Diagnostically speaking, treatment completers were
significantly more likely to have met criteria for only an alcohol use disorder and
significantly less likely to meet criteria for both an alcohol and at least one drug use
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disorder than their counterparts who did not complete treatment, χ2(3, N = 273) = 14.42,
p = .002. Treatment dropouts were significantly more likely to meet criteria for an opiate
use disorder, χ2(1, N = 273) = 4.47, p = .034, and/or a cocaine use disorder, χ2(1, N =
273) = 11.44, p = .001. Treatment dropouts also met criteria for both a substance use
disorder and a comorbid Axis I psychological disorder at higher rates than treatment
completers, χ2(2, N = 273) = 7.74, p = .021. In particular, treatment dropouts were more
likely to endorse diagnostic criteria for an anxiety disorder (e.g., obsessive-compulsive
disorder, social anxiety, post-traumatic stress disorder, and/or panic disorder) than
treatment completers, χ2(1, N = 273) = 10.68, p = .001.
Treatment completers attended significantly more treatment groups (M = 16.29,
SD = 3.54) than treatment dropouts (M = 11.17, SD = 5.40), t(271) = -8.80, p < .001.
Furthermore, the total duration of treatment for completers was an average of at least 11
days longer (M = 31.63, SD = 9.52) than dropouts (M = 20.46, SD = 10.65), t(271) = 8.90, p < .001.
Profile Analysis
Profile analysis was conducted to further compare participants who completed
treatment to participants who dropped out of treatment. A separate profile analysis was
performed on the selected variables from the following instruments: InDUC, Form 90,
SOCRATES-A, SOCRATES-D, and ASI. Raw scores on the InDUC, Form 90,
SOCRATES-A, and SOCRATES-D were first converted to standardized z scores and
then transformed into T scores (10z + 50). Outliers were subsequently recoded. Scores
deviating from the mean by more than 3 standard deviations were recoded to be either 3
standard deviations above (T = 80) or below (T = 20) the mean (n = 16). Responses on
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the ASI previous 30-day use variables were all on the same scale (i.e., 0 – 30 days), thus
no transformation was necessary.
For each profile analysis, two statistical tests were executed to allow for
comparison of the means of completers and dropouts on the variables of interest, as well
as the comparison of the pattern of means across each assessment measure (Norusis,
2006). The parallelism test deduces whether the pattern of means on the variables is the
same between groups. A multivariate analysis of variance (MANOVA) was executed and
the parallelism null hypothesis was rejected if a significant group by dependent variable
interaction effect was detected. Wilks' lambda, the test statistic of interest, is a direct
measure of the proportion of variance in the combination of dependent variables that is
unaccounted for by the independent variable (i.e., treatment completion status). The
equal levels test explores main effects and examines whether one group scored higher, on
average, across variables on a particular instrument.
Analyses of parallelism of each assessment measure produced only one
statistically significant interaction effect. Pattern of performance on the InDUC showed a
statistically significant difference between treatment completers and dropouts Wilks' Λ =
.69, F (1, 271) = 2.47, p = .045, η2 = .31. See Figure 2. Higher T scores reflect the
experience of more negative consequences. More specifically, treatment dropouts
experienced more negative consequences related to fulfilling social responsibilities (M =
51.68, SD = 9.37) as compared to their counterparts who completed treatment (M =
48.83, SD = 10.27), t(271) = 2.37, p = .019.
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Figure 2. Comparison of InDUC subscale scores.

Analyses of equal levels, or main effects, produced statistically significant results
on two of the assessment measures. Treatment dropouts had significantly higher average
scores than treatment completers across SOCRATES-D subscales (F (1, 271) = 13.43, p
< .001), indicating that dropouts demonstrated higher levels of drug problem recognition,
endorsed a higher degree of ambivalence about changing their drug use, and reported
they were taking more steps to reduce their drug use. Treatment dropouts also reported
more days of recent (i.e., past 30 days) alcohol, opiates, cocaine, and marijuana use as
measured by the ASI, (F (1, 271) = 12.25, p = .001). See Figure 3 and Figure 4 for
profiles.
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Figure 3. Comparison of SOCRATES-D subscale scores.
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Figure 4. Comparison of substance use in the 30 days prior to date of evaluation.

Identification of Subgroups
Cluster Analysis
Age, ASI composite scores, and InDUC subscale scores were selected as the
variables to be included in the cluster analysis as they appeared to be a comprehensive
snapshot of participant functioning across multiple domains at the outset of treatment.
These variables also had potential to produce a parsimonious grouping scheme with
clinical value in the treatment planning process by determining prominent areas of
concern for specific subtypes of clients. The hierarchical agglomerative clustering
technique known as Ward's method (Ward, 1963) was employed to identify a cluster
solution. The agglomeration schedule and dendogram were examined to ascertain the
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most appropriate cluster solution (Clatworthy et al., 2005; Norusis, 2006). More
specifically, potential cluster solutions were denoted by a prominent increase in the
agglomeration coefficient as compared to preceding increases. The “jump” between stage
269 and 270 suggested a greater degree of dissimilarity of clusters being combined at this
stage as compared to previous stages (see Table 6). The dendogram was also inspected,
though the figure was too extensive to depict visually. A large distance between
sequential vertical lines was the marker used to determine what stage the distances
between the combined clusters was large and that a prospective clustering solution was
found (Norusis, 2006). Based on these objective indicators, a four-cluster solution was
identified.

Table 6.
Cluster Analysis Agglomeration Schedule
Stage

Agglomeration Coefficient

Coefficient Difference Between Stages

266

2172.02

-

267

2295.48

123.46

268

2427.91

132.43

269

2567.47

139.56

270

2761.16

193.69

271

3008.83

247.66

272

3536.00

527.17
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The cluster solution is depicted in Table 7 and Table 8. The clusters range in size
from 51 to 87 participants. The interpretation of each cluster and corresponding label
were deduced primarily from the pattern of composite score means across ASI domains
and extent of substance use-related consequences noted on the InDUC. ASI composite
scores range from 0 to 1, with higher scores reflecting more severe problems. Higher
scores on the InDUC subscales also reflect more extensive problems in an area.

Table 7.
Mean (SD) Age and ASI Composite Scores for Cluster Solution

Pervasive
Concerns
Polysubstance
Use Disorder
(n = 73)

Serious
Concerns
Alcohol
Use
Disorder
(n = 87)

36.62
(9.23)

Medical

Moderate
Concerns
Drug Use
Disorder
(n = 51)

Minimal
Concerns
Alcohol
Use
Disorder
(n = 62)

Total
Sample
(N = 273)

43.92
(9.74)

33.14
(12.41)

43.11
(13.28)

39.78
(11.80)

.41 (.39)

.18 (.25)

.09 (.13)

.25 (.28)

.24 (.31)

Employment

.46 (.25)

.36 (.24)

.23 (.22)

.22 (.18)

.33 (.28)

Alcohol

.33 (.30)

.61 (.18)

.10 (.11)

.44 (.23)

.40 (.29)

Drug

.21 (.13)

.04 (.09)

.26 (.08)

.03 (.06)

.13 (.14)

Legal

.12 (.19)

.15 (.22)

.08 (.14)

.04 (.10)

.10 (.18)

Family/Social

.38 (.25)

.23 (.21)

.26 (.23)

.17 (.20)

.26 (.24)

Psychiatric

.48 (.21)

.32 (.25)

.27 (23)

.24 (.23)

.33 (.25)

Domain
Age
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Table 8.
Mean (SD) InDUC Subscale Scores for Cluster Solution

Items

Pervasive
Concerns
Polysub.
Use
Disorder
(n = 73)

Serious
Concerns
Alcohol
Use
Disorder
(n = 87)

Physical

8

6.63
(1.26)

Interpersonal

10

Moderate
Concerns
Drug Use
Disorder
(n = 51)

Minimal
Concerns
Alcohol
Use
Disorder
(n = 62)

Total
Sample
(N = 273)

5.83
(1.82)

5.1
(1.70)

3.1
(1.70)

5.29
(2.08)

8.27
(1.59)

7.18
(2.18)

6.24
(2.28)

4.32
(2.27)

6.65
(2.52)

8

7.60
(.88)

7.29
(1.01)

6.67
(1.57)

4.65
(2.35)

6.66
(1.87)

Impulse
Control

12

8.00
(2.50)

7.31
(2.56)

5.24
(2.02)

3.37
(1.92)

6.21
(2.93)

Social
Responsibility

7

6.25
(1.06)

5.05
(1.58)

5.06
(1.70)

2.5
(1.56)

4.79
(1.99)

Subscale

Intrapersonal

The pervasive concerns polysubstance use disorder cluster was characterized by
the highest average medical, employment, family/social, and psychiatric composite
scores, paired with considerable alcohol and drug composite score elevations. Cluster
members reported experiencing more substance use-related consequences across InDUC
subscales (e.g., physical, interpersonal, intrapersonal, impulse control, and social
responsibility) than their counterparts, and their age fell below the sample mean by about
three years (M = 36.62 years). Conversely, the minimal concerns alcohol use disorder
cluster had the lowest drug, legal, family/social, and psychiatric composite scores, paired
with the second highest average alcohol and medical composite scores. Members of this
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category endorsed the fewest number of substance-use related consequences, and their
age was above the sample mean by about three years (M = 43.11 years). The mean age of
the serious concerns alcohol use disorder group (M = 43.92 years) was comparable to
their fellow primary alcohol users. This particular cluster evidenced the most severe
alcohol and legal problems, significant employment and psychiatric problems (i.e.,
second highest average), and ranked second across InDUC subscales of substance-use
related consequences. The final cluster, moderate concerns drug use disorder, were the
youngest cluster (M = 33.14 years) and exhibited the highest average drug composite
score and significant family/social problems. InDUC subscale scores were third in rank
compared to the other clusters.
Validity of the Identified Cluster Solution
Table 9 presents a summary of the concurrent and predictive validation analyses
examining the four-cluster solution across a variety of variables: demographics,
diagnosis, psychiatric status, substance use, motivation for treatment, and treatment
characteristics. Chi-square tests (χ2) were executed for categorical variables and one-way
analysis of variance (ANOVA) tests were executed for continuous variables. For χ2 tests,
standardized expected cell residuals greater than 1 or less than -1 were used to detect
statistically significant cell effects (i.e., significantly more or fewer observations than
would be expected by chance alone). For ANOVA tests, Tukey’s HSD post hoc
comparisons were executed to determine if a cluster was significantly different from any
other cluster(s). Due to the large number of comparisons statistical tests being
undertaken, the p value was adjusted with the Bonferroni method to control for type I
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error. A total of 17 tests were completed, thus values of p < .003 (i.e., .05/17) were
considered significant.

Table 9.
Cluster Validation Results

Variable

Pervasive
Concerns
Polysub.
Use
Disorder
(n = 73)

Serious
Concerns
Alcohol
Use
Disorder
(n = 87)

Moderate
Concerns
Drug Use
Disorder
(n = 51)

Minimal
Concerns
Alcohol
Use
Disorder
(n = 62)

Statistic

Gender

χ2 = 1.66

Ethnicity

χ2 = 19.89

Marital Status
Married
Widowed
Separated
Divorced
Never Married

χ2 = 40.55
p < .001

+

+
-

+
+
χ2 = 21.62

Education
Depressive Disorder

+

-

χ2 = 33.94
p < .001
χ2 = 12.51

Anxiety Disorder

Alcohol Disorder

-

+

-

+

χ2 = 80.07
p < .001

Marijuana Disorder

+

-

+

-

χ2 = 19.39
p < .001

Opiate Disorder

+

-

+

-

χ2 = 75.89
p < .001
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Variable
Cocaine Disorder

SUD Diagnosis
Alcohol Only
Drug(s) Only
Alcohol + Drug(s)

Pervasive
Concerns
Polysub.
Use
Disorder
(n = 73)

Serious
Concerns
Alcohol
Use
Disorder
(n = 87)

Moderate
Concerns
Drug Use
Disorder
(n = 51)

Minimal
Concerns
Alcohol
Use
Disorder
(n = 62)

+

-

+

-

+
+

+
-

+

+
-

Statistic
χ2 = 30.52
p < .001
χ2 = 168.38
p < .001

χ2 = 47.22
p < .001

Dual Diagnosis
SUD only
SUD + Psychiatric

+

SOCRATES-Alcohol
Total Motivation Score

+

+

-

+

χ2 = 56.16
p < .001

SOCRATES-Drug Total
Motivation Score

+

-

+

-

χ2 = 79.96
p < .001

Total Drinking Days in
Past 90

+

+
+

-

+
+

χ2 = 37.18
p < .001

Average Weekly SEC

+

+
+

-

χ2 = 16.42
p < .001

+
+

-

F = 21.44
p < .001

Peak BAC for
Assessment Window
Treatment Completion
Status

+

+
-

χ2 = 6.44
F = 4.45

Treatment Days
F = 3.01
Treatment Duration
Note. Directions of significant effects are indicated using plus and minus signs. For χ2 a plus sign in a
column indicates that for that cluster, the observed frequency is significantly greater than what would be
expected by chance alone, and vice versa for a minus sign. For ANOVA, lines should be interpreted
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horizontally, one line at a time. A plus sign indicates that the mean value of that cluster is greater than the
mean value(s) of the cluster(s) denoted by the minus sign.

Concurrent validation procedures provided evidence in support of a four-cluster
solution, as results revealed that most of the observed relationships were in the
anticipated direction. Substance use disorder diagnostic categories coincided with the
primary substance(s) of use of each group. For example, the serious concerns and
minimal concerns alcohol use disorder groups were more likely to meet diagnostic
category for only an alcohol use disorder than their moderate concerns drug use disorder
and pervasive concerns polysubstance use disorder counterparts. The opposite pattern
was detected for marijuana, cocaine, and opiate use disorder diagnoses: the pervasive
concerns polysubstance use and moderate concerns drug use disorder clusters were more
likely to meet criteria for these drug-use disorders than the clusters that primarily used
alcohol. Furthermore, the pervasive concerns polysubstance use disorder cluster was
more likely to meet criteria for both an alcohol and at least one drug use disorder, while
the moderate concerns drug use disorder cluster was more likely to meet criteria for only
a drug use disorder.
Frequency of drinking also corresponded to primary substance(s) of use. The two
alcohol use disorder clusters tended to drink on more days in the 90 days prior to
treatment than the polysubstance and drug use disorder groups, and the polysubstance
use disorder cluster drank on more days than the drug use disorder cluster. A slightly
different pattern emerged for drinking severity indicators. The serious concerns alcohol
use disorder cluster drank significantly more drinks on a weekly basis and had a higher
peak BAC during the assessment window than their minimal concerns alcohol use
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disorder and moderate concerns drug use disorder counterparts. The pervasive concerns
polysubstance use disorder cluster exhibited a higher average weekly consumption rate
and a higher peak BAC than the moderate concerns drug use disorder group.
Level of motivation to change alcohol use and drug use, as measured by a total
score on the SOCRATES (i.e., higher scores reflect a higher level of motivation to
change), coincided with group membership. The serious concerns alcohol use disorder
displayed higher levels of motivation to change their alcohol use than all other groups,
and the moderate concerns drug use disorder and pervasive concerns polysubstance use
disorder groups endorsed higher levels of motivation to change their drug use than the
alcohol use disorder clusters. As evidenced by their labels, the pervasive polysubstance
use disorder cluster was more likely to be meet criteria for a comorbid psychiatric
disorder, specifically a depressive disorder, while the minimal concerns alcohol use
disorder cluster was less likely to meet criteria for a concurrent psychiatric disorder.
In addition to examining relationships with concurrent variables, the identified
clusters were also compared to treatment variables including treatment completion status,
number of treatment days, and treatment duration to explore the predictive validity of the
identified cluster solution. No significant statistical findings emerged, though trends were
detected in the anticipated direction based on the treatment retention literature suggesting
that clients with alcohol use disorders tend to complete substance abuse treatment at
higher rates than clients with drug use or polysubstance use disorders (De Leon et al.,
1997; Joe et al., 1999; McKellar et al., 2006). The moderate concerns drug use disorder
cluster was the only cluster wherein the majority of members did not complete treatment.
The retention rate for this cluster was 45.1%, compared to 67.7% for minimal concerns
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alcohol use disorder, 62.1% for serious concerns alcohol use disorder, and 57.5% for
pervasive concerns polysubstance use disorder. The moderate concerns drug use
disorder cluster also had the lowest mean number of treatment days (M = 12.94, SD =
5.05) and shortest average treatment duration (M = 23.98, SD = 11.50), while the serious
concerns alcohol use disorder cluster had the highest mean number of treatment days (M
= 15.75, SD = 4.39) and longest average treatment duration (M = 29.52, SD = 9.88).
Again, these differences were not statistically significant, though appeared to trend in the
expected direction based on the literature.
Taken together, the evidence for the validity of the identified four-cluster solution
was mixed. Diagnostically speaking, the clusters corresponded well with primary
substance(s) of use identified by the cluster title (i.e., alcohol use disorder clusters were
more likely to meet criteria for only an alcohol use disorder as compared to the
polysubstance use disorder and drug use disorder clusters). Some support was also
detected for the degree of concern identified by the cluster title. For instance, the
pervasive concerns cluster was more likely to meet criteria for a comorbid psychiatric
condition, while the minimal concerns cluster was less likely to meet criteria for a
comorbid psychiatric condition. Additionally, the pervasive concerns and serious
concerns groups exhibited a higher degree of substance use severity as evidenced by
greater average number of weekly drinks and peak BAC level, as compared to the
minimal concerns and moderate concerns groups. Unfortunately, there was relatively
poor evidence for the predictive validity of the identified cluster solution as the clusters
did not produce statistically significant relationships with treatment status, number of
treatment days, or total treatment duration; however, there were potentially important
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trends detected that suggested that the moderate concerns drug use disorder group may
not have fared as well as the other clusters. Moreover, the absence of statistically
significant findings does not negate the descriptive value of delineating subgroups of this
particular treatment-seeking population, which will be explored further in the discussion
section.
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Chapter V: Discussion

Overview
The purpose of this section is to evaluate the study findings. This chapter will
begin with an overview of the research questions set forth. A summary of the basic
characteristics of the sample and how they relate to treatment retention are then reviewed.
Next, the cluster analysis results will be summarized. The implications of these findings
will then be discussed along with identified study limitations and future research
directions.
Research Questions
A primary purpose of this study was to describe the characteristics of a sample of
clients entering an intensive outpatient chemical dependency treatment program at a
nonprofit, freestanding mental health clinic and to examine how these variables differ
between clients who complete treatment and clients who drop out prematurely.
Additionally, in an effort to accurately depict this particular treatment program
population, this investigation explored whether a classification system could be used to
categorize individuals into meaningful groups based on important pretreatment
characteristics and treatment variables. These areas of inquiry have both applied and
empirical value.
Clinically speaking, it is critical for individual treatment programs to examine
treatment outcomes; however, a treatment program must first learn more about who is
participating in its program, who is completing its program, and who is prematurely
dropping out to accurately portray information regarding its treatment outcomes. Upon
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identifying client characteristics and determining which ones positively and negatively
relate to retention, a treatment program is better prepared to design assessment
procedures that allow clinicians to quickly and efficiently detect clients who may be at
risk for dropout. Considering the well-established relationship between treatment
retention and the achievement of positive treatment outcomes (Anton et al., 2006;
Hubbard et al., 1997; Hubbard et al., 1989; Moyer & Finney, 2002; Project MATCH
Research Group, 1998b; Simpson, 1993; Simpson & Sells, 1982; Weisner et al., 2003),
such knowledge can inform the design of programmatic interventions to enhance
retention, which can potentially improve treatment outcomes. Empirically speaking, this
study will add to the existing literature describing the characteristics of clients who
participate in intensive outpatient substance abuse treatment programs and provide
additional evidence related to whether or not different subtypes of individuals with
substance use disorders exist. Furthermore, study findings can clarify the extent to which
current scientific research regarding client characteristics and their relationship to
treatment retention applies to this particular program and the clientele it serves.
Generalizability
Due to the practical difficulties that interfered with the assessment team’s ability
to evaluate each new client in the treatment program, the consequent sample in this study
(n =273) was only a portion of the target population (N = 444) that entered the treatment
program during the data collection period. Basic demographic information and treatment
characteristics were obtained for the individuals who were not included in the study (n =
171). Study participants and excluded individuals did not significantly differ on
sociodemographic characteristics including gender and race, though study participants
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were significantly older than those who were excluded from the study. This difference
was fairly small though: 39.77 years (SD = 11.80) compared to 37.20 years (SD = 12.18).
In examining treatment characteristics, it is apparent that the study sample had an
overrepresentation of treatment completers. The overall treatment completion rate for the
entire population was 49%, whereas a 59% treatment completion rate was detected within
the study sample. Study participants also attended significantly more treatment groups on
average than individuals who were not included in the study and stayed in treatment for a
longer duration. Consequently, caution needs to be exercised when interpreting results
because of the evident over-inclusion of individuals who are retained in treatment and
more research needs to be conducted to confirm or refute its results. However, the
preliminary and descriptive nature of this project upholds the relevancy of its results and
implications, particularly as they apply to the treatment program itself.
Treatment dropout is a common obstacle in substance abuse treatment research
and barriers to obtaining representative samples need to be considered in the initial stages
of the research process. Early treatment dropout likely influenced participant accessibility
in this study. Roffman et al. (1993) reported that 11% of clients dropped out of their
outpatient treatment for marijuana dependence prior to completing their 5th treatment
session. Since the average time elapsed between treatment admission and initial
evaluation was 5 calendar (not treatment) days, it is likely that some of the
nonparticipants dropped out of treatment prior to the assessment team even having a
chance to complete the evaluation. This reality is a common challenge of carrying out
research in an applied setting where resources including space, time, and data collection
coverage may be limited at times. Thus, researchers and the treatment programs they are

172
collaborating with should be prepared to address such challenges throughout all phases of
the research project and to make adjustments along the way to reduce protocol
implementation barriers.
Treatment Characteristics
The 49% completion rate detected for the population from which this study
sample was drawn falls within the range identified by other retention studies in
(intensive) outpatient settings. At the high end of the range lies White and associates
(1998) with 74% and Veach and colleagues (2000) with 72%. At the low end of the
spectrum lies Dobkin et al. (2002), Green et al. (2002), and Mammo and Weinbaum
(1991) with treatment completion rates equaling 47%. This degree of variability is likely
influenced by a multitude of factors, including treatment program structure and expected
length of stay. Consequently, these variables need to be taken into account when
comparing and contrasting study results.
Generally speaking, the program in this study adheres to the Minnesota treatment
model, which suggests that the typical outpatient treatment episode is 5 to 6 weeks of
intensive therapy (i.e., groups sessions lasting 3 to 4 hours, 3 to 4 nights a week) followed
by 10 or more weeks of aftercare sessions (i.e., 12-step meetings) (Owen, 2003). Of note,
these guidelines coincide with the American Society of Addiction Medicine (ASAM)
intensive outpatient treatment recommendations that advise any combination of group,
individual, and family counseling at least 3 times per week that total a minimum of 9
hours of services (American Society of Addiction Medicine, 1996). Although decisions
regarding treatment frequency and duration in this program are made based on factors
including recommended level of care, treatment goals, scheduling availability, and
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insurance benefits, providers indicated that an expected treatment episode would consist
of attendance at 3 or 4, 3-hour group sessions and at least 1 individual session per week,
for 4 to 5 weeks. Results of this study coincide: participants who completed treatment
attended an average of 16 treatment groups and generally stayed in treatment for a total
of 32 days.
Based on this information alone, it is not “fair” to compare this study’s retention
rates and average length of stay estimates to research undertaken in treatment programs
that have notably longer (expected) lengths of stay: 10 to 11 weeks (Mertens & Weisner,
2000) and 115 days (Dobkin et al., 2002). Additionally, the 72% treatment retention rate
detected by Veach and colleagues (2000) was greater than the 49% detected in this study;
however, they examined participants in an intensive outpatient, Minnesota model-based
program who received either 16 or 30 hours of treatment contact per week. These values
vary substantially and are greater than the 10 to 13 hours typically received in this
program, thus the applicability of the results are questionable. On the other hand, White
and colleagues (1998) had a similar intensive outpatient program structure, with 10 to 13
contact hours per week, for 4 weeks. Though their average length of stay for treatment
completers was equivalent to the length of stay detected in this study (32 days), their
completion rate was 25% higher (74%) than the rate in this study. The treatment
programs included in Green et al. (2002) generally adhered to ASAM’s intensive
outpatient treatment guidelines. Treatment involved four, two and one-half hour sessions
per week, for five to six weeks. The overall retention rate was comparable (47%) to the
rate in this study. This significant variation in retention rates among (intensive) outpatient
programs that have similar program structure and philosophy provides further evidence
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that research needs to be conducted at the individual treatment program level in order to
adequately gauge treatment statistics like average length of stay, typical number of
treatment days, and retention and what influences these variables.
From a larger perspective, the average treatment duration for completers in this
study, as well as in the aforementioned (intensive) outpatient treatment studies, is
considerably less than the 90-day threshold that has been implicated in the achievement
of more positive treatment outcomes in previous large-scale drug treatment research
(Hubbard et al., 1989; Simpson, 1981; Simpson, Brown et al., 1997; Simpson, Joe et al.,
1997; Simpson & Sells, 1982). Recommended length of stay in these studies for
outpatient treatment was 6 months and the median treatment stays was 3 months
(Simpson, Joe et al., 1997). These values contrast those delineated by this study, and
consequently call into question the applicability of these large-scale research findings as a
90-day treatment stay is well beyond what would be expected, and what is likely possible
based on existing third-party reimbursement benefits, in this particular program. It is
evident that past large-scale substance abuse treatment research efforts do not reflect how
contemporary substance abuse treatment services are actually being delivered.
With regards to actual treatment stay, treatment completers in this study attended
about 5 more treatment groups, and were in treatment for a total of 11 more days than
treatment dropouts. Considering the wealth of research linking positive relationship
between length of time spent in treatment and favorable outcomes (e.g., increased
abstinent days, reduced negative substance use-related consequences, improved
psychological social, and employment functioning) (Hubbard et al., 1997; Hubbard et al.,
1989; McLellan, Luborsky, Woody, O’Brien, & Duley, 1983; Moos & Moos, 2003;
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Simpson, 1981; Simpson & Sells, 1982), this particular treatment program should further
examine if the extra 5 treatment groups and 11 days spent in treatment are statistically
and/or clinically significant differences in treatment outcomes between completers and
dropouts. Such research could guide the treatment program’s focus and assist in
determining if treatment completion is the defining factor in accomplishing more
favorable outcomes or if there is a particular threshold of treatment days or total
treatment duration wherein clients generally achieve more positive outcomes. Depending
on the results, the treatment program could design their program to better align with the
identified time frame. For example, if results indicate that positive treatment outcomes
plateau at 5 weeks of treatment, the program could design a 5-week curriculum and aim
to retain clients for at least that length of time.
Sample Characteristics
Considering that substance abuse treatment research is conducted in a range of
treatment settings (i.e., publicly- vs. privately-funded funding; inpatient vs. outpatient;
alcohol only vs. drug only vs. polysubstance), the populations from which samples are
drawn are highly diverse. This variability affects generalizability and applicability of
results, thus further examination of basic sociodemographic sample characteristics is
necessary when conducting research at the program level. Nearly two-thirds of the
sample in this study was male (62%) and the large majority was Caucasian (86%).
Almost half of the sample (45%) was married. Mean age was 40 years. This sample was
fairly educated, with about 92% completing high school and 60% of these individuals
attending some college or earning an advanced degree. Overall, demographic
characteristics of this sample are relatively consistent with other research in private,
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managed care (intensive) outpatient substance abuse treatment programs that primarily
treat insured or self-pay clients (Green et al., 2002; Mertens & Weisner, 2000; Satre et
al., 2004; Veach et al., 2000; White et al., 1998). Aside from gender, these characteristics
contrast those detected in research projects undertaken within publicly-funded substance
abuse treatment agencies. Participants in these studies are generally younger, more
racially diverse, less likely to be married, and less educated (Arfken et al., 2001; Klaus &
Kindleberger, 2002; McCaul et al., 2001; Patkar et al., 2004). Such fundamental
discrepancies in study sample characteristics challenges the applicability of results from
publicly-funded treatment program research to private treatment agencies since the
clientele vastly differs. For example, a single African American male in his early 30’s
who has not earned his high school diploma may have primary treatment goals related to
maintaining his sobriety and earning his GED. These aims may be in stark contrast to the
treatment goals to a married Caucasian male in his late 30’s who has earned his
bachelor’s degree, who may be more focused on exploring how his substance use has
impacted his marriage and improving his relationship with his wife. Consequently,
individual treatment programs need to closely scrutinize study characteristics including
sample demographics and type of treatment program in order to effectively determine if
results are relevant.
In regards to substance use, the ASI substance use variables were fairly consistent
with diagnostic indicators. In other words, the percentage of participants using a
particular substance in the 30 days prior to the evaluation was similar to the percentage of
participants that met DSM-IV diagnostic criteria for either abuse or dependence of that
substance. Approximately 75% of the sample met criteria for an alcohol use disorder and
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80% of the sample reported using alcohol in the past 30 days. Nearly 25% of the sample
reported using cocaine in the past 30 days, while 22% met criteria for cocaine abuse or
dependence. The percentage of those who used opiates in the previous 30 days and those
who met criteria for an opiate use disorder was exactly the same (20%). In contrast, a
slight discrepancy in this pattern emerged for marijuana: 31% of the sample reported use
while only 15% met criteria for a marijuana abuse or dependence. As compared to Veach
and colleagues (2000), this sample had comparable rates of cocaine and marijuana use
disorders, but higher rates of alcohol and opiate use disorders. Similarly, this sample also
had higher rates of alcohol use disorders and comparable rates of cocaine use disorders as
Dobkin and associates (2002).
In the end, about half of the sample only met criteria for an alcohol use disorder, a
quarter of the sample only met criteria for a drug use disorder, and the remaining quarter
met criteria for both an alcohol use and drug use disorder(s). These rates were very
consistent with Green et al. (2002): 51% of the sample met criteria for only an alcohol
use disorder, 20% met criteria for only a drug use disorder, and 29% met criteria for both
an alcohol use and drug use disorder(s). Satre et al. (2004) and Mertens and Weisner
(2000) separated abuse and dependence diagnoses and found similar prevalence rates:
just over 40% of their samples met criteria for alcohol dependence, just under 30% met
criteria for drug dependence, just under 20% met criteria for both alcohol and drug
dependence, and about 10% met criteria for substance abuse. On the whole, the treatment
program in this study appears to be serving a range of clients who present with distinct
types of substance use patterns (i.e., some alcohol only, some drug only, some both
alcohol and drug). Prevalence rates of substance use disorders is relatively comparable to
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other (intensive) outpatient treatment programs identified in the literature, thus these
research findings should be of interest to this particular program.
The prevalence of comorbid psychiatric problems in this sample was high. Over
half of the participants previously participated in psychiatric treatment (58%) and a
majority (52%) met criteria for at least one substance use disorder and at least one Axis I
psychiatric disorder at the time of the intake evaluation. More specifically, 43% of the
sample met criteria for major depression and 29% met criteria for an anxiety disorder
(e.g., PTSD, OCD, panic disorder, social phobia). These rates parallel the prevalence of
depressive (39%) and anxiety (29%) symptoms in a large sample (N = 2784) of clients
attending an outpatient program at a comprehensive addiction treatment center in Canada
(Castel et al., 2006). Additionally, Charney and associates (2005) found that 63% of
participants presenting to an addictions treatment unit at a university hospital-based
treatment program in Canada presented with comorbid psychological symptoms
including depression (15%), anxiety (16%), or combined depression and anxiety (32%).
Considering the high level of psychiatric comorbidity detected in this study, the extent to
which this treatment program is addressing the needs of dually-diagnosed clients is an
important question to consider and will be further discussed in subsequent sections.
Treatment Retention
Despite the large number of diverse methodological investigations carried out
across various treatment settings, no consistent “treatment dropout” profile has been
detected in the literature, In fact, the generalizability of many of these research findings
are often questioned at the local programmatic level because of the stark differences that
exist between a particular treatment program and its clientele and those studied. Thus, a
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series of analyses were carried out in this investigation in order to determine the
applicability of previous research to the population from which this sample was drawn.
Consistent with previous research, age was positively related to treatment
retention in this study (Green et al., 2002; McKellar et al., 2006; Maglione et al., 2000a;
Maglione et al., 2000b; Mertens & Weisner, 2000; Roffman et al., 1993; Satre et al.,
2004; Siqueland et al., 2002; Wickizer et al., 1994). Treatment completers (M = 42.32
years, SD = 11.00) were, on average, 6 years older than treatment dropouts (M = 36.10
years, SD = 11.98). Though the difference was relatively small (i.e., about one-half of a
standard deviation), it was detected. Multiple theories have been proposed to explain this
relationship. Stark (1992) hypothesized that younger adults exhibit greater impulsivity
and lack self-discipline, which may impact the decision to drop out of substance abuse
treatment prematurely. Alternatively, McKellar et al. (2006) propose that younger adults
have shorter substance abuse/dependence histories, thus exhibit less chronicity and fewer
adverse consequences. These realities in turn lead to a lower perceived need for
treatment. Stark (1992) also purported that younger adults generally have fewer social
ties to two potential sources to support their treatment efforts: their families and
communities. This line of reasoning coincides with the finding that married participants
in this study were more likely to complete treatment than their never married
counterparts. Consideration of the observed variation in retention based on age in this
program should be taken into account during the treatment planning and goal
identification process. Younger treatment participants may respond more positively and
stay in treatment longer if there is less emphasis on chronicity and severity of substance
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use and more stress on building sober social support networks and decision-making
skills.
A higher income was positively associated with treatment retention in the present
investigation, with treatment completers earning an average of $2298 (SD = $3483) from
employment in the past month as compared to $1517 (SD = $1856) earned by treatment
dropouts. This difference may be an artifact of a small number of large earners in the
treatment completion group. Thus, median monthly income estimates may be a better
indicator of the strength of the relationship. Median income for treatment completers was
$1500, while median income for treatment dropouts was $1000. Roffman et al. (1993)
detected a similar positive relationship between income and retention in a sample of
outpatients in a marijuana-dependent counseling program, while this trend only emerged
for female participants in Green et al. (2002) and Mertens and Weisner (2000). A
common explanation of this positive relationship between socioeconomic indicators and
substance abuse treatment retention is that a higher income can reduce or offset some of
the frequently encountered barriers to substance abuse treatment including access to
treatment (i.e., insurance coverage) and cost of treatment (i.e., child care costs accrued
during treatment sessions, insurance co-pays). However, since this relationship is not
consistently detected in the literature, it may also be true that having a higher income may
increase or intensify some barriers to treatment including lost wages while participating
in treatment (Stark, 1992). Based on this study’s finding that income was positively
related to retention, it appears worthwhile for this treatment program to explore clients’
financial status and to identify methods to defray treatment costs (i.e., co-pay payment
plans, funding for child care) if financial barriers to treatment are detected.

181
Experiencing more severe comorbid psychiatric problems has regularly been
linked to substance abuse treatment dropout, though gender has often been implicated in
this relationship. For example, Siqueland et al. (2002) found that higher psychiatric
severity kept men in substance abuse treatment longer, while Green et al. (2002)
observed that it put men at risk for dropping out. More severe psychiatric problems and
greater levels of psychiatric distress have been related to dropout in cocaine-dependent
women (Siqueland et al., 2002), drug-dependent women (Haller et al., 2002), women in
an HMO-based outpatient treatment program (Mertens & Weisner, 2000), and marijuanadependent individuals (Roffman et al., 1993); however, Castel and colleagues (2006)
reported that clients endorsing psychiatric symptoms of multiple clusters (e.g.,
depression, anxiety, mania, schizophrenia-like, eating, conduct disorder) attended more
visits and had a lower attrition rate than clients endorsing fewer psychiatric symptoms
across clusters. With regards to specific types of psychological problems, depression has
been positively linked to treatment retention (Joe et al., 1999; Justus et al., 2006),
positively linked to treatment dropout (Broome et al., 1999), and unrelated to whether or
not clients remain in treatment (Booth et al., 1991; Curran et al., 2002). Anxiety has also
been associated with treatment dropout (Broome et al., 1999). In this study, clients who
had been previously treated for psychological problems (i.e., taken psychotropic
medications, participated in psychotherapy) or met criteria for an anxiety disorder (e.g.,
PTSD, OCD, panic disorder, social anxiety disorder) were more likely to dropout out of
treatment.
Potential explanations for the tenuous relationship between substance abuse
treatment retention and psychiatric comorbidity vary. It may be that when clients are
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experiencing more significant distress, their motivation to stay in substance abuse
treatment is greater because the desire to reduce psychiatric and substance-related
symptoms and improve their overall quality of life is at the forefront. Alternatively, if
psychiatric problems are only mildly upsetting for a particular client, the impetus to
continue participating in substance abuse treatment to explore and alleviate such
symptoms may not be a top priority and the perceived need for treatment may be low
(Castel et al., 2006; Curran et al., 2002). The actual symptoms of psychopathology (e.g.,
unstable and dysphoric mood, delusions, lack of social support, hostile affect, social
anxiety, poor self-image, low frustration tolerance, lack of trust) can also directly
interfere with therapeutic processes that facilitate treatment retention and positive
treatment outcomes (Broome et al., 1999; Haller et al., 2002).
For this particular treatment program it appears that the types of psychological
symptoms, as opposed to general psychological distress, are important markers.
Participants who meet criteria for PTSD, OCD, panic disorder, or social anxiety disorder
were more likely to drop out of treatment prematurely than individuals who did not
endorse considerable anxiety. Of note, this pattern did not emerge for depression.
Unfortunately, much of the literature regarding the integrated treatment of comorbid
mood or anxiety disorders and substance use disorders – treating both disorders
concomitantly – lumps these psychiatric disorders together, suggesting that treatment
should incorporate pharmacotherapy, cognitive-behavioral techniques, relaxation
training, stress management, and coping skills training in their treatment (Center for
Substance Abuse Treatment, 2005; Petrakis, Gonzalez, Rosenheck, & Krystal, 2002).
Yet, there are unique aspects of anxiety disorders and their treatment that these
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recommended interventions do not address and substance abuse treatment providers have
likely not received adequate training in (e.g., trauma, exposure therapy, response
prevention). For example, substance abuse treatment providers can focus on helping
clients with PTSD gain control of the self-destructive behaviors associated with trauma
and develop alternative coping strategies, but detailed exploration of the trauma is
generally not advised (Center for Substance Abuse Treatment, 2005).
A recent review of integrated treatment for substance use disorders and comorbid
psychological problems provides support for the notion that there may be inherent
differences between the integrated treatment of substance use disorders and mood
disorders and substance use disorders and anxiety disorders (Hesse, 2009). A metaanalysis of five randomized studies providing manual-guided treatment for comorbid
depressive symptoms and substance use disorders was carried out. Results indicated that
integrated psychosocial treatment for depression and substance use disorders is a
promising approach for clients with this comorbidity, as analyses generally favored
integrated treatment over single-focus treatments for percent days abstinent at follow-up,
depressive symptoms, and retention in treatment. However, the difference was only
statistically significant for percent days abstinent at follow-up. A meta-analysis could not
be carried out for integrated treatment for anxiety and substance use disorders because of
the high degree of variability in the reporting of outcomes in the original articles;
however, several studies reported that clients assigned to substance abuse treatment only
fared better. The author concluded that integrated treatment for comorbid depression and
substance use disorders is a promising approach, but does not have sufficient empirical
support at this time. On the other hand, integrated treatment for comorbid anxiety and
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substance use disorders is not empirically supported at present and there is a definite need
for the development and evaluation of new treatment options for comorbid anxiety and
substance use disorders. Ultimately, each substance abuse treatment program must
determine, on an individual client basis, if it has the knowledge, training, and skills to
provide adequate treatment for each client presenting with a substance use disorder(s) and
comorbid psychological problem(s). If not, the client should be referred to a program that
can provide effective integrated treatment (i.e., the Seeking Safety treatment model for
PTSD and substance abuse) (Najavits, 2002) or to a specialty psychiatric treatment
program, either before or after substance abuse treatment.
Another important diagnostic indicator that was related to treatment retention in
this study was the type of substance use disorder(s) clients met criteria for. Clients who
met criteria for alcohol abuse or dependence were more likely to complete treatment,
while individuals who met criteria for an opiate use disorder or a cocaine use disorder
were more likely to drop out of treatment. Such findings have frequently emerged in
substance abuse treatment retention investigations across treatment settings (Alterman et
al., 1996; De Leon et al., 1997; Joe et al., 1999; Paraherakis et al., 2000; Rowan-Szal et
al., 2000). Generally speaking, more frequent drug use and a higher degree of drug
dependence have also been linked to treatment dropout (Green et al., 2002; McKellar et
al., 2006; Maglione et al., 2000a; Maglione et al., 2000b; Mertens & Weisner, 2000;
White et al., 1998). Profile analysis results paralleled this trend and indicated that
treatment dropouts reported, on average, more frequent use of alcohol, opiate, cocaine,
and marijuana use in the 30 days prior to treatment. Treatment dropouts also experienced
more negative consequences related to their substance use than their counterparts. In
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particular, dropouts tended to report more problems related to fulfilling social
responsibilities (e.g., missed days of work/school, money problems) than completers.
Results of motivational analyses suggest that although treatment dropouts demonstrated a
higher degree of problems recognition and were taking more steps to reduce their use,
they were generally more ambivalent about making these behavioral changes and were
unsure whether they needed treatment. This finding is consistent with Joe et al. (1998)
who noted that treatment readiness, or degree of commitment to active change process
through participation in a treatment program, was positively related to treatment
retention. Thus, one would expect that the more ambivalent clients are about changing
their behavior, the less committed they will be to participating in treatment. It should also
be noted that clients who did not report drug use would likely demonstrate lower levels of
motivation because they did not need to change their drug use behavior because they
were already abstinent.
An array of conjectures have been put forth about what dynamics may be at play
in the observed connections between substance(s) of use and substance abuse treatment
retention. A common hypothesis suggests that since the majority of substance abuse
treatment programs in the U.S. are rooted in the Minnesota model approach that was
initially designed to treat alcohol dependency, the needs of treatment participants who are
presenting with a drug use disorder(s) or both a drug and alcohol use disorder(s) may not
be adequately met (Luke et al., 1996; Mammo & Weinbaum, 1991; Veach et al., 2000).
More specifically, the Minnesota model of treatment maintains:
Chemical addiction is a primary, chronic, and progressive disease. It is primary
because it is an entity in itself and not caused by other factors, such as
intrapsychic conflict. It is chronic because a client cannot return to “normal”
drinking once an addiction is established. It is progressive because symptoms and
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consequences continue to occur with increasing severity as use continues.
(Owens, 2003).
This view stems from the disease model of alcoholism, which views alcoholism as a
medical ailment involving an abnormality of structure and/or function of the brain that
results in behavioral impairment (Jellineck, 1960; Pattison, Sobell, & Sobell, 1977).
However, etiological research purports that the development of substance use disorders is
much more complex. Hesselbrock, Hesselbrock, and Epstein (1999) have augmented the
family disease model with family systems theory (i.e., alcohol stabilizes family
equilibrium and families strive to sustain alcohol problems despite negative
consequences) and behavioral family theory (i.e., some familial behaviors are viewed as
antecedents to and reinforcing consequences of alcohol use). Carroll (1999) applied
learning theory to the development of alcohol use disorders and suggested acquisition,
maintenance, and modification of drinking behavior is largely learned, while Sayette
(1999) suggested the tension-reduction hypothesis, wherein certain groups of people
under certain circumstances may be motivated to drink in times of stress in order to
reduce stress. Cultural and sociological factors have also been explored in relation to
alcohol use disorders (Wilsnack et al., 2000).
On the other hand, the etiological picture for drug addiction is less wellestablished. Ott, Tarter, and Ammerman (1999) identify a range of factors that may
influence the transition from drug use to drug addiction: drug availability, route of
administration, genetics, family history of drug use, family environment, stress, and life
events. In particular, research has demonstrated that genetic and environmental
contributions may vary by substance. In a sample of male twins, Kendler, Karkowski,
Neale, and Prescott (2000) reported that cannabis and hallucinogen use was influenced by
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both genetic and environmental factors; whereas, genetic factors predominated for
cocaine, opiate, sedative, and stimulant use. Though additional research is needed in the
etiology of substance use disorders, it is evident that there is a lack of consensus from
substance to substance about the impact of biological, psychological, and sociological
factors. Thus, if a substance abuse treatment program places too much emphasis on the
disease model of addiction (i.e., addiction is an entity on to itself, inevitable progression
of disease with continued use), at the expense of other aspects related to the development
of the disorder (i.e., learned coping strategies, social network), certain clients may be at
risk for dropping out prematurely because they do not identify with the treatment
philosophy. For example, it is conceivable that a client in his mid-20’s may be “turned
off” by or less receptive to the Minnesota treatment model, particularly if he only meets
criteria for substance abuse, because he may not agree that he is “destined” to be
dependent and may attribute his problematic use to factors aside from a genetic
predisposition (e.g., social support network that uses, availability of the substance,
relaxing effects). Further research that incorporates a comparison group(s) is needed to
examine this conjecture more precisely. In this study, all individuals participated in the
same treatment program, so statements regarding the differential effectiveness of the
Minnesota model with certain individuals (e.g., those who primarily use alcohol vs. those
who primarily use drugs) remain speculatory.
From a psychosocial perspective, individuals who use drugs more frequently may
be more impulsive, may engage in more illegal activities, and may be involved in a social
network that thwarts treatment efforts (McKellar et al., 2006; Mertens & Weisner, 2000).
Additionally, the particular legal ramifications related to drug use may interfere with
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treatment participation and force clients to drop out more frequently than their alcoholusing counterparts. For instance, a cocaine-using client who relapses while in treatment
may be arrested for cocaine possession and jailed, and consequently unable to attend
treatment session. However, an alcohol-using client who relapses while in treatment, as
long as s/he is not engaged in reckless behavior while under the influence, will likely not
experience an equivalent legal barrier to treatment participation. In the end, based on the
results of this study, it may be worthwhile for this treatment program to further examine
these notions in clients with opiate and cocaine use disorders because they were more
likely than their counterparts to drop out of treatment. Areas of exploration may included
how well the client is identifying with the treatment model and connecting with its
assumptions, to what extent the client is involved in illegal activities, and what influence
has the client's social network had on his substance use.
A marked methodological drawback of this study was that the relationships
between pretreatment characteristics and treatment retention were approached in a
univariate manner: separate t-tests and chi-square analyses were run for each variable.
Additional examination of the relationship amongst the variables (i.e., covariation) and
completion of multivariate analyses would be valuable in describing the characteristics
sample more comprehensively and identifying more precise correlates and predictors of
treatment retention. For example, age, income, marital status, previous psychiatric
treatment, meeting criteria for an opiate use disorder, meeting criteria for a cocaine use
disorder, and meeting criteria for comorbid anxiety disorder were all related to treatment
retention in this study. Entering these variables into a regression model could determine
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the amount of variance each of these variables contributes to the observed variance in
treatment retention.
Subgroups
The current study did examine how multiple pretreatment variables could be
organized to form a coherent taxonomy of a substance abuse-treatment seeking sample.
Not surprisingly, the sample demonstrated a high degree of heterogeneity across variables
measuring age, patterns of substance use, comorbid psychiatric problems, social
functioning, legal standing, health status, and negative consequences related to substance
use. Even so, cluster analysis results were successful in devising a categorization scheme
that produced four distinguishable subgroups that varied along two broad dimensions:
primary substance(s) of use and degree of functional impairment. A comparable
taxonomy was detected by Luke et al. (1996) in a sample of dually-diagnosed individuals
using the ASI severity ratings wherein seven clusters were deduced according to level of
functioning (e.g., good, moderate, poor) and pattern of substance use (e.g., alcohol, drug,
alcohol and drug). Based on the identified grouping scheme in this study, over half of the
current sample endorsed problems primarily related to alcohol (55%), about a fifth of the
sample reported problems primarily related to drugs (19%), and just over a quarter of the
sample demonstrated considerable problems with both alcohol and drugs (27%). This
breakdown roughly corresponded to the overall diagnostic classification of the sample
based on the M.I.N.I.: 49% of the sample met criteria for only an alcohol use disorder,
23% met criteria for only a drug use disorder(s), and 26% met criteria for both an alcohol
and a drug use disorder(s).
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Degree of functional impairment amongst the subgroups in this study ranged from
severe to minor. As the title implies, the pervasive concerns polysubstance use disorder
cluster demonstrated high levels of comorbid problems as evidenced by the highest
average medical, employment, family/social, and psychiatric ASI composite scores
paired with considerable alcohol and drug composite score elevations. The serious
concerns alcohol use disorder group demonstrated the highest average alcohol and legal
composite scores, along with the second highest employment and psychiatric composite
scores. The moderate concerns drug use disorder individuals fell below the average
composite score means for the entire sample in all domains except drug problems, where
they had the greatest degree of problems compared to their counterparts. The minimal
concerns alcohol use disorder cluster had the lowest average drug, employment, legal,
family/social, and psychiatric composite scores paired with the second highest alcohol
and medical composite scores.
Scores across the physical, interpersonal, intrapersonal, impulse control, and
social responsibility InDUC subscales aligned with the degree of functional impairment
of each group. The pervasive concerns group endorsed the greatest number of negative
consequences in all realms, the serious concerns group ranked second, the moderate
concerns cluster ranked third, and the minimal concerns group endorsed the least number
of negative consequences. Interestingly, no specific type(s) of substance-use related
consequence(s) was associated with a particular cluster. For instance, the scientific
literature suggests that individuals who use drugs more frequently may be more
impulsive, may engage in more illegal activities, and may be involved in a social network
that thwarts treatment efforts (McKellar et al., 2006; Mertens & Weisner, 2000). From
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this perspective, it would be reasonable to suspect that the moderate concerns drug use
disorder cluster would report experiencing more consequences contained on the impulse
control InDUC subscale (e.g., I have been arrested for driving under the influence of
alcohol or drugs, I have taken foolish risks when I have been drinking or using drugs, I
have gotten into a physical fight while drinking or using drugs). However, this
supposition was not supported in this study. Instead, number of consequences across
domains corresponded with degree of functional impairment implied from the cluster
label. As a result, the treatment planning process may look different for the various
clusters. Individuals in the minimal and moderate concerns groups may able to identify a
few specific problematic areas to concentrate on (e.g., interpersonal conflicts, social
responsibilities such as employment difficulties), while members of the serious and
pervasive concerns groups may have to prioritize and select a manageable number of
domains to focus on in treatment because it is unrealistic for all identified problem areas
to be adequately addressed in a single, three- to four-week treatment episode in this
program.
In addition to the principle distinguishing factors of primary substance(s) of use
and degree of functional impairment, the clusters could also be differentiated by age. The
moderate concerns drug use disorder cluster was an average of 10 years younger than
both of the alcohol use disorder clusters: 33-years-old compared to 43-years-old and 44years-old. The pervasive concerns polysubstance use disorder cluster fell in the middle
and were on average, 37-years-old. As previously noted, younger adults tend to have
shorter substance abuse/dependence histories and exhibit less chronicity and fewer
adverse consequences, which may in turn lead to a lower perceived need for treatment
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and higher treatment dropout rates (McKellar et al., 2006; Stark, 1992). In line with this
view, the youngest group, moderate concerns drug use disorder, exhibited fewer
substance-related consequences on the InDUC and less severe comorbid problems on the
ASI than their older pervasive concerns polysubstance use disorder and serious concerns
alcohol use disorder counterparts. However, in contrast to this view, the youngest cluster
endorsed more consequences and demonstrated higher comorbid legal, family/social, and
psychiatric problems than the older minimal concerns alcohol use disorder group. The
pervasive concerns polysubstance use disorder group also exhibited the highest degree of
negative consequences and comorbid problems and was about seven years younger than
the two alcohol use disorder groups that were less functionally impaired. Accordingly,
the complex interaction of age with primary substance(s) of use and degree of functional
impairment needs to be further explored to reveal how these factors relate to and impact
one another, as well as how they relate to and impact other variables of interest to
substance abuse treatment researchers (e.g., treatment retention).
Concurrent and predictive validation procedures suggest that the four-cluster
solution was a suitable way to identify subgroups of this sample. Substance use disorder
diagnostic categories coincided with the primary substances of use of each group (i.e.,
serious concerns and minimal concerns alcohol use disorder groups were more likely to
meet diagnostic category for only an alcohol use disorder than their moderate concerns
drug use disorder, and pervasive concerns polysubstance use disorder counterparts,
while the drug use disorder group was more likely to meet criteria for only a drug use
disorder than both alcohol use disorder groups). With regards to substance use patterns,
both alcohol use disorder clusters exhibited a higher degree of alcohol use on the
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drinking indicators (e.g., days of use, average number of weekly drinks, peak BAC) than
the drug use disorder group. Level of motivation to change alcohol use and drug use also
coincided with group membership. For example, the serious concerns alcohol use
disorder displayed higher levels of motivation to change their alcohol use than all other
groups, and the moderate concerns drug use disorder and pervasive concerns
polysubstance use disorder groups endorsed higher levels of motivation to change their
drug use than the alcohol use disorder clusters. Some support was detected for the degree
of concern identified by each cluster title as well (i.e., the pervasive concerns cluster was
more likely to meet criteria for a comorbid psychiatric condition, while the minimal
concerns cluster was less likely to meet criteria for a comorbid psychiatric condition).
With regards to treatment outcomes including treatment completion status,
number of treatment days, and total treatment duration, no significant statistical findings
emerged between the clusters. However, trends were detected in the anticipated direction
based on the treatment retention literature suggesting that clients with alcohol use
disorders tend to complete substance abuse treatment at higher rates than clients with
drug use or polysubstance use disorders (De Leon et al., 1997; Joe et al., 1999; McKellar
et al., 2006). The moderate concerns drug use disorder cluster was the only cluster
wherein the majority of members did not complete treatment. The retention rate for this
cluster was 45.1%, compared to 67.7% for minimal concerns alcohol use disorder, 62.1%
for serious concerns alcohol use disorder, and 57.5% for pervasive concerns
polysubstance use disorder. The moderate concerns drug use disorder cluster also had
the lowest mean number of treatment days (M = 12.94, SD = 5.05) and shortest average
treatment duration (M = 23.98, SD = 11.50), while the serious concerns alcohol use
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disorder cluster had the highest mean number of treatment days (M = 15.75, SD = 4.39)
and longest average treatment duration (M = 29.52, SD = 9.88). Again, these differences
were not statistically significant, though appeared to trend in the expected direction based
on the literature and may be of clinical value to the treatment program.
The varying rates of treatment completion deserve further discussion. The clusters
that primarily used alcohol demonstrated the highest treatment retention, while the
clusters that primarily used drugs or both alcohol and drugs fell below these rates. This
particular treatment program’s incorporation of the disease model of addiction and 12step principles, which evolved from alcohol addiction research, may better fit the
treatment needs of those abusing alcohol as opposed to other substances. As previously
noted, there is a lack of consensus regarding the biological, psychological, and
sociological factors associated with the development of drug use disorders and these
dynamics may vary from substance to substance (Kendler et al., 2000; Ott, Tarter, &
Ammerman, 1999). Thus, a treatment program emphasizing the disease model may
inadvertently overlook factors related to the etiology of drug addiction that drug-using
clients consider more important for their recovery (e.g., ineffective coping skills, life
events). Additionally, treatment programs need to consider that individuals who use
drugs more frequently tend to be younger and may be more impulsive, may engage in
more illegal activities, and may be involved in a social network that thwarts treatment
efforts (McKellar et al., 2006; Mertens & Weisner, 2000). Accordingly, interventions
aimed at helping clients reduce impulsivity (i.e., CBT focusing on the interconnection
amongst events, thoughts, emotions, and behaviors) and establish sober social networks
(i.e., 12-step meetings) may be beneficial.
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The validity of the current cluster analysis results can also be examined
comparing the identified classification system with other typologies outlined in the
scientific literature. Unfortunately, many of the common variables utilized in past
typology research with individuals with substance use disorders (e.g., family history, age
of onset, substance use pattern over time, personality characteristics) were not assessed in
the current study; however, other comparisons can be made to substantiate and refute
previously outlined taxonomies. The Type A – Type B distinction has been explored in a
sample of alcohol-dependent individuals (Babor, Hofmann et al., 1992), a diverse sample
of cocaine users (Ball et al., 1997), and a sample of drug addicts (Garcia et al., 2006). In
general, the Type A/chronic cluster is characterized by fewer childhood risk factors, later
age of onset, less severe dependence, fewer substance use-related consequences, fewer
comorbid psychiatric problems, and lower levels of distress in the areas of work and
family. In contrast, the Type B/functional cluster has more familial risk factors, an earlier
age of onset, greater severity of dependence, increased levels of polysubstance use, more
serious functional impairment, a greater level of comorbid psychiatric dysfunction, and
more life stress.
In this study, the serious concerns alcohol use disorder groups seems to fall under
the Type B/chronic umbrella due to the high level of comorbid concerns and negative
consequences across functional areas, paired with severe alcohol problems as evidenced
by the highest ASI alcohol composite score and high Form 90 alcohol use indicators
(e.g., number of drinking days, average weekly drinks, and peak BAC). The minimal
concerns alcohol use disorder cluster coincides with the Type A/functional taxonomy as
these individuals exhibited less severe alcohol problems, a low degree of comorbid
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problems, and fewer negative substance-use related consequences. Unfortunately, the
remaining clusters do not fit “neatly” into either of these categories. Although the
moderate concerns drug use disorder demonstrated the most severe drug use, they
reported relatively low levels of comorbid concerns as compared to their counterparts.
Alternatively, the pervasive concerns polysubstance use disorder cluster reported a high
level of comorbid problems, but had lower alcohol severity than both alcohol use
disorder groups and a lower drug severity than the drug use disorder cluster. Evidently,
the dichotomous nature of the Type A – Type B conceptualization does not adequately
capture the heterogeneity of this particular sample and their presenting problems.
Expanded taxonomies of substance users also have shortcomings when compared
to four-cluster solution delineated in this study. Del Boca and Hesselbrock (1996)
identified groups based on severity and risk: low risk–low severity (few problems at low
levels), internalizing (moderate risk, high depression and anxiety), externalizing
(moderate risk, high antisocial behavior), and high risk–high severity (multiple problems
at high levels). The pervasive concerns polysubstance use disorder and minimal concerns
alcohol use disorder clusters appear to fall at the opposite ends of this risk-severity
spectrum, while there is not enough information known about the internalizing and
externalizing markers in this sample in order to determine if the remaining two clusters
could align with either of these groups. The serious concerns alcohol use disorder cluster
does exhibit the highest legal composite score, and a greater degree of negative
consequences related to their substance use than the moderate concerns drug use disorder
counterparts, which may indicate more antisocial behavior and provide support for
categorizing them as the externalizing cluster. However, neither of these groups is more
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likely to meet criteria for a depressive disorder or an anxiety disorder based on the
M.I.N.I., suggesting an absence of an internalizing group.
Windle and Scheidt (2004) investigated a group of inpatients from five alcohol
treatment centers in both rural and urban areas and purported four subgroups in their
sample. The mild course subtype was characterized by low rates of familial history of
alcoholism; few childhood conduct problems; a later age of onset; fewer years of
drinking; and lower levels of consumption and impairment. High levels of polydrug use
and benzodiazepine use demarcated the polydrug subgroup, while the negative affect
subgroup was distinguished by symptoms of depression and anxiety and high
characterological vulnerability to a substance use disorder. The chronic/antisocial
typology was distinguished by high levels of alcohol consumption and impairment, a
longer duration of drinking, and high levels of adult antisocial behaviors. The mild course
subtype parallels the minimal concerns alcohol use disorder group in this study because
of the low levels of consumption and impairment, while the serious concerns alcohol use
disorder group resembles the chronic/antisocial group because of its high levels of
consumption and impairment. However, this taxonomy diverges from the current
typology because there are two identified groups with considerable drug problems in the
current study and a lack of a distinguishable group that is primarily characterized by
comorbid depression and anxiety to correspond with the polydrug and negative affect
subtypes.
Taken together, there appears to be nuances within and across samples of
substance users that demand programmatic-level inquiry to determine the distinguishing
characteristics. General trends detected in taxonomy research and in this study suggest
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that type and severity of substance use, and degree of impairment in other domains of
functioning often delineate subgroups of substance users (Babor, Hofmann et al., 1992;
Ball et al., 1997; Del Boca & Hesselbrock, 1996; Garcia et al., 2006; Luke et al., 1996;
Windle & Scheidt, 2004). More specifically, clusters of individuals positioned at the ends
of the substance use and functioning spectrums comprise two respective groups (e.g., low
severity/adequate functioning and high severity/poor functioning), although great
heterogeneity certainly exists. Further examination of the critical differences amongst
substance abuse treatment subgroups can enhance a treatment program’s abilities to meet
the distinctive needs of its consumers.
Implications and Future Directions
Theory Building
From the wealth of scientific literature reviewed here, and the results of the
current study, it is evident that the substance abusing population is a heterogeneous
group. Previous taxonomic research in the substance use disorder field has not produced
clear-cut, easily identifiable coherent classification systems for individuals who meet
criteria for substance abuse and dependence; however, it has shed light on commonalities
of particular subgroups and how such factors relate to pertinent treatment factors such as
treatment retention. Moreover, according to Peters (1997):
Devising optimal treatment and prevention for a disease or disorder is facilitated
by knowing the causal process(es) involved. Because a specific causal process
often leads to a specific constellation of symptoms in subjects exposed to or
involved in that specific causal process, researchers – in their search for causes –
often try first to identify the different types of subjects, each type characterized by
a unique symptomatology. (p. 1649)
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According to this line of thinking, typology research with individuals with substance use
disorders can be viewed as a starting point for generating theoretical hypotheses
regarding the development, expression, and course of various substance use disorders.
In this particular sample, the categorization scheme appeared to sort participants
into groups based on two broad dimensions: substance(s) of use and degree of functional
impairment. Consequently, further empirical research examining what factors influence
one’s decision(s) to use certain substances and not others may help better understand the
observed differences in treatment retention and treatment outcomes between assorted
persons with substance use disorders and may also aid prevention efforts. For example, if
a study with in a particular treatment program linked impulsivity to both cocaine use and
treatment dropout, it could employ treatment interventions with these clients targeting
this behavior (i.e., anger management training). A more in-depth analysis of what
dynamics influence general and specific functioning may elucidate how and why
individuals with substance use disorders differ in their abilities to cope with life
events/stressors and what role substance use plays in these coping processes. Ultimately,
typology research has the potential to generate numerous theoretical hypotheses and
subsequent empirical investigations that could both expand and refine etiological
considerations in substance use disorders. However, researchers need to keep in mind that
“it is conceivable that a more parsimonious model would be useful for some purposes
(e.g., patient placement), whereas a more complex model would be better for other
purposes (e.g., theory building)” (Ball et al., 1995, p.123).
Assessment
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An obvious shortcoming of typology research and theory in populations with
substance use disorders has been its relative failure to influence assessment procedures
and differential diagnosis quandaries (Babor, Dolinsky, et al., 1992). At the individual
program level in particular, this type of information could be extremely useful as
programs design and revise their evaluation processes. From the outset of this study, an
underlying objective was to construct a valuable research protocol that could be
effectively implemented and would produce clinically-useful data. However, various
treatment programs employ a variety of assessment methods because the objectives of
their respective evaluations differ. For example, certain programs may utilize more
diagnostic tools because a client’s diagnosis or multiple diagnoses are the main factor
that drives treatment decisions, at least at the outset. Alternatively, a treatment program
that uses more motivationally-based interventions will likely incorporate more measures
examining the client’s perceptions of their substance use and their motivation(s) to
change. Selecting tools that have both empirical and clinical value is the key. In this
study, the M.I.N.I. was a tool that demonstrated both scientific and applied utility:
anxiety disorder, opiate use disorder, and cocaine use disorder diagnoses were negatively
related to treatment completion and these diagnoses were useful in the treatment planning
process to ensure that comorbid psychiatric conditions were being addressed. By
adopting an assessment approach that integrates both science and practice, treatment
programs can remain scientifically-guided when making programmatic decisions. For
example, when considering whether or not to incorporate auxiliary legal counseling, a
program can look at its data in this area (i.e., what percentage of clients have legal
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problems, what types of legal problems do clients commonly enter treatment with, how
do legal problems relate to treatment completion) to inform its decision.
A secondary upshot of this study was that the research team scrutinized how to
create, implement, and evaluate a particular assessment protocol for an intensive
outpatient substance abuse program at a nonprofit, freestanding mental health hospital.
Most of the assessment instruments or components of the instrument proved useful in
differentiating between clients who completed treatment and those that dropped out
prematurely. The ASI also demonstrated utility in classifying subgroups of clients that
exhibited commonalities. Although only one subscale emerged as significantly related to
retention on the InDUC, this measure may still be a clinically important tool to utilize to
encourage clients to reflect on how substance use has impacted lives. Anecdotally, clients
tended to report that the review of these consequences was useful as they did not realize
how pervasive their substance use-related problems were. Furthermore, although scores
on the SOCRATES-A were not able to differentiate between completers and dropouts,
gauging the extent a client recognizes they have a problems with alcohol, what steps s/he
is taking to change this behavior, and the degree of ambivalence that exists in relation to
making such changes also has value for a clinician who is attempting to facilitate
treatment engagement and participation.
In this particular treatment program, there appear to be several “red flags” that
indicate a client may be at risk for premature treatment dropout. From a demographic
standpoint, clinicians should be aware that younger clients and clients who are not
married tend to drop out of this program more frequently than their older, married
counterparts. Diagnostically speaking, clients who meet criteria for an anxiety disorder,
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opiate use disorder, or cocaine use disorder are also more likely to drop out of treatment
than other clients. Armed with this information, clinicians in this program may be better
able to detect and attend to the unique treatment needs of these particular clients by
consistently checking directly with these clients to see if their needs are being met,
openly discussing what unmet needs remain, and brainstorming about how to address the
unmet needs.
In order to keep the substance abuse treatment field moving forward and tackling
the complex nature of treatment retention, future research needs to move beyond focusing
solely on the client and examine interaction between client attributes (e.g., demographic
characteristics, substances of use, level of functioning), treatment processes (e.g.,
therapeutic alliance, satisfaction with treatment), and the philosophy of the treatment
program and the services it has to offer (Luke et al., 1996; Mertens & Weisner, 2000;
Stark, 1992). Assessment also needs to take place throughout the treatment process
because the decision to stay in treatment or to drop out is not a one-time occurrence;
rather, it is an ongoing choice that clients make. In addition to actual treatment
interventions, the dynamics of the treatment process including a positive therapeutic
alliance and client satisfaction with services have been linked to enhanced treatment
retention (Meier et al., 2005; Simpson, Brown et al., 1997; Simpson & Joe, 2004;
Simpson, Joe, Rowan-Szal, & Greener, 1997). More qualitative inquiries may be of
particular utility in developing a better understanding of these processes and their
relationship to substance abuse treatment dropout.
More specifically, prospective studies that follow clients through treatment and
obtain information including personal characteristics, treatment process factors, and
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treatment services that impact the client’s decision to stay in treatment or to drop out
would be beneficial. In an exploratory study of adolescent substance abuse treatment,
White, Godley, and Passetti (2004) utilized in-depth interviews with 12 adolescents and 4
parents to examine expectations of treatment compared to actual treatment, reactions to
different types of treatment sessions, definitions of treatment success, and aspects of
treatment were regarded as the most and least helpful. The authors noted that in a field
where a premium is put on treatment engagement and retention, taking the consumer’s
treatment experience into consideration when designing and enhancing treatment
programming and increasing consumer input in treatment planning can only improve
treatment retention and in turn, treatment outcomes.
Treatment
Within the behavioral health field as a whole, and in the substance abuse
treatment field in particular, there has been increasing pressure to move beyond the mere
description and identification of factors that are associated with treatment retention
and/or positive treatment outcomes. The focus is slowly shifting to designing,
implementing, and evaluating individually-tailored treatment interventions that
correspond to the distinct, yet shared, needs of various subgroups of clients (Castel et al.,
2006; Mertens & Weisner, 2000; Rapkin & Dumont, 2000; Veach et al., 2000). Although
positive substance abuse treatment outcomes have been detected across a multitude of
modalities and programs, and it appears that the actual treatment interventions employed
may not have as much impact as previously thought (Hubbard et al., 1997; Joe et al.,
1999; Miller, 1992; Miller et al., 2001; Project MATCH Research Group, 1998b);
however, “matching treatment settings, interventions, and services to each individual’s
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particular problems and needs is critical to his or her success in returning to productive
functioning in the family, workplace, and society” (NIDA, 1999, p. 3). The components
of comprehensive drug abuse treatment are outlined in Figure 5 and encompass core
services (e.g., intake assessment, treatment planning, behavioral therapy) and wraparound
services (e.g., legal services, child care services, vocational services).

Figure 5. Components of comprehensive drug abuse treatment. From Principles of Drug
Abuse Treatment: A Research-Based Guide (2nd ed.) by the National Institute of Drug
Abuse, 2004, p. 8.

Research at the individual program level should guide the program’s decisions
regarding resource allocation to the delineated core treatment services and wraparound
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services. For example, this study detected a high rate (52%) of psychological
comorbidity, thus efforts should be made to integrate mental health treatment into the
substance abuse treatment program and to establish relationships with specialized mental
health service providers in the event a referral is necessary. On the other hand, this
sample was particularly educated, with only about 8% not earning a high school diploma.
Consequently, apportioning a great deal of resources to secure educational services for
clients in this program would likely be an ineffective use of provider time and program
money.
The general manner in which treatment services are matched to client needs in
this particular program could be anchored in the subgroup classification scheme detected
by this study: pervasive concerns polysubstance use disorder, severe concerns alcohol
use disorder, moderate concerns drug use disorder, and minimal concerns alcohol use
disorder. For example, the pervasive concerns polysubstance use disorder cluster had
considerable elevations on alcohol and drug ASI composite scores, along with multiple
comorbid issues: highest medical, employment, family/social, and psychiatric composite
scores. Thus, providers could anticipate that these individuals would require a great deal
of case management interventions to link them to employment/vocational resources,
medical services, legal aid, and mental health treatment. On the other hand, individuals
falling into the minimal concerns alcohol use disorder group would likely need minimal
adjunct services and providers might focus primarily on the core aspects of substance
abuse treatment: behavior therapy, substance use monitoring, participating in self-help
groups, and arranging for aftercare. The moderate concerns drug use disorder reported
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extensive family/social relationship problems, thus a key treatment component for this
group would likely be involving a significant other(s) in treatment.
Luke et al. (1996) outlined a potential treatment matching heuristic based on their
cluster analysis results that would align well with the results detected in this study. See
Table 10. Interventions are organized along two broad dimensions: level of functioning
and types of substance use. Applied to the clients in this program, the serious concerns
alcohol use disorder group might respond well to a moderate-length outpatient treatment
stay and involvement in Alcoholics Anonymous. Due to relatively high employment and
legal concerns, these clients might also benefit from an approach that links the client to
specific community resources such as Wisconsin’s Department of Vocational
Rehabilitation and Legal Action of Wisconsin, an agency that provides legal
representation to low-income persons. Alternatively, the minimal concerns alcohol use
disorder group may get their needs met with a shorter outpatient treatment episode
focused on more proactive measures to avert significant functional decline such as
relapse prevention and aftercare, while providers may seriously consider a referral to
residential treatment for the pervasive concerns polysubstance use disorder group due to
the high degree of concurrent medical, employment, family/social, and psychiatric
distress.
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Table 10.
Treatment Matching Heuristic for Substance Use Treatment Clients
General Domain

Specific Category

Characteristics of Treatment Module

Level and
breadth of
functioning

Relatively high
functioning across all
domains

•
•
•

Short-term
Links to community support
Prevention-oriented

Low functioning in
specific domains

•
•
•

Moderate length
Targeted to specific problem areas
Specific community links

Low functioning in
multiple domains

•
•
•

Long-term
Broad-based focus
Most appropriate for residential care

Minimal substance use
problems

•
•

Assess for potential substance abuse
Prevention

Only alcohol use
problems

•

Alcoholics Anonymous or other
substance-specific support group

Only drug use
problems

•

Narcotics Anonymous or other
substance-specific support group

Polysubstance use
problems

•

Link to multiple or general substance
abuse support group
Integrative substance abuse treatment

Type of
substance use
problem

•

Note. Adapted from “Exploring the Diversity of Dual Diagnosis: Utility of Cluster Analysis for Program
Planning,” by D. A. Castel et al., 1996, Journal of Mental Health Administration, 23, p. 312.

Such frameworks seem plausible and make theoretical “sense,” but without
subjecting them to scientific scrutiny, they will merely remain conjecture. Designing and
carrying out effectiveness investigations based on treatment matching heuristics like the
one outlined above would assist individual treatment programs in their quest to design
service delivery programs that are scientifically-driven and empirically-validated. Such
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research would likely improve the provision of substance abuse treatment, which would
in turn enhance treatment retention, which would consequently help clients achieve more
positive treatment outcomes, the ultimate goal of substance abuse treatment research.
Additional areas of inquiry to consider based on this particular study sample is the
level of psychiatric comorbidity detected. A further examination of whether or not clients
are receiving adequate treatment of concurrent psychiatric conditions will be important to
assess how well this particular program is meeting the needs of its dually-diagnosed
clientele and whether or not such symptoms are impacting participation in substance
abuse treatment. Specialized, integrated treatment could also be considered for this
subgroup; however, further well-controlled research is needed to identify exactly which
interventions, both psychotherapeutic and pharmacological, are safe and effective
(Petrakis et al., 2002). Though previous substance abuse treatment research has explored
treatment retention and found that correlates may differ by gender, this factor did not
receive much attention in this particular study (Siqueland et al; Green et al.; Mertens &
Weisner, 2000). Additional inquiry may consider differences in the development and
identification of substance use disorders between the sexes, and explore how these
dynamics influence various aspects of substance abuse treatment: treatment-seeking
behaviors; access and barriers; initiation, engagement, retention, and treatment outcomes
(Green, 2006). Quality and availability of social support as also been implicated in
substance abuse treatment processes (Broome et al., 2002; Dobkin et al., 2002), though
was not thoroughly examined here. Future research in this program may want to explore
the role of social support and social networks within the context of treatment in order to
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incorporate ancillary services that may enhance treatment retention and treatment
outcomes.
Mammo and Weinbaum (1993) note that “systems that by virtue of their design
inadvertently neglect particular groups should be corrected to reflect appropriate and
effective treatment plans for a mix of clients” (p. 101). The dynamic nature of substance
abuse and dependence and the continuous transformation of substance abuse treatment
clientele (i.e., prevalence in certain demographic groups, substance(s) of choice, routes of
administration) call for an ongoing reassessment of treatment participants, treatment
programs, and treatment systems.
Limitations of Present Study
Important limitations should be considered in interpreting the findings of this
study. Firstly, various protocol implementation difficulties interfered with the data
collection process. The timing of new client notification, space constraints, and
inconsistent client attendance at treatment groups affected the assessment team’s ability
to evaluate each new client in the treatment program. In particular, treatment participants
who dropped out of treatment after only a few treatment sessions or had inconsistent
attendance at the outset of treatment posed problems for the assessment team because the
client may not have been available for testing during the window of accessibility.
Consequently, the study sample contained an overrepresentation of treatment completers.
Study participants were more likely to complete treatment, participated in significantly
more treatment groups, and stayed in treatment for a longer period of time than
nonparticipants. The study’s retention rate (59%) was also greater than the retention rate
detected in the population from which it was drawn (49%). Generally speaking, future

210
investigations with substance abuse treatment outpatients should carefully contemplate
the logistics of carrying out the investigation, anticipate potential problems, and work
with the treatment program staff to devise reasonable solutions. More specifically, since
this study was an initial cooperative attempt to create and execute a comprehensive
assessment protocol, additional research within this program can improve upon the
foundation outlined here by addressing the identified logistical concerns.
Although the primary aims of this study were to describe the treatment
characteristics of the current sample and identify differences between those who
completed treatment and those who dropped out, this dichotomy was likely too narrow of
a categorization to adequately encapsulate treatment status. An alternative classification
scheme could consist of the following: completion (i.e., client accomplishes the initially
agreed upon treatment plan or revised treatment plan), dropout (i.e., client leaves
treatment against staff advice or client contact is lost), therapeutic discharge (i.e.,
treatment is discontinued for reasons such as nonadherence with program rules), and
other (i.e., medical or psychiatric hospitalization) (Mammo & Weinbaum, 1993). Of note,
the current study did attempt to expand the dichotomous treatment status, to an extent, by
reporting the incidence of clients who returned to the same treatment program for a
subsequent treatment episode. Of the treatment dropouts, 25% returned for a subsequent
treatment episode (i.e., treatment stopout), while about 19% of treatment completers also
returned for additional treatment at a later date (i.e., treatment repeater). However, no
additional statistical analyses were carried out to determine the distinguishing
characteristics of these subgroups to better describe this sample of substance abuse
treatment participants and ascertain potential elements that impact reengagement in this
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treatment program. Furthermore, the treatment dropout group in this study included both
clients who were expelled from the program due to violation of treatment rules and
clients who stopped attending treatment. As Rabinowitz and Sergio (1998) highlight,
there are likely fundamental differences between these subgroups of dropouts that should
be examined to enhance understanding of the substance abuse treatment dropout
phenomenon.
One variable that was not examined in this study that has been linked to treatment
retention and treatment outcomes, and has become a driving force in contemporary
substance abuse treatment, is third-party reimbursement. The power of managed care
entities to control the type and quantity of substance abuse treatment calls for a more indepth investigation of the impact of insurance coverage on substance abuse treatment
processes. For this particular program, future research should consider insurance carrier
status and respective benefits (i.e., approved number of treatment sessions) when
examining treatment retention and dropout. Moreover, employer referrals, psychiatric
services, and drug-related services may enhance retention among insured populations
(Mertens & Weisner, 2000), thus exploring how available supplementary services can
impact substance abuse treatment may be a worthy area of inquiry. This treatment
program also serves a number of self-pay clients and should consider if the treatment
needs and outcomes of these clients differ from those who utilize insurance benefits.
An additional variable that was virtually neglected in this study that has been
positively linked to treatment entry and retention in previous research is external legal
pressures and sanctions (Green et al., 2002; Hiller, Knight, Broome, & Simpson, 1998;
Hubbard et al., 1989; Joe et al., 1999; Simpson, 1993). Although being prompted to
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complete treatment was an element of the ASI legal composite score, it did not receive
any individual attention in the analyses. The criminal justice system has utilized
substance abuse treatment as part of their efforts to control illicit drug use and reduce
alcohol abuse for much of the past century (Hiller et al., 1998). External pressure from
the criminal justice system may be directly tied to a particular charge or sentence, such as
court-mandated substance abuse treatment as part of a sentence for driving while
intoxicated or a provision of one’s probation or parole. In these instances, violations of
the stipulation would result in a legal ramification such as jail time, thus clients have high
external motivation to complete substance abuse treatment. Alternatively, a client may
seek to be more proactive and complete a substance abuse treatment program in order to
obtain a more lenient sentence in an outstanding legal matter, such as a driving while
intoxicated charge or a drug possession charge (Hiller et al., 1998). In both instances, the
likelihood of entering and completing substance abuse treatment his often enhanced by
the existing pressure from the criminal justice system. Consequent investigations should
examine this variable more closely to better describe the attributes of individuals entering
substance abuse treatment and this factor’s impact on treatment retention.
Finally, not unlike the large majority of existing substance abuse treatment
research, this study employed quantitative methods to answer the research questions of
interest. Within the substance use disorder field, “qualitative techniques have played an
important role in complementing quantitative research by helping to interpret, illuminate,
illustrate, and qualify empirically-determined statistical relationships” (Neale, Allen, &
Coombes, 2005, p. 1591). Researchers have advised that qualitative methods should be
employed both independently and in conjunction with quantitative investigations to
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elucidate factors that facilitate and hinder treatment entry; treatment engagement; lapses
and relapses to substance use during and following treatment; planned and unplanned
treatment termination; and treatment readmission. Further examination of the existing
treatment system in terms of the services provided and their suitability for the populations
served has also been suggested (Battjes, Onken, & Delany, 1999; Neale et al., 2005). A
fitting follow-up to this study could explore the reasons and factors related to remaining
in substance abuse treatment or dropping out, which could potentially validate the
findings from the present investigation and expand the conceptualization of the relatively
elusive phenomenon of substance abuse treatment dropout (Neale et al., 2005).
Conclusion
Despite the limitations outlined above, this study was a successful initial step in
describing the clientele served in the intensive outpatient drug-free chemical dependency
program at Rogers Memorial Hospital. Furthermore, it identified client attributes that
relate to treatment retention, including age, marital status, income, psychological
comorbidity, substance(s) of use, and extent of use. It also delineated subgroups of clients
based on age, negative consequences related to substance use, and ASI composite scores
across medical, employment, alcohol and drug, legal, social, and psychiatric domains.
Identified subgroups appeared to vary along two broad dimensions: degree of functional
impairment and type(s) of substance use. Hopefully, these results will serve as a catalyst
for future investigations within this treatment program as it continues to design,
implement, and evaluate clinically-relevant and empirically-driven assessment
procedures and subsequent interventions aimed at improving treatment retention and
treatment outcomes.
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Appendix A
Marquette University Agreement of Consent for Research Participants
RESEARCH SUBJECT INFORMATION AND SUBJECT CONSENT FORM
Rogers Memorial Hospital, West Allis, WI
Marquette University, Milwaukee, WI
TITLE:

Rogers Memorial Hospital Chemical Dependency Program
Assessment Project, Phase 2

SPONSOR:

Rogers Memorial Hospital,
Center for Addiction and Behavioral Health Research - Marquette
University

PRINCIPAL INVESTIGATOR:

Todd C. Campbell, Ph.D., CADCIII, CCSII

PURPOSE OF STUDY
When I sign this statement, I am giving consent to the following basic considerations:
I understand clearly that the purpose of this study is to evaluate the treatment processes
and treatment outcomes for the Chemical Dependency Program at Rogers Memorial
Hospital-West Allis. I understand that all patients admitted into the Chemical
Dependency Program are required to participate in the standard clinical intake procedure
and that the information obtained is kept in my medical record. The information in the
medical record is utilized by the treatment staff and subject to state and federal
regulations regarding confidentiality. I understand the standard clinical intake Session
will last approximately 2 to 4 hours. I understand that I may be asked to complete several
questionnaires about my age, education level, my alcohol and other drug use history,
health history, mental health history, and perceptions regarding treatment. I understand
that I will be contacted when I am discharged from the Chemical Dependency program
and by telephone or mail at one-month, 3 months, 6 months, and 12 months postdischarge to complete an interview assessment regarding my drug and alcohol use and
progress in my recovery. I understand that these follow-up interviews/assessments will
last approximately 30 minutes. I also understand that this study is ongoing and there will
be approximately 208 participants in this study during any given year.
AUDIOTAPING
Session I and Session II may be audiotaped. The audiotapes will be used to supervise the
research assistants who are conducting the sessions. The research assistants will be
supervised by the primary investigator, Todd C. Campbell, Ph.D. All audiotapes will be
erased utilizing a large magnet designed to fully erase audiotapes after feedback has been
provided by the primary investigator (a process which is expected to take approximately
1-2 weeks following the sessions). The tapes will then be destroyed and thrown away.
Participant Initials _________
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CONFIDENTIALITY
I understand that there are two purposes for collecting the assessment information: 1.
Clinical purposes to inform the treatment team regarding my treatment plan, and 2.
Research purposes to assist in the evaluation of the program’s treatment processes and
outcomes.
I understand that for the clinical purposes the assessment information is contained in my
medical record, is available to appropriate treatment staff, and is protected by all relevant
state and federal regulations pertaining to medical records.
I understand that for the research purposes of this research project, the data from the
standard intake assessment will be copied and the copies will be placed in the research
file. These copies will be de-identified (i.e., my name and other identifying information
will be removed) and assigned an arbitrary code. I understand that if I choose to
participate in this study that all information I reveal in this study will be kept confidential.
Your name will not be publicly disclosed at any time, and the records will be strictly
maintained according to current legal requirements. When the results of the study are
published, I will not be identified by name. I have been promised that any information
obtained from this study that can be identified with me will remain confidential.
However, I am in agreement that scientific data not identifiable with me resulting from
the study may be presented at meetings and published so that the information can be
useful to others. No references to individual participants, or any identifying information
will be released to anyone other than the investigative professionals at Rogers Memorial
Hospital or Marquette University without my express written consent, unless required by
law. I understand that once the data is no longer of use it will be destroyed and will be
held no longer than 7 years.
This applies to the audiotapes of treatment sessions as well as to any written records
obtained. Only authorized study personnel will have access to the session audiotapes and
records. This protection, however, is not absolute. It does not, for example, apply to any
state requirement to report certain communicable diseases. In addition, the investigators
will report certain cases of child or elder abuse to appropriate authorities. Furthermore, if
you indicate that you are in imminent danger of hurting yourself or others, the
investigators may need to reveal this in order to protect you or that person. However, it is
the policy of these agencies and of the investigators that every attempt will be made to
resist demands to release information that identifies you.
RIGHT TO REFUSE OR WITHDRAW FROM THE STUDY
Your participation in this study is voluntary. Thus, you may refuse to participate or
withdraw at any time once the study has started. I have been informed that my decision
about whether or not to participate will not change my present or future relationship with
Rogers Memorial Hospital or the staff of this institution; nor will it change the quantity or
quality of care that is otherwise available to me. If I participate, I understand that I am
free to withdraw at any time without prejudice, and that withdrawal would not in any way
Participant Initials _________
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affect the nature of the care or treatment otherwise available to me. Information collected
on participants who choose to withdraw will remain in the study files.
The primary investigators have the right to stop your participation in the study at any
time. This could be because you have had an unexpected reaction, or have not followed
instructions, or because the entire study has been stopped. Regardless of whether you
choose to withdraw or if your participation in the study is terminated, certain procedures
must be followed in ending your participation in the study in order to protect your safety.
You may be asked questions about any reactions you may have had with this project.
PAYMENTS TO PARTICIPANTS
There are no payments for participation in this study. Should you need further treatment
for alcohol-related problems after leaving Rogers Memorial Hospital, you and your
insurance provider will be responsible for such costs in the same way that you would if
you did not participate in this study.
RISKS
I understand that there are no known risks associated with participation in this study. I
also understand that the only benefit of my participation is to help improve scientific
understanding of the intake assessment process, treatment processes, and treatment
outcomes. I understand that participating in this study is completely voluntary and that I
may stop participating in the study at any time without penalty or loss of benefits to
which I am otherwise entitled. I am not involved in any agreement for this study, whether
written or oral, which includes language that clears Marquette University or its
representatives from liability for negligence, if any, which may arise in the conduct of the
research project.
NEW INFORMATION
Participation in this study could have risks that we cannot anticipate. If new information
is found during the study that might influence your willingness to continue to participate,
we will inform you as soon as possible.
OFFER TO ANSWER QUESTIONS AND CONTACTS FOR INFORMATION
If you have any questions about the general nature of the study, you may contact Dr.
Todd C. Campbell at (414) 288-5889 or Mr. Mickey Gabbert at (414) 327-3000.
INSTITUTIONAL REVIEW BOARD REVIEW:
This project has been reviewed by the Rogers Memorial Hospital Human Subjects
Committee and the Marquette University Institutional Review Board for the Protection of
Human Subjects. All my questions about this study have been answered to my
satisfaction. I understand that if I later have additional questions concerning this project, I
can contact Todd C. Campbell. If you believe that there is any infringement upon your
rights or if you have any questions about your rights as a research subject, you may
contact the Rogers Memorial Hospital Human Subjects Committee at (414) 327-3000
and/or you may contact Marquette University's Office of Research Compliance at 414288-1479. Participant Initials _________
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I, ________________________________________, have read the information provided
above. I voluntarily agree to participate in this study. My signature also indicates that I
have been given a copy of this documented informed consent, and may request an
additional copy at any time. I know that this research has been reviewed by the Rogers
Memorial Hospital Human Subjects Committee and the Marquette University
Institutional Review Board for the Protection of Human Subjects and has been found to
meet the federal, state, and the Rogers Memorial Hospital Human Subjects Committee
and the Marquette University Institutional Review Board for the Protection of Human
Subjects guidelines for the protection of human subjects. Finally, I understand that if the
principal investigator decides it is wise to limit or terminate my participation in the study,
he can do so without my consent.
I agree to have my intake session(s) audiotaped, as described above:
____________________________________________
Signature of Subject or Authorized Representative

______________________
Date

____________________________________________
Signature of Witness

______________________
Date

I have defined and fully explained the study as described herein to the subject.
TYPE OR PRINT:
___________________________________________________________
Name of Principal Investigator or Authorized Representative

TYPE OR PRINT:
___________________________________________
Position Title
____________________________________________
Signature

Participant Initials _________

______________________
Date
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Appendix B

Personal Feedback Report for:
Date Completed:
Client Perception of Problem/Need for Treatment
Medical Employ Alcohol Drug Legal Family Social Psych
A B A B A B A B A B A B A B A B
4
4
4
4
4
4 4 4 4 4 4 4 4 4 4 4
3
3
3
3
3
3 3 3 3 3 3 3 3 3 3 3
2
2
2
2
2
2 2 2 2 2 2 2 2 2 2 2
1
1
1
1
1
1 1 1 1 1 1 1 1 1 1 1
0
0
0
0
0
0 0 0 0 0 0 0 0 0 0 0
Legend:
A= Perceived Problems, B= Desire for Treatment
0=Not all, 1=Slightly, 2=Moderately, 3=Considerably, 4=Extremely
Interview Severity Ratings
Medical Employ Alcohol Drug Legal Family Psych
9
9
9
9
9
9
9
8
8
8
8
8
8
8
7
7
7
7
7
7
7
6
6
6
6
6
6
6
5
5
5
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
0
0
0
0
0
0
0
Legend:
0-1: No Real Problem, 2-3: Slight Problem, 4-5: Moderate Problem, 6-7: Considerable
Problem, 8-9: Extreme Problem
Treatment Problem List
According to the ASI interview, the following are possible problem statements that could
be addressed on the treatment care plan:
Medical:

Legal:

Employment:

Family/Social:

Alcohol/Drug:

Psychiatric:
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Alcohol Use
YOUR DRINKING
Last 90 days: _____ days abstinent
_____ days light drinking (1-4 standard drinks)
_____ days heavy drinking (5+ standard drinks)
Typical week: _____ standard drinks
Your drinking compared to American adults: _________ percentile (same sex)
Estimated BAC level on heaviest drinking day: _________ mg%

Other Drug Use
Percentiles (US Adults)
Your use (days) in last 90
Drug
Tobacco Marijuana Stim./Amph. Cocaine Opiates

Preparation for Change
Socrates Profile
Very Low Low Medium High Very High
Recognition _______
7-26
27-30 31-33 34-35
N/A
Ambivalence ______
4-8
9-13
14-15 16-17
18-20
Taking Steps ______
8-25
26-30 31-33 34-36
37-40
*Alcohol Use:
Socrates Profile
Very Low Low Medium High Very High
Recognition _______
7-26
27-30 31-33 34-35
N/A
Ambivalence ______
4-8
9-13
14-15 16-17
18-20
Taking Steps ______
8-25
26-30 31-33 34-36
37-40
*Drug Use:

Inventory of Drug Use Consequences Scores
Physical

Interpersonal

Intrapersonal

Impulse
Control

Social
Responsibility

Out of 8

Out of 10

Out of 8

Out of 12

Out of 7

Total
Score

Control
Scale*

Out of
Out of 5
45
*This score is separate, and does not contribute to the Total InDUC score. Scores on
Control Scale items may indicate careless or dishonest responding.
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Alcohol Abstinence Efficacy Scale: Temptation to Drink
Negative
Affect

Social/Positive

Physical and Other
Concerns

Cravings and
Urges

Total

0-Not at all

1-Not very

2-Moderately

3-Very

4-Extremely

Alcohol Abstinence Efficacy Scale: Confidence in Ability to Abstain
Negative
Affect

Social/Positive

Physical and Other
Concerns

Cravings and
Urges

Total

0-Not at all

1-Not very

2-Moderately

3-Very

4-Extremely

Diagnostic Criteria Met (Mini International Neuropsychiatric Interview)
DSM-IV-TR Axis I:
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________

Client Strengths
1.

2.

3.

Components of Interview or Results Processed with Client (i.e. percentiles, peak BAC):

Overall Impression of Client:

